Cyclic variation of the common carotid artery structure in relation to prior atherosclerotic burden and physical activity by Caviezel, Seraina
  
 
Cyclic variation of the common carotid artery 
structure in relation to prior atherosclerotic burden 
and physical activity 
 
 
Inauguraldissertation 
 
zur 
Erlangung der Würde eines Dr. sc. med. 
vorgelegt der 
Medizinischen Fakultät 
der Universität Basel 
 
 
 
von 
Seraina Caviezel 
aus Siat, Kanton Graubünden, Schweiz 
Basel, 2015 
 
 
 
 
 
Original document stored on the publication server of the University of Basel 
edoc.unibas.ch 
 
 
This work is licensed under the agreement  
„Attribution Non-Commercial No Derivatives – 3.0 Switzerland“ (CC BY-NC-ND 3.0 CH).  
The complete text may be reviewed here: 
creativecommons.org/licenses/by-nc-nd/3.0/ch/deed.en 
  
 
 
Genehmigt von der Medizinischen Fakultät 
 
auf Antrag von 
Fakultätsverantwortlicher  Prof. Dr. med. Arno Schmidt-Trucksäss 
Dissertationsleitung  Prof. Dr. med. Arno Schmidt-Trucksäss 
Korreferent    Prof. Dr. med. Nino Künzli  
Externer Experte   Prof. Dr. med. Giuseppe Schillaci 
 
  
 
Basel, den 23.03.2015 
Dekan 
Prof. Dr. med. Christoph Beglinger 
  
Figures and Tables 
  
 
 
   
3 
 
 
Table of contents 
 
 
 
Figures and Tables 4 
 
Acknowledgments 6 
 
Summary 8 
 
Common abbreviations 10 
 
CHAPTER 1 – Introduction 11 
 
CHAPTER 2 – PhD research objectives 27 
 
CHAPTER 3 – SAPALDIA 30 
 
CHAPTER 4 – Publication 1 34 
Carotid intima-media thickness as a biomarker of subclinical atherosclerosis  
 
CHAPTER 5 – Publication 2 50 
An automated, interactive analysis system for ultrasound sequences of the 
common carotid artery  
 
CHAPTER 6 – Publication 3 67 
Variability and reproducibility of carotid structural and functional parameters 
assessed with transcutaneous ultrasound – results from the SAPALDIA Cohort 
Study  
 
CHAPTER 7 – Publication 4 85 
Sex-specific associations of cardiovascular risk factors with carotid stiffness – 
results from the SAPALDIA Cohort Study  
 
CHAPTER 8 – Publication 5 111 
Carotid stiffness and physical activity in elderly – results from the SAPALDIA 3 
Cohort Study  
 
CHAPTER 9 – Synthesis, discussion and perspectives   127 
 
APPENDIX  
Contribution to the PhD project 157 
Figures and Tables 
  
 
 
   
4 
 
 
Figures and Tables 
 
 
 
FIGURES 
Figure 2.1:  Direct pathways of major cardiovascular risk factors and carotid stiffness 18 
Figure 2.2:  Main pathways between major carotid stiffness risk factors 19 
Figure 4.1:  Ultrasound image 39 
Figure 4.2:  Carotid plaque formation 39 
Figure 4.3: Potential implementation of CIMT-measurements in the daily clinical practice 44 
Figure 5.1:  Artery interfaces 54 
Figure 5.2:  Examples of original common carotid artery sequences with bounding boxes and sample 
detection 55 
Figure 5.3:  Bland-Altman plots for inter-reader variability for for completely automatic (CA) and 
manual and automatic (MA) datasets at evaluation time T1 (reader R1 vs. reader R2) 59 
Figure 5.4: Bland-Altman plots for intra-reader variability for completely automatic (CA) and manual 
and automatic (MA) data of reader R1 (time T1 vs. time T2) 59 
Figure 5.5:  Virtual M-mode showing the results of automatic vs. completely manual tracing 61 
Figure 5.6:  Examples for lumen diameter (LD) and intima media thickness values (CIMT) for both 
readers and evaluation times over a heart cycle 62 
Figure 6.1: Participation and feasibility flow chart 70 
Figure 6.2:  Ultrasound images of the common carotid artery 71 
Figure 6.3:  Bland-Altman plots of functional parameters at two ultrasound examinations (T1, T2) with 
mean difference as thin black line and limits of agreement as bold black lines 76 
Figure 7.1:  Analytic sample - flow chart of subject inclusion 89 
Figure 7.2:  Sex-specific associations of single cardiovascular risk factors (per 1 SD) for each carotid 
stiffness parameter (log-transformed). Women = grey line, men = black line 94 
Figure 7.3:  Association patterns of cardiovascular risk factors (per 1 SD) and six carotid stiffness 
parameters (log-transformed) separately for men and women 98 
Figure 8.1:  Flow chart of subject inclusion 114 
Figure 8.2: Box plots of carotid distensibility values and amount of moderate and vigorous physical 
activity (PA) for both sexes across three 10-year age categories 117 
Figure 8.3:  Pathway analyses based on the Directed Acyclic Graph (DAG) of vigorous physical activity 
(PA) and distensibility using standardised betas 121 
Figure 9.1: Illustrational diagram of the 95% confidence area for the intraclass correlation coefficients 
(ICC) of structural and functional parameters 131 
Figure 9.2:  Modified circular adaption of the common carotid artery (McEniery & Wilkinson, 2013) 139 
 
  
Figures and Tables 
  
 
 
   
5 
TABLES 
Table 4.1:  Prospective studies about the prediction of cardiovascular events via CIMT-measurement 
in subjects without manifest cardiovascular atherosclerotic disease 38 
Table 4.2:  Potential clinical implementation of CIMT-measurements with respective suggestions of 
therapy 45 
Table 5.1:  Descriptive statistics for for completely automatic (CA) and manual and automatic (MA) 
clips at evaluation time T1 58 
Table 5.2:  Bland-Altman statistics for inter-reader variability for completely automatic (CA) and 
manual and automatic (MA) quality clips for observation times T1 and T2 58 
Table 5.3: Bland-Altman statistics for intra-reader variability (R1 vs. R2) for completely automatic 
(CA) and manual and automatic (MA) clips 60 
Table 5.4: Bland-Altman statistics for inter-reader variability for completely manually (CM) evaluated 
data for evaluation times T1 and T2 60 
Table 5.5:  Bland-Altman statistics for inter-method variability (CA/MA vs. CM) 61 
Table 6.1:  Structural and functional parameters based on a 1 cm detection segment 73 
Table 6.2:  Descriptive characteristics of study population with number (N), mean value and standard 
deviation (SD) and the p-value for the difference of the two examinations (T1, T2) 74 
Table 6.3:  Mean ICC and mean CV with 95% confidence interval (CI) and percent variation explained 
by the factors study subject, sonographer, reader and residuals 75 
Table 6.4:  Overview of structural and functional reproducibility within population based studies 79 
Table 7.1:  Characteristics of study population with respect to cardiovascular risk factors assessed in 
SAPALDIA 2 and carotid stiffness and hemodynamic parameters assessed in SAPALDIA 3, 
for men and women 92 
Table 7.2:  Significance of the associations of single cardiovascular risk factors (per unit) across all six 
carotid stiffness parameters (log-transformed) separately for men, women and for the 
respective sex differences 92 
Table 7.3:  Ranges of association estimates of cardiovascular risk factors on carotid stiffness 
parameters for different models 97 
S-Table 7.4:  Formulas of carotid stiffness parameters based on a one centimetre detection segment 103 
S-Table 7.5:  Sex-specific associations of cardiovascular risk factors (per unit) with six CS parameters for 
men, women and for the respective sex differences 103 
S-Table 7.6:  Sex-specific associations of cardiovascular risk factors (per 1 SD) with six CS parameters for 
men, women and for the respective sex differences 107 
S-Table 7.7:  Significance of heterogeneity in the associations of single cardiovascular risk factors (per 1 
SD) across all six CS parameters (log-transformed) separately for men, women 110 
Table 8.1:  Characteristics of the study population by sex described by numbers (N) and percentages 
(%), mean value and standard deviation (SD) or median and interquartile range (p25, p75) 115 
Table 8.2:  Estimates of associations between different PA determinants and carotid distensibility 
adjusted for different covariates 119 
Table A:  Appendix - Contribution to the PhD project 157 
  
Acknowledgments 
  
 
 
   
6 
 
 
Acknowledgments 
 
 
 
First of all, it is my considerable pleasure to express my deepest gratitude to everyone who 
contributed to the development and finalisation of this dissertation.  
I am very grateful to my supervisor and member of the PhD committee Prof. Dr. med. Arno 
Schmidt-Trucksäss who gave me the opportunity to work on my PhD thesis at the 
Department of Sport, Exercise and Health. We had numerous lively discussions resulting in a 
pleasant collaboration. You gave me room for an individual scientific development and 
concurrently, you supported me whenever I needed your expertise despite your tight 
schedule. I really appreciated your support and your trust in me throughout the whole PhD 
study time. 
Prof. Dr. med Arno Schmidt-Trucksäss was not only my supervisor; he was also a member of 
the PhD committee with Prof. Dr. med. Nino Künzli. Our annual PhD meetings regarding the 
progress report were very constructive, enabled my process and provided me an optimal 
working environment. Thank you very much. 
I am especially thankful to the members of the SAPALDIA CIMT Working Group for the 
extensive assistance and feedbacks of all PhD related research projects in many different 
ways. Your inputs were highly valued: Dr. Julia Dratva, Simon Endes, Dr. Eric de Groot, Prof. 
Dr. med Nino Künzli, Prof. Dr. Nicole Probst-Hensch, Emmanuel Schaffner, PD Dr. Christian 
Schindler and Prof. Dr. med. Arno-Schmidt-Trucksäss 
A smoothly data transfer with subsequent analysis would not have been possible without 
the expertise of the biostatistics and computational science team. I wish to express special 
thanks to Dr. Manfred Baumstark, Emmanuel Schaffner, Michael Tarantino, Dirk Keidel, Prof. 
Dr. Alexandra Teynor, and PD Dr. Christian Schindler. 
Overall, this present PhD thesis was undertaken within the framework of the Department of 
Sport, Exercise and Health at the University of Basel in cooperation with the Swiss Tropical 
and Public Health Institute in Basel and the Swiss Cohort Study on Air Pollution and Lung and 
Heart Diseases In Adults (SAPALDIA). This study could not have been done without the help 
of the SAPALDIA participants and the whole medical teams, field workers and SAPALDIA 
researchers. SAPALDIA was supported by the Swiss National Science Foundations (grants no 
33CSCO-134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 
3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, PMPDP3_129021/1, 
PMPDP3_141671/1), the Federal Office for Forest, Environment and Landscape, the Federal 
Acknowledgments 
  
 
 
   
7 
Office of Public Health, the Federal Office of Roads and Transport, the canton's government 
of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Valais, and Zürich, the Swiss Lung 
League, the canton's Lung League of Basel Stadt/ Basel Landschaft, Geneva, Ticino, Valais, 
Graubünden and Zurich, Stiftung ehemals Bündner Heilstätten, SUVA, Freiwillige 
Akademische Gesellschaft, UBS Wealth Foundation, Talecris Biotherapeutics GmbH, Abbott 
Diagnostics, European Commission 018996 (GABRIEL), Wellcome Trust WT 084703MA.  
During the first two years of my PhD, I had the chance to meet the members of the Reading 
Center Team namely Livia Grüter, Claudia Mang, Gil Meyer, Phillip Pauli, Yves Schaffner, 
Mirjam Schneider, Renate Wyss, Dominique Würth and Felix Zimmermann. We analysed 
together thousands upon thousands of single ultrasound images and were in close 
collaboration with Prof. Dr. Alexandra Teynor who developed the analysis program. We 
appreciated the fast improvement in terms of new features and usability of the program. I 
am sure we will never forget the fancy colours of our analysing system. A very grateful thank 
goes to PD Dr. Henner Hanssen who trained the SAPALDIA sonographer which was highly 
important for the quality assurance. I would say out of a regular working relationship of 
SAPALDIA Reading Center members established a lasting friendship. Thank you very much 
for this wonderful time and I’m looking forward to see you soon, at latest at the next “Basler 
Herbstmesse”.  
Many thanks go to all the former and present colleagues at the Department of Sport, 
Exercise and Health. Amongst others: My heartfelt thanks go to Dr. Ursina Meyer, Dr. Iris 
Bänteli-Niederer and Dr. Flavia Bürgi for sharing your PhD experience with me. Furthermore, 
I would like to thank Monique Nussbaumer, Stefanie Müller, Simon Endes, Yanlei Li, Claudia 
Mang and Dr. Juliane Schäfer for the various critical discussions in all stages of my PhD. I 
appreciated it very much that you were completely honest in work- and personal-related 
questions. 
During my PhD I had the opportunity to enhance my statistical and methodological skills by 
visiting educational courses and presenting our data at different conferences. This would not 
have been possible without the good organisations and financial support of the Swiss School 
of Public Health (SSPH+). Thanks to Dr. Sina Henrichs and Prof. Dr. med. Charlotte Braun-
Fahrländer who organised and managed this high level academic training program in public 
health research. Moreover, I gratefully acknowledge the additional financial support for 
conferences from the “Reisefond für den akademischen Nachwuchs der Universität Basel”.  
I am also very grateful to Monique Nussbaumer, Anja Rossmeissel, Sofie Hansen, Dr. 
Inmaculada Aguilera and Dr. Juliane Schäfer for the at least partial proofreading of this 
dissertation. 
Last but not least, my deepest thanks go to my family, my best friends and especially to 
Simon Fry for their untiring dedication, enormous patience and motivation at all stages of 
my life.  
 Summary 
 
 
 
   
8 
 
 
Summary 
 
 
 
Background and aims 
Cardiovascular disease (CVD) accounts for the most deaths of non-communicable diseases 
worldwide. It begins with structural and functional changes of the arterial system commonly 
known as the atherosclerotic process, starting asymptomatically in early childhood, adapting 
arterial structure and function with advancing age depending on genetic and environmental 
exposures and finally resulting in CVD events such as myocardial infarction or stroke. CVD 
risk prediction today is generally based on risk scores, but substantial disadvantages occur 
since they account only for specific risk factors at one time point. Carotid structure and 
function (also called carotid stiffness) parameters measured by ultrasound may overcome 
this disadvantage, since they can provide information on structural and elastic carotid 
properties and reflect therefore vascular damage accumulated over time.  
Thus, the aims of this thesis were to summarise the state of the arte of ultrasound 
measurements, to validate the new developed ultrasound analysis system, to assess the 
variability and reproducibility within the study sample and to investigate the long- and short-
term associations of cardiovascular risk factors and carotid stiffness with main focus on 
physical activity in elderly participants of the SAPALDIA cohort.  
  
Methods 
The SAPALDIA cohort study is an ongoing multicentre study with a population-based random 
sample of adults from eight rural and urban areas started in 1991 (SAPALDIA 1), with a first 
follow-up in 2001-2003 (SAPALDIA 2) and a second follow-up in 2010-2011 (SAPALDIA 3).  In 
SAPALDIA 3, sequential B-mode ultrasound images of the common carotid artery were 
examined in 3489 participants (51% women) aged between 50-81 years at the time of 
examination. Expert readers analysed these ultrasound images with a new analysis system 
called DYARA (DYnamic ARtery Analysis) according to the state of the art assessed in the 
review. Thereof, carotid structure parameters were measured and carotid stiffness indices 
were derived considering blood pressure at time of ultrasound assessment. Validation of the 
ultrasound analysis program DYARA and reproducibility of carotid parameters were 
performed in subgroup within the SAPALDIA 3 survey. The presented studies within this 
thesis comprise cardiovascular risk factor data from the first and second follow-up and 
therefore, long- and short-term associations with carotid stiffness could be investigated.  
 Summary 
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Results 
The intra- and inter-reader results of the validation study were highly consistent with slightly 
higher bias for analyses with manual interactions compared to the automatic detection. 
Among the carotid structure parameters, average values across heart cycle showed lower 
variability than single images in diastole and systole, whereby the relative difference was 
smaller in lumen diameter values compared to the carotid intima media thickness (CIMT). 
Based on different statistical approaches, reproducibility values within SAPALDIA 3 were 
consistently good to excellent for carotid structure and function indices. Findings 
additionally revealed that subjects itself were the greatest source of variability between two 
measurements.  
Multivariate regression analyses suggested that most single cardiovascular risk factors in 
SAPALDIA 2 were long-termly associated with increased carotid stiffness in SAPALDIA 3 except 
physical activity and high-density lipoprotein cholesterol (HDL-C). HDL-C was the only protective 
vascular determinant and no relation was observed for physical activity. Most carotid stiffness 
parameters were similar strong associated within each cardiovascular risk factor (except 
compliance showed main deviances among several risk factors). Estimating sex-specific 
associations of atherosclerotic risk factors and carotid stiffness indicated that increased 
heart rate was more strongly associated with stiffer arteries across all carotid stiffness 
parameters in men than in women. Low-density lipoprotein cholesterol (LDL-C) was 
significantly associated with carotid stiffness only in men and triglyceride only in women.  
Multifactorial pathway analyses of cardiovascular risk factors in SAPALDIA 3 showed that age 
was the strongest predictor of carotid stiffness, followed by mean arterial blood pressure 
and heart rate. Age strongly confounded the association of physical activity and carotid 
stiffness in multiple regression analyses and therefore, only an univariate association of 
physical activity and carotid stiffness could be observed.  
 
Conclusion 
DYARA tackles the challenge of being able to analyse varying ultrasound image qualities with 
high precision. The high reproducibility and the feasible application in a large sample size 
suggest that this program can be recommended for epidemiological research, diagnostics 
and clinical practice. Long- and short-term cardiovascular exposures have added important 
information to the overall vascular damage assessed by carotid stiffness for both sexes. 
Although age was the strongest predictor, sex-differences in long-term associations may 
indicate a certain differentiated susceptibility to cardiovascular risk factors among men and 
women, which should be investigated in more detail.  
The presented studies within this thesis provide an important basis towards future 
investigations targeting the early and late consequences of atherosclerosis, its progression 
and possible implementations of preventive and/or personalised interventions.  
 Common abbreviations 
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Common abbreviations 
 
 
 
BMI Body mass index 
BP Blood pressure 
CCA Common carotid artery 
CI Confidence interval 
CIMT Carotid intima media thickness  
CRP  C-reactive protein 
CV Coefficient of variation 
CVD Cardiovascular disease 
DAG Directed acyclic graph 
DYARA DYnamic ARtery Analysis 
HDL-C High-density lipoprotein cholesterol 
ICC Intraclass correlation coefficient 
LD Lumen diameter 
LDL-C Low-density lipoprotein cholesterol 
NO Nitric oxide 
PA  Physical activity 
SAPALDIA Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults 
SD Standard deviation 
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INTRODUCTION 
Already Thomas Sydenham (1624-1689) – an English Physician and medical doctor – stated: 
“A man is as old as his arteries” [1]. Four centuries later, arterial research is still of scientific 
interest, not only due to more refined investigational techniques [2,3], but also due to an 
increased burden of cardiovascular disease (CVD) [4,5]. CVD is the general term for a 
systemic disease based on atherosclerotic processes starting asymptomatically in early 
childhood, adapting arterial structure and function with advancing age depending on genetic 
and environmental exposures and finally resulting in CVD events such as myocardial 
infarction or stroke [6,7]. Overall, CVD accounts for the most deaths of non-communicable 
diseases worldwide [4] and the prevalence increased especially in developing countries 
during the last few decades while in high-income countries a steady state could be 
maintained [5,4,7]. However, although primary and secondary prevention may have 
prolonged a life free of CVD or reduced CVD symptoms, life expectancy is assumed to 
increase resulting in a population with a higher proportion of elderly people and thus a 
higher CVD prevalence is expected [4,5,7].  
As CVD reduction and cardiovascular health promotion remain a major public health issue 
[8], it is essential to gain further knowledge on vascular health, which may help to identify 
people in an early state of the vascular changing process [7]. Moreover, this might provide a 
solid basis for an early implementation of effective prevention strategies to reverse or at 
least postpone this process aiming to deliver significant cardiovascular health gains. Thus, 
this thesis focuses on classical cardiovascular risk factors and their relations to arterial 
structure and function of the common carotid artery (CCA) in elderly people free of CVD 
based on a new sophisticated and validated ultrasound analysis technique.  
 
THE DISEASE OF THE ARTERIAL SYSTEM 
‘Arteriosclerosis’ should not be confused with ‘atherosclerosis’, although the terms are often 
used interchangeably describing the disease of the arteries [1]. ‘Arteriosclerosis’ (also called 
‘senile arteriosclerosis’) reflects the generalised stiffening and hardening progression of the 
arterial system with advancing age while ‘atherosclerosis’ (also called ‘nodular 
arteriosclerosis’) is a specific form of arteriosclerosis defined by a local degenerative process 
of the artery wall structure in medium to large sized arteries [1,9]. 
 
Anatomical background of large arteries 
Large arteries are closely located to the heart (e.g. aorta or CCA) and consist of elastic 
properties to buffer the pulsating blood pressure (BP) from ventricular ejection fraction 
[1,9,10]. The arterial wall structure is composed of three main zones: the tunica intima, the 
tunica media and the tunica adventitia [10]. The intima is the inner layer of the artery 
consisting of a single stratum of vascular endothelium and the internal elastic lamina, which 
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separates histologically the intima from the media [10]. The media composes smooth muscle 
cells, elastin and collagen fibres and lies between the intimal and the adventitial boundary 
[10]. The adventitia is the outer layer of the artery consisting of fibroblasts and fibrocytes 
surrounded by connective tissue [10].  
 
Basic mechanisms of vascular remodelling  
When looking at the basic mechanisms of vascular remodelling, a differentiation between 
arteriosclerosis and atherosclerosis is needed. Arteriosclerosis is mainly a disease of the 
medial layer [1]. The degeneration of elastin fibres in the media structure due to tiring 
effects of cyclic stress is accompanied by an increase in collagenous material and a 
disorganisation of elastin patterns [10–12]. Overall, investigation of normal vascular ageing 
are challenging since it is difficult to distinguish between a normal ageing process and other 
affecting diseases such as atherosclerosis or hypertension [1]. Thus, studies investigating the 
arterial system are often based on assessments of atherosclerotic changes.  
While arteriosclerosis is mainly a systemic disease, atherosclerotic wall alterations are 
predominantly locally placed and reflect the thickening of the intimal layer [10]. The 
underlying mechanism are based on accumulation of lipid, inflammatory cells and their 
waste products, calcium deposits and collagen fibres [10,13,14]. In addition, smooth muscle 
cells shift from the media to the intima and proliferate resulting in a narrowing of luminal 
area [10,13,14]. Within the arterial system, wall changes and plaque development are more 
likely located in arterial segments with low wall shear stress and turbulent blood flow such 
as the bifurcation of the CCA since the endothelium as first inner boundary is especially 
exposed to mechanical stress such as BP and other chemical signals [15–20]. As both low 
wall shear stress and turbulent blood flow affect endothelial cells and their function, this 
plays also a major role for vascular tone and lumen diameter (LD) regulation [1,6,19]. Intact 
endothelial cells modulate not only vascular homeostasis by realising vasoconstrictor 
(endothelin-1, angiotensin II) and vasodilator (nitric oxide (NO), prostacyclin) factors, it also 
protectively regulates inflammation, cellular and platelet adhesion and proliferation of 
smooth muscle cells [6,18,19]. If endothelial function is impaired (endothelial dysfunction) 
anti-atherosclerotic protection is diminished and bioavailability of NO is reduced based on a 
lower metabolism of endothelial NO synthase (eNOS) [6,18,19].  
Overall, vascular remodelling of the intimal and medial layer affects the arterial structure 
and function [11]. Determination of these changes provides an insight into the 
cardiovascular system and might improve evaluation of CVD risk assessment [21–23].  
  
 1 | Introduction 
 
 
 
14 
ESTIMATION OF CARDIOVASCULAR DISEASE RISK  
Understanding the impact of different risk factors on CVD burden is essential to assess the 
CVD risk [24]. This is even more important for the implementation of preventive treatment 
aiming to reduce the CVD risk. However, comparisons of general evidence based 
recommendations of CVD prevention and real applications in clinical practice indicate a 
persistent gap between the theory and the reality [25]. Risk prevention in daily clinical 
practice is usually based on treatment of established classical CVD risk factors implemented 
in middle old to older individuals at high risk [7]. However, the burden of untreated risk 
factors remained quite constant across decades [26]. For a long-term population strategy, a 
stricter and earlier treatment allocation of people even at low risk may delay CVD, improve 
quality of life and prevent CVD events [7,25]. Hence, identifying and classifying individuals at 
risk and apply the respective treatment may result in substantial population-based health 
benefit and is a main goal of CVD prevention, CVD risk prediction and also for promotion of 
cardiovascular health [7,8,27,28]. 
 
Classical cardiovascular risk factors 
Estimation of CVD risk is commonly based on established risk scores such as Framingham, 
PROCAM, HEART or ASCVD based on specific combinations of classical CVD risk factors such 
as age, sex, dyslipidaemia, hypertension, diabetes mellitus and smoking [29–31]. Single CVD 
risk factors are acknowledged to be associated with CVD morbidity and mortality [32–37]. 
But it is also recognised that multiple risk factors are able to interact with each other and 
lead to an increased CVD risk compared to an optimal risk factor profile [26].  
Overall, risk score systems are generally well accepted by clinicians and patients due to a 
cost-effective application and a relatively simple interpretation connected with an applied 
medication management of classical CVD risk factors [38]. However, risk scores have also 
substantial disadvantages since they account only for specific risk factors and disregard 
other important exposures or modifiers such as metabolic syndrome, lifestyle or novel CVD 
risk factors such as endothelial function [30]. Moreover, the unfavourable load of risk factors 
can change over time and since risk score systems estimate the risk only at one time point, it 
does not reflect risk factor burden longitudinally [39]. Vascular biomarkers may overcome 
this disadvantage since the overall structural and functional vascular changes reflect the 
accumulated arterial damage of a multifactorial lifetime exposure [31,39,40]. 
 
Vascular biomarkers  
The terminologies of vascular biomarkers are partially confusing [41]. While structural 
parameters refer to the arterial anatomy, functional indices describe in general the elasticity 
or vice versa the stiffness of the arterial structure [23,41]. Arterial stiffness is defined as the 
reduced ability of the arterial structure to adapt to pressure changes [1], but also other 
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terms are interchangeably used for arterial stiffness such as distensibility or compliance 
[23,41]. Depending on the measured arterial segment, arterial stiffness indices give 
information about the systemic or local arterial stiffness [41].  
Among non-invasively determined biomarkers of arterial stiffness, carotid-femoral pulse 
wave velocity is the gold-standard measurement of systemic arterial stiffness [2]. Systematic 
reviews and meta-analyses showed that pulse wave velocity is a strong predictor for CVD 
events and all-cause mortality and improves risk prediction and classification beyond 
established risk factors [42,43]. However, pulse wave velocity and other systemic measures 
(e.g. brachial ankle index) only extrapolate the vascular properties over a known distance of 
the arterial tree although elastic properties vary among different arterial segments [2,44]. 
Thus, local arterial assessments have the advantage to directly evaluate structural properties 
and their haemodynamic effects of a particular arterial section [2]. The cylindrical anatomy 
of the CCA, its size and the superficial location to the skin make high-resolution ultrasound 
observation of wall and diameter change upon adaptation to pulsating BP feasible [1].  
 
Structural parameters of the common carotid artery 
Several studies investigated the CVD risk prediction based on subclinical adaptions of the 
arterial wall structure and plaque occurrence mostly in the CCA assessed by non-invasive 
and widely available ultrasound [45–48]. Since ultrasound analyses are not able to measure 
the single layers, the thickness of the intima-media complex is assessed to measure the 
atherosclerotic change. Carotid intima-media thickness (CIMT) is defined as the distance 
between the leading edges of the lumen-intima and the media-adventitia interfaces of the 
far arterial wall and it is now an established subclinical biomarker for early atherosclerotic 
progression and prediction of the CVD risk [45–48]. Importantly to mention is, that an 
increased CIMT has to be distinguished from plaque formation since plaques are always of 
pathological nature while an increased CIMT addresses the preclinical atherosclerotic stage 
[49]. A CIMT above 1.5mm or a luminal narrowing of more than 50% from the surrounding 
tissue is defined as plaque [49]. Hence, for interpretation of preclinical atherosclerotic 
structure and function of the CCA, plaques were excluded in this thesis.  
Besides CIMT, several authors observed an enlargement of the LD with increasing CIMT 
underlying the mechanism of compensating and preserving the lumen area [50–52]. The 
outer LD is defined as the distance between the interface of the media-adventitia of the near 
wall and the media-adventitia interface of the arterial far wall [1]. Although the relationship 
between both CIMT and LD is dependent, it has been shown that the presence of a higher 
CIMT and an equivalent enlargement of the LD more precisely classifies an atherosclerotic 
high-risk phenotype [53]. But also increased LD alone predicts independently CVD events 
and mortality risk [54,55]. Moreover, it is positively associated with increased BP, left 
ventricular hypertrophy based on mechanical respond mechanisms [56–58] and several 
other risk factors such as body mass index (BMI) or smoking [58–60]. As the absolute size of 
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LD is strongly dependent on body composition (age, sex, height) [52,61] and hemodynamic 
influences (BP, heart rate or stroke volume) [57], studies focused more on relative 
dilatations (change of systolic LD and diastolic LD) or dilatation curves (relative change in 
CIMT and LD across heart cycles in time) together with BP values representing the vascular 
function (also called functional parameters, carotid stiffness or local arterial stiffness) [62]. 
 
Functional parameters of the common carotid artery 
While there is evidence based on several researches that carotid-femoral pulse wave 
velocity is an intermediate outcome and predictor of CVD events and mortality [42,43], 
carotid stiffness is less often examined and it is still under discussion [55,63–70]. In contrast 
to pulse wave velocity, some researchers are still struggling with the preconception that a 
high degree of technical expertise is needed to investigate carotid stiffness using ultrasound, 
even though structural parameters of the CCA are well established and functional 
parameters are based on structural indices [2]. In addition, the technical application 
developed tremendously fast in the last two decades resulting in qualitatively high-
resolution ultrasound systems with increased image acquisition speed and integrated 
automatic image analyses programs, which are now widely available [71–77].  
As a basis for high quality and comparability of research, the expert consensus of the general 
arterial stiffness covered already to some extent the methodological issues for local arterial 
assessments [2]. However, a specific guideline for carotid stiffness determination is needed. 
In summary, the most important methodological study criteria for ultrasound assessments 
[78] and other vascular devices [2] are: the description of the measured arterial segment; 
the standardisation of examinations, methods and devices; the report of measurement and 
data validation including description of validation study sample; the exact description of the 
used arterial stiffness parameter; the use of brachial or central BP for arterial stiffness 
calculation, the investigated subjects and the outcome or covariate of interest.  
Returning to the estimation of CVD risk by carotid stiffness, some studies indicated an 
association of carotid stiffness and CVD events and/or mortality [63–66] while others did not 
[55,67–70]. Considering the above mentioned methodological study criterions, all 
predictability studies measured carotid stiffness near the bifurcation of the CCA and used 
standardised examination methods and reported the respective reproducibility of carotid 
stiffness parameters (strain [65–69], distensibility [55,63–70], compliance [55,64,66–69], 
beta-stiffness index [66–69], Peterson’s elastic modulus [66,67], Young’s elastic modulus 
[63,64,66–69], for a detailed description inclusive calculation of these parameters see also 
chapter 6). However, comparability of results is aggravated since some studies were based 
on small sample sizes [55,63,65], investigated specified subjects [55,63,65,67] and carotid 
stiffness parameters were based on brachial BP [55,63–68,70] or central pulse pressure 
measures [64,69].  
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Nevertheless, the most recently published study – investigating the predictability of carotid 
stiffness and CVD events in a population-based study sample – tried to overcome the 
mentioned concerns and addressed for the first time the issue of carotid stiffness based on 
different BP measures [64]. They reported independent associations of carotid stiffness and 
incidence of CVD events and all-cause mortality beyond traditional CVD risk factors and 
documented that carotid stiffness based on brachial BP (compared to central BP) is an 
accurate measure in an elderly population [64]. Thus, there is some indication that carotid 
stiffness might be a predictor of CVD events and mortality in the general population [64].  
 
TRIGGERS OF VASCULAR HEALTH 
Vascular remodelling in all sections of the arterial wall is a consequence of adaption due to 
mechanical- and biochemical-induced stress aiming to preserve a homeostasis (e.g. constant 
condition of blood supply) as long as possible [11]. Among the triggers of vascular changes, 
age plays a pivotal role herein [79]. On one hand, age is an element of the normal 
generalised age-dependent process within the arterial system (arteriosclerosis) [80]. On the 
other hand, age is determined as a CVD risk factor and reflects a certain possible exposure 
time to other risk factors [80]. There is clear evidence that carotid stiffness increases with 
age [11,39,61,62,80,81]. The whole concept of ‘vascular ageing’ is defined by vascular 
changes based on a ‘normal vascular ageing’ process and ‘early vascular ageing’ (EVA) 
[39,81]. EVA is the consequence of premature structural and functional changes in the 
arterial system due to an early exposition of risk factors [39,80,81].  
 
Association of cardiovascular risk factors and carotid stiffness 
The sources of EVA are multifactorial [7]. Beside inevitable expositions (such as genetic 
predisposition, ethnicity, age or sex), the effect of EVA is intensified by an unfavourable 
lifestyle behaviour and other modifiable risk factors [20,39,82]. The direct pathways of major 
cardiovascular risk factors and carotid stiffness are presented in figure 1.1. Blood pressure 
(systolic BP, diastolic BP, mean arterial pressure, hypertension) is a major direct mechanical 
stress on vascular structure and it is associated with increased carotid stiffness [69,83–89]. 
However, it is not yet clear whether hypertension or increased stiffness occurs first [85]. 
Besides BP, previous studies have shown that increased carotid stiffness was partially 
independently associated with heart rate [90,91], body composition (height, weight, body 
mass index, waist circumference, skinfold thickness, obesity or adiposity) [69,88,89,92–95], 
lipids and inflammatory markers (C-reactive protein (CRP), total cholesterol, triglyceride, 
low-density lipoprotein cholesterol (LDL-C) or low values of high-density lipoprotein 
cholesterol (HDL-C)) [69,87,89,94–97], diabetes mellitus (insulin, insulin resistance or plasma 
glucose) [87,94,98–101], smoking [89,94,102] and physical inactivity (or contrarily, physical 
activity (PA) was associated with reduced carotid stiffness) [103–111].  
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Figure 1.1: Direct pathways of major cardiovascular risk factors and carotid stiffness 
 
Carotid stiffness increased with increasing number of cardiovascular risk factors [40]. A 
further familiar clustering of cardiovascular risk factors is known as the metabolic syndrome 
[112]. Metabolic syndrome is diagnosed if three or more of the following five risk factors are 
fulfilled: elevated waist circumference, triglycerides, BP, fasting glucose and reduced HDL-C 
[112]. Similar as before, individuals with diagnosed metabolic syndrome [89,95,100,101] and 
a cluster of at least three metabolic syndrome risk factors [95] were independently 
associated with stiffer carotid arteries. Although the prevalence of metabolic syndrome did 
not differ by sex [101], a significant increase of carotid stiffness with increasing number of 
metabolic syndrome risk factors was observed in women, but not in men [89] suggesting 
certain sex-specific differences in associations between risk factors and carotid stiffness. 
Indeed, former studies already reported sex- and age-related cardiovascular morbidity, 
mortality risk and vascular remodelling [61,113–116]. But so far, only little research has been 
devoted to the topic of sex-specific associations between different cardiovascular risk factors 
and carotid stiffness indices, which might be of importance for a better CVD risk 
stratification.  
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Risk factor pathways and carotid stiffness  
The observed adverse effects in the carotid function based on the burden of cardiovascular 
risk factors seem to be dose dependent although the respective impact vary between risk 
factors [40,89,95]. This might suggest that increased carotid stiffness is a consequence of a 
complex interrelation between different risk factors on vascular remodelling mechanisms 
[95]. For a deeper understanding of the complex vascular relationships, it is therefore 
necessary to reflect the different pathways between the major risk factors of carotid 
stiffness (see figure 1.2). 
BP is not only a strong independent carotid stiffness modifier; it acts also as an important 
mediator since BP is affected by various pathways (age, sex, body composition, heart rate, 
PA, smoking) [117–123]. In addition, similar known multifactorial influences exist also for 
heart rate [120–123], body composition [123–126], lipids and inflammatory markers 
[123,127–129], smoking [130,131] and blood glucose [114,132–134]. Depending on the 
research question, some of the mentioned risk factors are also confounders. Per definition, a 
confounder variable affects both, the dependent outcome variable (here carotid stiffness) 
and the independent exposure (carotid stiffness risk factor) [135]. Thus, major confounders 
visible in figure 1.1 and figure 1.2 are sex, age and PA, since they possibly affect both, carotid 
stiffness as well as single risk factors (please see also chapter 8).  
 
 
 
Figure 1.2: Main pathways between major carotid stiffness risk factors   
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Physical activity and the cardiovascular system 
Inactivity or low physical activity PA are nowadays acknowledged cardiovascular risk factors 
which causes about 6-10% of the non-communicable diseases [136] and contributes majorly 
to the global burden of disease [24]. Avoiding inactive behaviour and being only 15 min per 
day physically active can significantly reduce all-cause mortality whereby the health gains 
were curvilinear [137]. This dose-response effect regarding the amount of PA has also been 
shown for CVD risk reduction with greatest health gains for those who were previously 
barely active [138]. Even stronger benefits were yielded after PA or exercise training with 
higher intensity [139]. Therefore, actual PA guidelines recommend a minimum amount of 
150 min per week of moderate intensity or 75 min per week of vigorous PA or a combination 
of moderate and vigorous intensity (20 min of moderate intensity corresponds to 10 min of 
vigorous intensity) to improve health outcomes [140,141]. 
Physical activity plays a special role in the multifarious relationship between the different 
cardiovascular risk factors since it promotes evidence-based cardiovascular health benefits 
by several pathways (see figure 1.2). It has been shown that PA favourably modulates BP 
values, heart rate parameters, body composition, lipid profile and smoking behaviour 
[123,131,132]. Therefore, mechanisms through which risk factor may influence carotid 
stiffness are various and PA or exercise training has been discovered and promoted for 
primary and secondary CVD prevention [142].  
Mostly smaller studies investigated the effect of PA on carotid stiffness specified groups 
considering highly trained versus untrained individuals [103–111]. Their results suggest a 
certain dose-dependent effect of PA on reduction of carotid stiffness [103–111]. However, 
the only study including a representative sample indicated only in a sub analysis a weak 
association between vigorous PA and carotid stiffness [143]. Thus, it is unclear whether 
these findings can be generalised. In addition, we noticed that divergent associations of 
different carotid stiffness parameters with different health outcomes within one study have 
been reported e.g. for CVD risk, mortality or PA [64,66–69,104,107]. It is assumed that all 
carotid stiffness parameters (strain, distensibility, compliance, beta-stiffness index, 
Petersons elastic modulus, Young’s elastic modulus) yield the same prediction based on the 
shared pathophysiological mechanisms (e.g. BP and vascular diameter), but up to date, this 
has never been tested (please see also chapter 7).  
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PHD RESEARCH OBJECTIVES 
Summarising the previously mentioned gaps of knowledge on which research objectives of 
the publications were based, the aims of this thesis were:  
 
Background of study aim 1: Manual measurements of carotid intima media thickness (CIMT) 
are nowadays widely replaced by sophisticated ultrasound analyses programs, which are 
able to analyse carotid structure across heart cycle. This allows the investigation of carotid 
function, also known as functional parameters or carotid stiffness. However, since carotid 
stiffness is based on structural parameters, a review about carotid structure assessments, 
validations results and possible predictability of cardiovascular disease (CVD) risk assessment 
provides a solid basis for further research (Chapter 4, Swiss Med Wkly. 2012;142:w13705). 
Aim 1: To describe the anatomical and histological background of artery wall structure; to 
summarise standardisations of ultrasound examinations and analysis using different 
measurement methods; to report measurement-variability; to describe normal values of 
CIMT and link it to CIMT progression based on cardiovascular risk factors; to review whether 
a supplemental implementation of CIMT measurements, compared to validated 
cardiovascular risk assessments, would enhance the power of discrimination between 
healthy and pathological values; and how the latter one could be implemented in clinical 
practice. 
  
Background of study aim 2: As described in our review, automatic ultrasound programs 
showed the highest reproducibility. However, there is no gold standard for analysing 
ultrasound images. A major point of criticism on automatic programs is that misdetection by 
the program due to insufficient ultrasound data had to be discarded from the evaluation. 
The development of a novel analysis program called DYnamic ARtery Analysis (DYARA) 
solved this deficit but it had to be validated (Chapter 5, Ultrasound Med Biol. 2012 
Aug;38(8):1440-50).  
Aim 2: To describe the detection algorithm of DYARA; to assess the inter-reader and intra-
reader variability for sequential images based on completely automatic detection and 
combined manual and automatic detection; to make the complete validation dataset freely 
available upon request for an easy comparison of further validation studies. 
 
Background of study aim 3: In order to investigate and validate not only the ultrasound 
program but also the SAPALDIA ultrasound data quality, a validation study considering 
different structural and functional carotid parameters had to be executed within a 
subsample of SAPALDIA study population and within the same study setting (Chapter 6, 
Atherosclerosis. 2013 Dec;231(2):448–55). 
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Aim 3: To investigate the SAPALDIA ultrasound data quality; to describe the SAPALDIA 
ultrasound study sample, the ultrasound examination and the respective sequential image 
analysis, definitions of carotid structural (CIMT, lumen diameter) and the carotid functional 
indices (strain, distensibility, compliance, β-stiffness index, Peterson’s elastic modulus and 
Young’s elastic modulus); to investigate the variability and reproducibility of carotid 
structural and functional parameters by means of repeated ultrasound scans using different 
statistical approaches; and to compare our findings of structural and functional 
reproducibility with other different population based studies.  
 
Background of study aim 4: Even though it has been reported that incidence of 
cardiovascular morbidity and mortality is sex- and age-related, it has never been 
investigated whether carotid stiffness parameters (a discussed biomarker for CVD) are sex-
specifically associated with cardiovascular risk factors. In addition, it is also unknown 
whether all carotid stiffness parameters provide similar association patterns (Chapter 7, 
Atherosclerosis 2014 Jun;235(2):576-84) . 
Aim 4: To examine the associations of cardiovascular risk factors with six different carotid 
stiffness parameters separately for men and women, using multivariate regression analyses 
to deal with multiple comparison issues; to investigate whether sex differences in these 
associations exist; and to assess the heterogeneity of these association patterns among all 
six carotid stiffness parameters.  
 
Background of study aim 5: Although regular physical activity (PA) has been shown to 
reduce CVD risk in the general population, reduction in carotid stiffness was only found 
comparing extreme groups of highly trained vs. untrained subjects. However, it is unclear 
whether these associations remain if considering a representative sample (Publication 5, 
submitted to PLOS ONE). 
Aim 5: To determine whether moderate, vigorous or total PA are associated with reduced 
carotid stiffness adjusting for main cardiovascular risk factors; to describe pathway 
associations of PA, cardiovascular risk factors and carotid stiffness based on prior assumed 
effect directions. 
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SAPALDIA – The Swiss Cohort Study on Air Pollution and Lung and Heart 
Diseases in Adults 
This thesis is implemented in the ‘Swiss Cohort Study on Air Pollution and Lung and Heart 
Diseases in Adults’ (SAPALDIA) and focuses on the cyclic variation of the common carotid 
structure in relation to prior atherosclerotic burden and physical activity (PA). To better 
understand the study development and cohort participants, a short summary of the Swiss 
demography and the main SAPALDIA aims, results and methodology are given in the 
following pages. 
 
Swiss demography - background  
In the last century, the Swiss population has more than doubled and the age composition 
fundamentally changed [1]. While in 1900, 40.7% of the overall population were under 20 
years, 5.8% older than 64 years and 0.5% older than 80 years the actual distributions in 2009 
changed radically to 21.0%, 16.9% and 4.8%, respectively [1]. The ageing population is a 
consequence of the industrial and medical development combined with a certain economic 
wealth, which raises life expectancy by a simultaneous decrease in birth rate [1]. Thus, it is 
not surprising that, within an ageing population, chronic diseases based on age-related 
changes occur more frequently with advancing age, although these diseases may manifest in 
earlier life stages due to unfavourable lifestyle [2]. In Switzerland, cardiovascular diseases 
(CVD) are the leading cause of death since more than 20 years, followed closely by cancer 
and at some distance by respiratory diseases, which is still a major public health issue [3].  
 
SAPALDIA - background 
Given the described demographical background, the first SAPALDIA examination (SAPALDIA 
1) was initiated in 1991 with a primary focus on respiratory health outcomes, allergies and 
air pollution exposure [4]. SAPALDIA is a multicentre cohort study based on a random 
sample of 9651 adults (18-60 years at first examination) from eight different Swiss 
communities (Aarau, Basel, Davos, Genève, Lugano, Montana, Payerne, Wald) representing 
a wide range of cultural and environmental conditions across Switzerland [4]. Based on the 
scientific findings obtained in SAPALDIA 1, the Swiss Federal Council implemented air 
pollution emission limits in their air pollution control guidelines [5], which contributed to the 
scientific evidence revised by the World Health Organization (WHO) for the publication of 
the Air Quality Guidelines in 2006 [6].  
In the first follow-up survey (SAPALDIA 2) in 2001-2003, 8047 participants (83% of 
participants in SAPALDIA 1) underwent a new examination. The research focus was extended 
to cardiovascular health, with special focuses (besides air pollution) on sex and gender-
related risk factors, second-hand tobacco smoke exposure and genetic and molecular issues 
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[7]. Methodological details of cross-sectional and longitudinal investigations in SAPALDIA 1 
and SAPALDIA 2 are described elsewhere [4,7]. Main results of SAPALDIA 2 attracted 
worldwide attention since they showed for the first time that reducing exposure to air 
pollutants, even from low levels, could attenuate the normal age-related decline in lung 
function in the general adulthood [5,8]. Among other results, exposure to nitrogen dioxide 
was associated with reduced heart rate variability in elderly women and adults with CVD, 
suggesting a relation between air pollutant and cardiac dysfunction [9,10]. A list of all 
SAPALDIA publications can be found on the SAPALDIA website [11]. 
 
SAPALDIA 3 
SAPALDIA 3 was the second follow-up survey performed in 2010-2011 focusing again on air 
pollution, cardiovascular health with special attention to systemic inflammation and chronic 
diseases in particular to asthma, COPD (chronic obstructive pulmonary disease) and 
atherosclerosis [5]. The new generated SAPALDIA database, combining three examinations 
over 20 years in a uniform format, is an optimal basis for current and future investigations. 
In addition, the follow-up rate between SAPALDIA 1 and SAPALDIA 3 among survivors was 
about 68%, which shows a high level of commitment to the study. 
 
SAPALDIA 3 – ultrasound data 
Within SAPALDIA 3, new measurements of arterial vessels health state were performed. 
Among all vascular measurements, arterial structure and function of the common carotid 
artery was of particular interest for this dissertation. Therefore, ultrasound examinations 
were performed in 3489 SAPALDIA participants aged 50 years and older within the same 
eight Swiss regions using standardised ultrasound instruments (UF-870 machine LA385-16 
MHz array transducer, Fukuda Denshi, Japan) [12,13]. Medical staff was trained and 
certificated prior to the study [12,13]. Participants were bilaterally examined (ear to ear and 
horizontal scans) in supine position after a rest of at least 10 minutes with rotated neck 
standardised by a 45° foam wedge [12,13]. Ultrasound scans were transferred to the Swiss 
Tropical and Public Health Institute mirrored to the Department of Sport, Exercise and 
Health and offline analysed by the full automatic ultrasound analysis program called 
DYnamic ARtery Analysis (DYARA) [12,13]. Therefore, expert readers analysed carotid 
structure directly proximal of the carotid bifurcation over exactly on centimetre across at 
least one heart cycle and intimal and adventitial layer of for wall and adventitia layer of the 
near wall [12,13]. Results were automatically saved in a local database and at the end of the 
study uploaded to the official SAPALDIA database. The detailed description of ultrasound 
assessment and analyses, DYARA validation and SAPALDIA ultrasound data validation can be 
found in chapter 5 and chapter 6 [12,13]. 
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CAROTID INTIMA-MEDIA THICKNESS AS A BIOMARKER OF SUBCLINICAL 
ATHEROSCLEROSIS  
 
Abstract 
Intima-media thickness of the carotid artery (CIMT) and its increase is associated with 
several cardiovascular risk factors and manifest cardiovascular diseases (CVD). CIMT is 
suggested to be an important biomarker of subclinical atherosclerosis. CIMT is measured in 
B-mode ultrasound images of the carotid tree as a typical double line of the arterial wall. 
CIMT is best visible in the measurement segment of the distal common carotid artery (CCA) 
with lowest measurement variability. The measurement is most reliable over a one 
centimeter-segment with automatic or semiautomatic reading methods, which minimizes 
reading errors. Further structured training of sonographer and reader is important for valid 
and reproducible results. CIMT is an accepted predictor for future cardiovascular events 
independent of age, gender and cardiovascular risk factors. Measurement seems to be best 
applicable in patients with intermediate risk in order to readjust cardiovascular risk. Plaques 
in the carotid tree and thickening of the CIMT are different atherosclerotic processes. From 
childhood to early adulthood CIMT is the only atherosclerotic marker of the carotid tree; 
plaques occur later in life. Both parameters contribute independently to risk assessment for 
future cardio-vascular events.  
Aims of this review are to outline measurement procedures, reproducibility, prognostic 
value and ability to discriminate healthy subject and patients with manifest disease in a 
practical and scientifically contemporary manner.  
Key words: carotid intima-media thickness; B-mode sonography; subclinical atherosclerosis; 
cardiovascular prevention 
 
Introduction 
Carotid intima-media thickness (CIMT), recorded with B-mode sonography, is an important 
marker to quantify atherosclerotic burden in the common carotid artery (CCA). The last 
twenty years, the value of CIMT-measurement for risk estimation of atherosclerotic events 
(for e.g. myocardial infarction, stroke, sudden cardiac death) increased more than ever.  
Aim of the present review article is to 1) present anatomical and histological background of 
the vessel wall structure, 2) introduce the history of CIMT-imaging, to demonstrate 3) 
aspects of reproducibility, 4) prospective value in regard to cardiovascular endpoints and 
medical treatment, 5) the power of discrimination between healthy and pathological values, 
6) the additional benefit of CIMT-measurement compared to established cardiovascular risk 
stratification algorithms, and 7) its implementation in the daily clinical practice.  
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Anatomy and Histology 
The right CCA has its source in the Truncus brachiocephalicus, while the left CCA originates 
from the aortic arch. In its cervical course the CCA is medial located, slightly behind the 
internal jugular vein [1]. The carotid bifurcation (CB) into the internal (ICA) and external 
carotid artery (ECA) is located at the level of the 4th cervical vertebra [1]. The carotid artery 
has a superficial course, so that ultrasound examinations usually can be performed without 
bigger problems. In some cases the variability of the location of the carotid bulb makes the 
identification of the ICA and ECA somewhat difficult.  
The histological mural structure of the CCA is composed of three layers:  
1) Intima (Tunica intima): inner layer; monolayer of endothelial cells; between Tunica 
intima and Tunica media: internal elastic lamina 
2) Media (Tunica media): mainly composed of longitudinal smooth muscle cells, 
surrounded by connective tissue; containing elastic lamella that provides elastic 
property of vessels 
3) Adventitia (Tunica externa / adventitia): outer layer; generally embedded in the 
circumjacent tissue 
 
Histopathology 
Atherosclerosis is a systemic and chronic inflammatory disease, which may cause CVD, the 
most frequent cause of death in the world [2]. A long term thesis in the development of 
atherosclerosis was the “response-to-injury” theory [3], in which a physical injury of 
endothelium was considered to be responsible for atherosclerotic changes of vessel walls. 
This view was completed the last three decades, since endothelial dysfunction has been 
considered to be a functional trigger [4,5]. Briefly, the infiltration of low-density lipoprotein 
cholesterol (LDL-C) through the endothelium, LDL-deposition in the intima and the following 
oxidative and enzymatic processes has been described [6]. Hence, the intima-media complex 
of arterial walls plays an essential role in the pathogenesis of atherosclerosis and may reflect 
different stages in the development of the disease: a hypertensive hypertrophic response of 
medial cells can be observed in early phases of atherosclerosis (quantified by CIMT-
measurement), while carotid plaque formation are often seen in later stages of 
atherosclerosis, which may be caused by inflammation, oxidation, endothelial dysfunction, 
and/or smooth muscle cell proliferation [7]. An increased CIMT is typically seen at the CCA, 
while carotid plaque formations are more frequent at the carotid bulb (CB) or internal 
carotid artery (ICA). Plaque formation at the CB or ICA are more associated with 
hyperlipidaemia and MI, while an increased CIMT at the CCA shows a stronger relationship 
to hypertension and stroke [8].  
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History of CIMT-measurements 
Already in the 1980s Pignoli et al. could demonstrate a highly significant association between 
histological findings of the CCA and respective ultrasound examinations [9]. Since then, 
associations between CIMT and a) traditional and non-traditional cardiovascular risk factors, 
b) the extent and severity of atherosclerosis c) as well as cardio- and cerebrovascular events 
(outcome) had been examined and described in different studies ([4-6]; table 4.1). Regarding 
cardiovascular risk factors, an increased age has the most impact on an increased CIMT: 
depending on different studies, age may explain 50-80% of the variability for an increased 
CIMT. It has been described an annual increase of CIMT in the CCA about 0,007mm [10], 
with a nearby 5 years delay in women compared to men of the same age. 
 
Methods exposure 
B-mode sonography of the carotid artery is a safe, cheap, quick and painless examination, 
free of radiation exposure to the patient and enables a detailed evaluation of different 
regions of the carotid artery. Currently, B-mode sonography of the carotid artery mainly 
allows a noninvasive visualization and assessment of arterial wall changes via measurement 
and quantification of a) CIMT and b) carotid plaque formation: 
a) CIMT is defined as the viewable distance between the lumen-intima- and the media- 
adventitia interface (see figure 4.1)  
b) Carotid plaque formation differ from CIMT (as defined) by an increase of CIMT about 
at least 0,5 mm or an increase about 50% compared the adjacent CIMT as well as an 
increase of thickness about more than 1,5 mm [17].  
Another possibility is to regard CIMT as a continuous distance that also integrates 
those vessel regions in CIMT-measurements that are defined as “plaque formation”. In 
those cases CIMT is defined as mean CIMT in CCA or the mean maximum CIMT in the 
CCA, the CB and / or the ICA [18]. 
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Author Study Partici- pants Age Follow-up Endpoints 
Region of 
interest Risk estimation Comment 
Chambless 
et al. 1997 
[11] 
ARIC 12841 45 - 64 years 4-7 years 
fatal and non-
fatal 
cardiovascular 
events 
CCA, 
CB,ICA 
for CIMT  > 1 vs. < 1 mm, HR adjusted for Diabetes, HDL-, LDL-
cholesterol, hypertension, smoking status,  study center, age and 
race 1.18 (1.06–1.32) in men and 1.42 (1.24-1.64) in women  
CIMT = mean 
CIMT from 6 
different 
segments 
O’Leary  
et al. 1999 
[12] 
CHS 4.476 
72.5 years 
(mean age 
at 
beginning 
of the 
study) 
6.2 years  
(median) 
myocardial 
infarction, stroke, 
combination 
CCA, ICA 
RR-combined endpoint (adjusted for age, gender, blood pressure 
(sys, dia), smoking (pack years), Diabetes, atrial fibrillation) for max. 
CIMT CCA: 2.22 (1.58-3.13) for >1.18 mm (highest) vs. <0.87 mm 
(lowest CIMT-quintile);  2.47 (1.59–3.85) for >1.81 mm (highest) vs. 
<0.90 mm (lowest CIMT-quintile)   
Primary 
measurement 
value: max. CIMT  
Iglesias del 
Sol et al. 
2002 [13] 
Rotterdam 1.721 >  55 years 
4.6 years 
(mean 
age) 
cardio- or 
cerebro-vascular 
disease  
CCA, CB, 
ICA 
RR 1.41 (95% CI, 1.25-1.82) for stroke and 1.43 (95% CI,  1.16-1.78) 
for myocardial infarction 
Primary 
measurement 
value: max. 
CIMT; separated 
for different 
segments 
Lorenz et 
al. 2006 
[14] 
CAPS 5.056 
19–90 
years; 
mean age 
50.1 years 
4.2 years 
(mean 
age) 
myocardial 
infarction, stroke, 
combined 
endpoint 
CCA, CB, 
ICA 
HR (adjusted for risk factors) for CIMT-CCA > 0.79mm vs.  
< 0.63 mm 1.85  (1.09–3.15), for CIMT-CB > 0.79mm vs. < 0.63 mm 
1.27 (0.80–1.99), for CIMT-ICA > 0.79mm vs. < 0.63 mm 1.25 (0.84–
1.86) for combined endpoint 
mean CIMT; far 
wall  
*Nambi et 
al. 2010 
[15] 
ARIC 13.145 45 - 64 years 
15.1 years 
(mean 
age) 
fatal and  
non-fatal  
cardiovascular 
events, 
revascularisation  
CCA, CB, 
ICA 
men: CIMT increased AUC from 0.674 (only risk factors) up to 0.690 
(95% CI for difference of the adjusted AUC: 0.009 - 0.022) 
women: CIMT increased AUC from 0.759 (only risk factors) up to 
0.762 (95% CI for difference of the adjusted AUC: - 0.002 - 0.006) 
CIMT = mean 
CIMT from 6 
different 
segments 
Plichart et 
al. 2011 
[16] 
Three-City 5.895 
65-85 
years; 
mean age 
73.3  years 
5.4 years 
(mean 
age) 
new diagnosed 
coronary heart 
disease, fatal 
cardiovascular 
event 
CCA HR 5. vs. 1. quintile = 0.8; 95% CI = 0.5–1.2; p for trend < 0.48) (adjusted for risk factors) 
mean CIMT; far 
wall; plaque-free 
segment  
 
Table 4.1: Prospective studies about the prediction of cardiovascular events via CIMT-measurement in subjects without manifest cardiovascular atherosclerotic disease 
Hazard Ratio, RR = Relative Risk, CCA = common carotid artery, CB = carotid bifurcation, ICA = internal carotid artery), * = follow-up [11]. 
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Figure 4.1: Ultrasound image 
Ultrasound image of the common carotid (longitudinal axis) with tracing lines of automatic contour-detection 
at the lumen-intima and the media-adventitia interface. Outer lumen diameter in the common carotid artery in 
B-mode (left) over two heart cycles and with M-mode (right) generated by 180 single images of a this clip. The 
mean CIMT at the far wall was 0.87 mm.  
 
 
 
 
Figure 4.2: Carotid plaque formation 
Echolucent carotid plaque formation at the near wall of the right common carotid artery (male study 
participant of the population-based Heinz Nixdorf Recall study) [19]. 
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Proposals for a standardized preparation and performance of carotid ultrasound 
examinations  
 
a) Preparation 
1. Dimly lit room 
2. Room temperature 22-25°C 
3. Lying position 
4. Examination position: end-of-heading; with neck extended 
5. ECG-electrodes (control of heart cycles) [20] 
6. Standardized head-position (45°-50°-position to the right / left)  
7. Minimum requirements transducer: ultrasound frequencies 5-15 MHz (better: 10 
MHz linear ultrasound transducer); appropriate depth of focus 
8. Refresh rate: ≥25 Hz (minimal compression) 
9. Gain: ~ 60 dB  
 
b) Performance 
1. Sequential-based records over 3-4 heart cycles (longitudinal axis) 
2. optimal image-adjustment: visualizing the double line pattern of the carotid artery 
(near and far wall of the CCA) 
3. Record of at least three fixed images (longitudinal axis)  
à Optimal: vertical dipping ultrasound-rays (artery in horizontal focus) 
4. end-diastolic records of images /sequences (see “Preparation”) 
5. Image-acquisition: ICA and ECA 
· Using Pulse waved Doppler to distinguish between ICA and ECA 
· ICA: greater caliber than ECA 
· ICA: no extracranial vessel branches (ECA: supine thyroid artery) 
6. Sequential-based record of the vessel diameter (detection plaque formation) 
à Record of carotid plaque formation (longitudinal and transversal) 
 
An ultrasound arc (see “Meijer-Arc”) can be used for longitudinal-records in anterior, middle 
and posterior position.  
 
 
Different methods of CIMT-measurements 
Originally, CIMT-measurements were performed via a manual method that could be 
integrated in ultrasound systems or per additional acquired software. However, the last few 
years it could be demonstrated that this method is associated with a higher reader-
subjectivity compared to automatic or semiautomatic (automatic + manual correction) 
measurement software [21].  
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These can be implemented in the ultrasound system or can base a) on an image-analysis 
(contour-detection) (Figure 4.1) or b) on the analysis of radiofrequency signals. The 
radiofrequency - analysis is performed with single images or continuously over more heart 
cycles. It has been shown that sequentially-based CIMT-measurement contributes to an 
improved differentiation between subjects with and without coronary heart disease, 
compared to the analysis of a single image (AUC for mean CIMT 0.82 [95% CI 0.68 – 0.94] 
versus 0.64 [95% CI 0.55 – 0.80]) [22].  
CIMT-measurement is possible in different segments of the carotid artery: in the CCA, CIMT 
is measured automatically over a distance about 1 cm [23]. Further vessel segments, like the 
ICA and ECA or CB are commonly only depictable over a limited distance. Therefore, 
maximum CIMT is measured in these segments. Up to now, the different measurement-
localizations and –methods resulted in inconsistent CIMT-protocols. The limited 
standardization is the vulnerable weakness of this non-imaging method. Per 
electrocardiogram it is possible to standardize the CIMT-measurement during a complete 
heart cycle (R-wave) which is especially important in single images, because CIMT may vary 
between 5-10% during a heartbeat. Regarding the R-wave in the electrocardiogram, the 
wave represents the end-diastolic moment – the moment of the thickest CIMT [20,24]. 
Utilization of Meijer`s carotid arc is a further instrument to optimize reproducibility of CIMT-
measurements over specific carotid segments and time. This semicircle is divided into 30° 
angles one after another (30°, 60°, 90°, 120°, …) and was used in different studies (e.g. 
METEOR study) to optimize data acquisition [25]. 
 
Reproducibility 
Measurement-variability of CIMT depends on the carotid segment that is examined. The 
intraobserver variability of maximum CIMT in the CCA was found to be 0.14±0.16 mm and 
0.13±011 mm for mean CIMT. The interobserver variability is reported to be slightly higher 
(0.20±0.26 mm and 0.18±0.24 mm, respectively) [26]. In repetitive CIMT-measurements of 
the CCA the absolute mean difference in the CCA was only 20-25% of ICA or the CB 
(0.11±0.08 mm vs. 0.60 up to 0.66 mm) [27]. Due to the speckle pattern caused by the 
differences of acoustic impedance between wall components the near wall of the CCA and 
CB have a slightly higher CIMT-variability compared to the far wall [28]. 
Compared to CB (76 up to 96%) and ICA (54 up to 81%) the CCA can be depicted in nearby all 
patients (94 up to 99%). This applies also for the far wall compared to near wall (CCA 97% vs. 
88%, CB 87% vs. 80% and ICA 76 vs. 49%) [29,30]. Additionally, anatomic conditions and 
especially the experience of the reader influence the visibility considerably.  
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Normal CIMT-values 
Classification of CIMT-values in healthy and pathological values varies considerable, 
depending on the CIMT measurement protocol. Therefore, conclusions from measured CIMT 
must be drawn, by consideration of the underlying protocol. Every reader should pay 
attention that the same measurement value in two different studies may be considered as 
normal on one and as pathologic on the other hand.  
Nowadays, there are two main possibilities for the evaluation of CIMT-values: the utilization 
of a) fixed cut-off values or b) percentile-distribution. For fixed cut-off values, a prognostic 
value for prediction of future cardiovascular events has been established [11,16,31].  
Fixed CIMT-values ≥1mm were described in the literature, however, such high values are not 
achieved in different studies which can be explained by in- or exclusion of plaque formation 
(see also page 3) [10,32,33]. The differences in observations have resulted in the utilization 
of percentile-distributions [34]. Both, fixed cut-off- and percentile values have been 
previously and base on different measurement protocols. [35]. Like other markers of 
subclinical atherosclerosis (e.g. coronary artery calcium, ankle brachial index), CIMT 
increases with an increased age [10]. In contrast to other well-known cardiovascular risk 
factors, normal and pathological values differ over the years. Hence, it is reasonable to 
provide gender- and age-depending CIMT-values in consideration of the CIMT-protocol. 
Generally, Stein et al. provided very detailed information about gender- and aged-stratified 
CIMT-values in different international studies and the respective measured carotid segments 
[35]. In order to simplify these values, Jäger et al. developed an equation for calculating an 
individual CIMT threshold value (mm) from calculations of average CIMT as a function of age: 
Decade of life/10+ 0.2mm [36]. CIMT-based percentile-values are supplied on the homepage 
of the Heinz Nixdorf Recall study for a general population between 45- and 75 years [19].  
 
CIMT-Progression 
CIMT-progression has been examined in different studies and depends on included regions 
of CIMT-measurement [10,37]. Recently, Lorenz et al. included n=36.984 participants from 
16 different studies in a meta-analysis to investigate CIMT-progression as a predictor of 
cardiovascular events: the association remained unproven [38].However, due to well-known 
histopathological mechanisms in the intima-media complex (see above) and calculated 
cardiovascular risks being associated with an increased CIMT, the question of CIMT-
interference via medical treatment raised up the last decade. Therefore, in many studies 
CIMT-regression and –progression, induced by medical treatment of lipid metabolism, were 
conducted. It could be demonstrated that 40-mg dose of rosuvastatin significantly decreased 
maximum CIMT-progression over 12 carotid segments (common carotid, carotid bulb, 
internal carotid) in middle-aged individuals [37]. Based on these METEOR-results, the 
predictive value of CIMT-measurement as a detection and monitoring tool in subjects with 
low Framingham risk score was shown [37]. The effect of other different LDL-lowering 
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therapies on the regression of CIMT could be proven in different studies [39–41]. 
Furthermore, in some studies the association between different statins and CIMT-regression 
were examined [42,43]. CIMT-measurement, used as a monitoring tool in lipid-lowering 
studies, suffered a practical test and passed it, when Kastelein et al. examined the “null-
effect” of LDL-C: a combined therapy with ezetimibe and simvastatin did not result in a 
significant difference in changes in intima-media thickness, as compared with simvastatin 
alone [44]. Despite many comments in public, Brown et al. pointed out, that different 
preconditions led to the observed results [45]. 
 
Benefit of CIMT-measurements in addition to traditional and established cardiovascular 
risk stratification algorithms 
Actual cardiovascular risk stratification relies on risk calculations that base on the inclusion 
of different traditional and established risk factors (e.g. Framingham Risk Score, European 
HEART Score). However, the solely utilization of these risk scores is afflicted with different 
problems. There is a variation in risk estimation in different populations [46], different 
endpoints in risk algorithms are evaluated (e.g. coronary morbidity, CV-mortality), many 
important lifestyle and other risk factors are not included in stratification algorithms [47], 
and cross-sectional risk assessment does not account for variation in risk factor exposure.  
Up today, risk factors are used to classify cardiovascular risk in low, intermediate and high 
risk. Subjects with a low risk are recommended to modify risk factors, while high-risk 
subjects receive a medical therapy. The management for subjects with an intermediate risk 
is unsettled. These persons are recommended for further risk assessment including new 
markers of a subclinical atherosclerosis (for example CIMT-measurement). However, the 
value of CIMT-measurement in the cardiovascular risk stratification is still under debate.  
For reclassification of cardiovascular risk via CIMT-measurement (according the Framingham 
Risk Score), the investigators of the Atherosclerosis Risk in Communities Study (ARIC-Study) 
provided data about 13.145 subjects (mean observation: 15.1 years) that were observed 
with regard to the onset of acute myocardial infarction, coronary death and cardiovascular 
revascularization [15]. A total of 16.7% subjects with intermediate risk (5-20% 10-year risk) 
could be reclassified.  
Using CIMT- and carotid plaque-measurement in all carotid segments, a total of 9.9% 
subjects could be reclassified. In subjects with an intermediate risk (5-20%), 12.4% persons 
were reclassified in the low risk group and 10.8% in the high risk group. The number of 
reclassification was considerably lower in the Carotid Atherosclerosis Progression Study 
(CAPS-Study) (5.3%) [48]. However, in this study cardiovascular risk has been evaluated 
according the European Heart Score that calculate fatal cardiovascular events as the 
outcome [48]. So the data are not comparable with each other. 
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For subjects with a 10-year risk for cardiovascular events of 6-20%, the American Heart 
Association (AHA) finds CIMT-measurements reasonable. Hence, CIMT-measurement is one 
of the few biomarker that is attributed to the class IIa / level of evidence B. However, a 
suitable technical equipment and profound course of instruction and experience of the 
reader are conditions to keep up a high quality of the measurement method [49].  
Whether an increased CIMT is able to support correct clinical decision making and lead to 
specified anti-atherosclerotic therapy has not been investigated in meaningful endpoint-
studies until today. Additionally, appropriate clinical guidelines, with inclusion of CIMT-
measurements in the treatment of patients as well as proof of cost-effectiveness are still 
missing.  
 
Possible implementation of CIMT-measurements in the daily clinical practice, based on a 
combination of ASE-, AHA- and SHAPE-Task Force-recommendations 
 
 
 
 
 
Figure 4.3: Potential implementation of CIMT-measurements in the daily clinical practice 
General recommendation of SHAPE-Task Force [8]  
 
 
  
Measurement 
Evaluation: 
CIMT-measurement 
more aggressive therapy in subjects with several moderate distinctive risk factors (for e.g. according 
general recommendations of the SHAPE-Task Force based on CIMT- and plaque-measurements). 
- in asymptomatic subjects >45 years 
- for further risk estimation regarding the prediction of cardiovascular events in subjects with an 
intermediate cardiovascular risk according the Framingham Risk Score (FRS) about 6-20% 
without manifest atherosclerotic disease or Diabetes mellitus and special risk constellations, 
like 
a) family history of premature cardiovascular events in a first-degree relative (men <55 
years; women <65 years) 
b) severe abnormalities in a single risk factor in subjects <60 years, who otherwise would 
not qualify for medical therapy 
c) women <60 years with at least 2 atherosclerotic CVD risk factors 
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Table 4.2: Potential clinical implementation of CIMT-measurements with respective suggestions of therapy 
 
 
  CIMT 
Carotid plaque 
formation Therapy LDL-C 
moderate high 
risk 
<1mm and 50.-75. 
Pctl. no plaque lifestyle modification 
<130mg/dl (<3.37 
mmol/l) 
high risk ≥1mm or >75. Pctl. <50% stenosis agressive lifestyle modification 
<100mg/dl (<2.59 
mmol/l) 
very high risk ≥1mm or >75. Pctl.  ≥50% stenosis 
agressive lifestyle 
modification 
<70mg/dl (<1.82 mmol/l) 
myocardial ischemic test 
 
Lifestyle modification = lifestyle modifications and a LDL-C target of <130 mg/dl (<3.37 mmol/l); targeting to 
<100 mg/dl (<2.59 mmol/l) is optional. 
Aggressive Lifestyle modification = lifestyle modifications and a LDL-C target of <100 mg/dl (<2.59 mmol/l); 
targeting to <70 mg/dl (<1.82 mmol/l) is optional.  
 
Quantification of carotid plaque formation or CIMT-measurement 
Embedding carotid plaque formation in CIMT-measurements is debatable, since they are 
reported to be different biological and genetic atherosclerotic phenotypes [50]. It is certain 
that plaque formation is always pathologic. In a meta-analysis about 11 population-based 
studies (n=54.336 subjects) carotid plaque formation had a significantly higher diagnostic 
precision in the prediction of myocardial infarction compared to an increased CIMT (AUC 
0.64 vs. 0.61) [51]. The additive inclusion of plaque formation in CIMT-measurements may 
improve risk prediction of coronary heart disease [15].  
The last three decades, quantification and evaluation of carotid plaque formation changed 
remarkable. In addition to cursory assessments like degree of stenosis and echogenicity, 
other distinctive features were used to investigate carotid plaques. The most common used 
criteria for plaque investigation are echogenicity (echolucent, echogenic, mixed 
echogenicity), echogenic distribution pattern (homogeneous versus inhomogeneous) and 
evaluation of surface structure (regular versus irregular). Furthermore, measurement of two 
dimensions (2D) and three-dimensions (3D) are used to quantify total plaque area and total 
plaque volume [52,53]. Latterly, plaque vascularization on contrast-enhanced ultrasound are 
developed to optimize cardiovascular risk prediction [54,55]. Because the prevalence of 
carotid plaques in a population at 60 years is 60-90% [56] it seems to be of additional benefit 
for risk prediction to take this different ultrasound derived pattern into consideration at 
least in an elderly population. Finally both, quantification of CIMT and carotid plaque 
formation provide different information of the atherosclerotic status and burden in the 
carotid artery. Taking together these two parameters has been shown to result in a superior 
risk prediction for coronary heart disease than with one of the parameters alone [15].  
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Conclusion 
CIMT-measurement and plaque detection are already established measurement methods 
for detection of subclinical atherosclerosis in many studies. However, solid and efficient 
trainings of sonographer and reader are required for sufficient CIMT-quantification in studies 
as well as daily clinical practice. Among different CIMT-measurement methods, 
automatically based methods show the highest reproducibility. To differ between normal 
and pathological CIMT values an exact consideration of the underlying measurement 
protocol is obligatory. CIMT-measurement is a suitable method for an improvement of risk 
stratification in subjects with an intermediate risk factor profile above traditional 
atherosclerotic risk factors. The combination of CIMT-measurement and quantification of 
carotid plaque formation further increases the predictive value for first cardiovascular 
events.  
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AN AUTOMATED, INTERACTIVE ANALYSIS SYSTEM FOR ULTRASOUND 
SEQUENCES OF THE COMMON CAROTID ARTERY 
 
Abstract:  
Structural parameters of the Common Carotid Artery (CCA) have shown to correlate with the 
risk of cardiovascular disease (CVD), but their precise measurement is challenging. We 
developed an automatic detection system with manual interaction capabilities that can 
reliably analyze B-Mode ultrasound sequences of the CCA over several heart cycles.  
We evaluated 3824 frames from 40 sequences in two data qualities. Two readers measured 
the intima media thickness (CIMT) and the lumen diameter at two evaluation times (T1/T2).  
A Bland-Altman analysis of the average CIMT showed a bias ± SD of 0.002 ± 0.010 mm (T1), -
0.004 ± 0.008 mm (T2) for completely automatic detections, and -0.004 ± 0.010 mm (T1), -
0.003 ± 0.010 mm (T2) for clips with manual corrections.  
The combination of automated analysis and manual intervention provides precise 
parameters as biomarkers for the atherosclerotic process and makes the system suitable for 
large scale epidemiological research, diagnostic and clinical practice. 
Key Words: Common carotid artery, Intima media thickness, Lumen diameter, Automatic 
ultrasound analysis, Dual dynamic programming, Interactive system. 
 
Introduction 
Structural parameters of the common carotid artery (CCA) as the carotid intima media 
thickness (CIMT) have shown to correlate with the risk of cardiovascular diseases (CVD) [1–
3]. It is confirmed by many studies that a change in wall structure is a reaction to numerous 
physiological and pathological factors as age or hypertension [4–6]. They showed that the 
CIMT is not only a surrogate marker, but a direct consequence of the atherosclerotic 
process.  
CIMT and lumen diameter (LD) measurements can be achieved using B-Mode ultrasound 
images (e.g. Gustavsson et al. [7], Touboul et al. [8] an Wendelhaag et al. [9]) or directly by 
radio frequency based measurement methods (e.g. Hoeks et al. [10] or Rossi et al. [11]). 
While the latter ones are known for a higher resolution [12] and avoid image processing 
artifacts [13], B-Mode images are still the prevalent output of conventional US-machines, 
and thus the focus of this article.  
Reliable CIMT measurements in B-Mode US images are challenging in practice due to the 
varying quality of ultrasound images dependent on the training of the sonographer, the 
imaging protocols, the ultrasound settings, and the patient’s anatomy. Speckle noise, echo 
5 | Ultrasound Med Biol. 2012 Aug;38(8):1440-50 
 
 
 
 
52 
dropouts and motion artifacts are resulting issues. Thus, completely automated analysis 
systems will fail in some cases. Completely manual reading systems are not ideal either, 
since they are very time consuming and have shown higher variability than automatic 
systems [14].  
The measurement of relevant parameters from ultrasound images of the CCA has been 
attempted already since 1991 [9]. Soon it became evident that a manual, at worst single 
point measurement of the CIMT is insufficient as a reliable description of the condition of a 
cardiovascular system. (Semi-) automated methods were soon presented, the earliest by 
Touboul et al. [8], where intensity gradients in the ultrasound image were used as features. 
Cheng et al. [15] presented a snake based algorithm that has shown low intra- and inter-
reader variability [14], however the exact initialization of the algorithm has shown to be 
difficult. Loizou et al. [16] improved on this by extended preprocessing and an improved 
initialization procedure. Gustavsson et al. [7] used a dynamic programming approach and 
more complex features as edge strength, echo intensity and continuity, together with 
learned weight factors. Cheng et al. [17] extended this concept again to detect double 
contours, which lead to more stable detection results.  
Because of increased computational power and more sophisticated analysis algorithms, it 
became possible to analyze ultrasound sequences over several heart cycles. This revealed a 
variation of the CIMT of around 10% during a heart cycle [18]. Haller et al. [19] showed that 
a sequential analysis can offer a more extensive examination of the carotid wall than when 
using single images.  
The most recent systems for automated CIMT analysis were presented by Faita et al. [20], 
Lee et al. [21] and Molinari et al. [22]. Faita et al. [20] developed an automatic real-time 
analysis system with a heuristic search for measuring the CIMT. The system has shown very 
low inter- and intra- reader variability, but is only able to process single images. 
Misdetections had to be discarded from their evaluations. Lee et al. [21] used directional 
features for their dynamic programming approach in single images. This has shown to be an 
advantage for skewed or bended arteries. Molinari et al. [22] presented two image analysis 
systems, CULEXsa and CALEXia. The first one is based on signal analysis; the second one is 
based on an integrated approach using feature extraction, line fitting and classification. They 
deliberately disclaim the use of manual correction, which leads to about 15% data that 
cannot be evaluated by CULEXsa. 
The aim of this article is to present and evaluate a novel analysis program, DYnamic ARtery 
Analysis (DYARA), with superior detection and analysis capabilities. It automatically 
measures the CIMT and the arterial LD in every time frame in ultrasound sequences and 
offers the automatic detection of the minimum and maximum distention of the artery during 
a heart cycle. Whenever an automatic detection step fails due to a difficult imaging situation, 
the user can correct this instead of simply discarding the data. The system can reliably 
analyze B-Mode sequences of different quality over several heart cycles, thus making it 
suitable for large scale clinical research.  
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Materials and Methods 
Study design 
For the evaluation of the system, we use data of participants of the SAPALDIA study (Swiss 
Cohort Study on Air Pollution and Lung and Heart Diseases In Adults. SAPALDIA is a multi-
center cohort study in eight Swiss urban and rural regions, representing a broad range of 
environmental conditions (Aarau, Basel, Davos, Genève, Lugano, Montana, Payerne, Wald) 
[23,24]. The cohort population was recruited in 1991 as a population–based, random sample 
of adults, 18–60 years) to study the impact of air pollution on respiratory health. The second 
survey in 2001/02 extended the original study question to CVD. The third survey held in 
2010/11 repeated the measures and data collection of the earlier survey and included an 
ultrasound examination of the carotid artery in participants > 50 years of age (N ≈ 4000). The 
Institute of Exercise and Health Sciences is responsible for all readings of the recorded 
ultrasound sequences using the DYARA analysis system. The study protocol was approved by 
the ethical committees of the respective cantons, in which the study centers are situated. 
Participants gave written informed consent prior to participating in the study.  
The analyzed ultrasound images for this article belong to 40 study subjects with a mean age 
(SD) of 65.6 (8.7) years, range 52-81 years, including 19 females and 21 males. For each 
participant, ultrasound sequences of the CCA were acquired with Fukuda Denshi UF-870 
scanners equipped with a 10 MHz transducer. We used 20 consecutive clips where all 
readers agreed that the automatic detection was flawless (CA = completely automatic) and 
20 consecutive clips were some corrections of the automatic tracing result were necessary 
(MA = manual and automatic). The temporal resolution of the US system is 10.7 ms per 
frame, i.e. 93 Hz. The datasets were analyzed over one entire heart cycle, each containing 68 
to 131 single images depending on the heart rate. Altogether 3824 frames were analyzed by 
two experienced readers (R1 and R2) at two different points in time (T1 and T2), at least one 
day apart. Since CIMT is dependent on the location in the carotid tree, one reader marked 
the proximal start of the 1cm measurement region according to the Mannheim Consensus 
[25]. Then both readers were free to set the beginning of the evaluation box (region of 
interest) in an interval of 30 pixels around this marker. The analyzed clips started and ended 
in end-diastole. Typically, every research group evaluates their image analysis system with a 
different dataset, which makes a comparison of the results very difficult. To facilitate direct 
comparability, we make the complete dataset and the respective analysis of each patient, 
which was used for the evaluation of the program freely available upon request. 
 
Ultrasound examination 
The ultrasound clips for SAPALDIA were acquired in a standardized way. Each subject rested 
in supine position on an examination couch prior to the examination by a trained and 
certified sonographer. The head of the patient was rotated by 45° to either the left or the 
right side. For each patient, four locations were scanned: the left and right CCA, each from 
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ear to ear as well as horizontally. All clips had to follow certain criteria: the carotid bulb had 
to be visible on the left side of the image, the artery positioned horizontally and the intimal 
and adventitial boundaries of the arterial wall had to be visible over at least a 1cm segment 
proximal to the bulb for at least three heart cycles. In this study, one scan position per 
subject was used for the analysis. 
 
Ultrasound analysis 
After the ultrasound examination, the datasets were sent to the SAPALDIA data 
management, checked and then sent to the reading center (Department of Sports Medicine, 
University Basel). There the clips were analyzed with the novel analysis program. The 
readers set a 1cm bounding box (266 pixels) in the x-y view (B-Mode view) of the program to 
indicate where the measurements should be performed. Then the number of heart cycles to 
be analyzed was marked in the x-z view (virtual M-Mode). The lumen-intima (LIF) and the 
media-adventitia interfaces of the far wall (MAF), as well as the media-adventitia interface of 
the near wall (MAN) were then automatically detected and the results could be verified in 
both views. A schematic diagram of the interfaces is shown in Figure 5.1. Examples of 
original images with detected lines are shown in Figure 5.2.  
Whenever a misdetection took place by the automatic analysis due to difficult data quality, 
the reader could supersede the result by editing the respective contour as much as 
necessary. When the reader has controlled all tracing results, CIMT and LD were calculated 
for the selected region. Markers of the arterial minimum (end-diastole) and the maximum 
distention (systole) were displayed automatically. Additionally, the readers traced 5 
consecutive frames of each dataset completely manual (CM), resulting in 5 x 40 = 200 
manually traced images per reader and time point. The temporal location of the 5 frames 
was distributed evenly between systole and diastole over the datasets. From these tracings, 
a manual ground truth was created by averaging the contours for both readers and 
evaluation times for each clip. 
 
 
 
Figure 5.1: Artery interfaces 
Media adventitia oft the near wall (MAN), lumen intima (LIF) and media adventitia (MAF) interface of the far 
wall. The lumen diameter (LD) and the carotid intima media thickness (CIMT) are also marked. 
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Figure 5.2: Examples of original common carotid artery sequences with bounding boxes and sample 
detection 
A.& B.: Clips that could be analyzed completely automatically (CA). C.& D.: Clips were manual corrections had 
to be performed (MA). For each sequence, an x-y view (current B-mode frame, left side) and an x-z view (virtual 
M-mode, right side) are shown. Vertical red lines in either view indicate the location of the other view, 
respectively. The white vertical line shows the minimum lumen diameter in end-diastole and the blue line 
shows the maximum lumen diameter in systole. 
 
Detection Algorithm 
To achieve a system with low measurement variability, a key ingredient is a robust, 
repeatable contour detection algorithm that minimizes manual correction steps to the 
absolute minimum. In this work, we use a dual dynamic programming approach based on 
the work of Cheng et al. [17]. However, instead of using the original image features 
presented in their work, we use features inspired by Gustavsson et al. [7], which have 
proven to be more robust in our experiments.  
The idea of dynamic programming is to build a solution to a problem from (simpler) sub-
problems, instead of trying to solve everything at once. In our case, we try to calculate 
optimal contours based on evolving them pixel by pixel, from left to right in each frame of 
the clip. Optimality in this case is defined by a cost function that describes how well our 
solution fits to a model that we have defined. We look at a ܯ ൈܰ pixel grid, with ሺͲǡͲሻ 
being in the upper left corner, representing the ultrasound image area under consideration. 
Let ݂ሺݔǡ ݕሻ be a normalized image feature with Ͳ ൑ ݂ሺݔǡ ݕሻ ൑ ͳ. We are simultaneously 
looking for a contour ܤଵ ൌሼሺݔଵǡ ݕͳଵሻǡ ሺݔଶǡ ݕͳଶሻǡ ǥ ǡ ሺݔே ǡ ݕͳேሻሽ representing the LIF 
boundary together with a contour ܤଶ ൌ ሼሺݔଵǡ ݕʹଵሻǡ ሺݔଶǡ ݕʹଶሻǡ ǥ ǡ ሺݔேǡ ݕʹேሻሽ , representing 
the MAF boundary. 
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In order to obtain an anatomically plausible solution, we enforce certain constraints. The 
first one is that ͳ ൑ ݕͳ ൑ ݕʹ ൑ ܯ. This prevents the boundaries from crossing each other. A 
second one is that the contours must have a minimal and maximal distance ሺ݀௠௜௡ǡ ݀௠௔௫ሻ, 
where Ͳ ൏ ݀௠௜௡ ൏ ݀௠௔௫ ا ܯ and ݀௠௜௡ ൏ ݕʹ െ ݕͳ ൏ ݀௠௔௫. To ensure a certain degree of 
smoothness of each contour, we use a parameter ݀௥ ൐ Ͳ which indicates in which range a 
contour might deviate from the previous stage. Small values of ݀௥  will lead to smooth 
contours. Since we consider two contours simultaneously, we can also restrict the change in 
distance between the curves. This parameter is referred to as dual curve smoothness and is 
defined as |ݓ௫ െݓ௫ିଵ| whereݓ௫ ൌ ݕʹ௫ െ ݕͳ௫. 
For the calculation of the cost function, we use two different established feature terms. The 
main role plays the gradient magnitude of the derivation of the ultrasound image in ݕ 
direction. Since we are going to minimize a cost function later on, we use 1 minus the 
gradient magnitude and denote it as ݂ீ ሺݔǡ ݕሻ. Using only this term would force a contour to 
lie exactly at the point with the highest degree of intensity change. In order to tweak the 
detected contours towards a boundary that would be manually chosen, we also use the 
intensity image itself as proposed by Gustavsson et al. [7]: we calculate the average 
“brightness below” a contour as well as the average “darkness above” inside a predefined 
area and combine this to a feature ூ݂ሺݔǡ ݕሻ. 
The cost function used in this work then looks like: ܥሺݔǡ ݕͳǡ ݕʹሻ ൌ ሼ୨ଵǡ୨ଶሽאሼିୢ౨ǡڮǡୢ౨ሽሼܥሺݔ െ ͳǡ ݕͳ ൅ ݆ͳǡ ݕʹ ൅ ݆ʹሻ ൅ߣீ൫݂ீ ሺݔǡ ݕͳሻ ൅ ݂ீ ሺݔǡ ݕʹሻ൯ ൅ߣூ൫ ூ݂ሺݔǡ ݕͳሻ ൅ ூ݂ሺݔǡ ݕʹሻ൯ ൅ߣୱୡୡሺȁͳȁ ൅ ȁʹȁሻ ൅ߣୢୡୱȁ୶ െ୶ିଵȁሽ 
As initialization for the previous cost of the first location, the gradient values of the first 
position are used. The weight factors λ define the relative contribution of the different 
terms. We use 0.8 for λG (gradient), 0.15 for λI (intensity), 0.025 for λscc (single curve 
smoothness) and 0.025 for λdcs (dual curve smoothness). These values were determined prior 
to the study on different, independent datasets: several detection results were presented to 
expert readers who selected the visually best parameter combination. The optimal values ͳכ and ʹכ (i.e. the ͳ and ʹ where ܥሺݔǡ ݕͳǡ ݕʹሻ is minimal) can be stored and traced 
backwards once the cost function for the entire double contour has been evaluated. 
The far wall interfaces are always detected by dual dynamic programming. In some 
ultrasound sequences, the near wall does not show a double contour, though. Then the 
algorithm is likely to miss the MAN because it searches for a “best solution” to a double 
contour. In these cases, the operator might choose to select a dynamic programming 
algorithm that searches for a single contour following Gustavson et al. [7]. 
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From the three interfaces, we calculate several parameters for further evaluation. Let ܮܦതതതത௧ ൌσ ሺܯܣܨ௫ െܯܣ ௫ܰሻȀݓ௕௫ୀ௔ be the averaged LD in frame t, where a is the x-coordinate of the 
beginning of the bounding box, b the end and w the width (ݓ ൌ ܾ െ ܽ ൅ ͳ). Then we define 
the avg. LD to be σ ܮܦതതതത௧ௗ௧ୀ௖ Ȁ݊, where c is the first frame of the heart cycle, d the last one 
and n the number of frames (݊ ൌ ݀ െ ܿ ൅ ͳ). For the systolic/diastolic measurements we 
use the frame where ܮܦതതതത is maximal/minimal, i.e. sys. LD = ܮܦതതതതୟ୰୥ ୫ୟ୶ሺ௅஽തതതത೟ሻ and dias. LD = ܮܦതതതതୟ୰୥ ୫୧୬ሺ௅஽തതതത೟ሻ. The CIMT values are calculated in a similar fashion: ܥܫܯܶതതതതതത௧ ൌ σ ሺܯܣܨ௫ െ௕௫ୀ௔ܮܫܨ௫ሻȀݓ, and the avg. CIMT is σ ܥܫܯܶതതതതതതത௧ௗ௧ୀ௖ Ȁ݊. The sys. CIMT = ܥܫܯܶതതതതതതୟ୰୥ ୫ୟ୶ሺ௅஽തതതത೟ሻ and the 
dias. CIMT = ܥܫܯܶതതതതതതୟ୰୥ ୫୧୬ሺ௅஽തതതത೟ሻ. When we consider more than one heart cycle, the respective 
values are averaged. 
 
Statistical Analysis 
In order to show the general characteristics of the data, we calculated descriptive statistics 
in form of mean, SD and range of the measurements of the 40 datasets. To assess inter- and 
intra-reader variability, we computed bias and SD with the Bland Altman method, as well as 
Bland Altman plots of selected results. The interval of agreement (IoA = ±1.96*SD) is shown 
in the plots as dashed lines. We also computed the relative scales of bias and SD in percent 
of the respective mean values. As a cross check of the method, we analyzed scatter plots of 
the percental change in LD versus the percentual change in CIMT relative to the respective 
diastolic values for each measurement value of a patient. All analyses were performed in 
with the R statistical software version 2.12.0 [26] on an Ubuntu Linux system. 
 
Results 
Descriptive statistics for average, diastolic and systolic measurements for CIMT and LD for 
both readers are shown in Table 5.1. The results for T2 are very similar and are thus omitted 
due to space reasons. Table 5.2 shows results for the inter-reader analysis. 
Bland-Altman plots for average CIMT and average LD are shown in Figure 5.3. The bias in 
CIMT measurements for CA clips was 0.002 mm (T1) and -0.004 mm (T2), for MA clips -0.004 
mm (T1) and -0.003 mm (T2). The relative scales of these values (in percent of the respective 
mean values) are 0.3% (T1) and 0.5% (T2) for CA clips, 0.5% (T1) and 0.4% (T2) for MA clips. 
The LD bias in good quality clips was -0.003 mm (T1) and -0.016 mm (T2), for MA clips it was 
higher: -0.021 mm (T1) and -0.015 mm (T2). The relative values for the LD bias are 0.04% 
(T1) and 0.2% (T2) for CA, 0.3% (T1) and 0.2% (T2) for MA clips. Low inter-reader variability 
could be achieved for average CIMT in CA clips. The SD between R1 and R2 was 0.010 mm 
for T1 and 0.008 mm for T2. Here we obtain relative values of 1.2% (T1) and 1.0% (T2). The 
SD of MA clips are about in the same range at 0.010 mm, relative value 1.3%, for T1 and 
1.4% for T2. In general, LD variability was higher than CIMT variability, and measurements of 
medium clips had a higher variability than of good clips.  
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Table 5.1: Descriptive statistics for for completely automatic (CA) and manual and automatic (MA) clips at 
evaluation time T1 
Mean values together with standard deviation (SD) and range of the data in mm.  
 
 
    R1  R2 
    mean (SD) range  mean (SD) range 
CA clips T1      
 Avg. CIMT  0.78 (0.15) 0.56-1.09  0.78 (0.15) 0.56-1.09 
 Sys. CIMT 0.77 (0.15) 0.54-1.05  0.77 (0.14) 0.54-1.04 
 Dias. CIMT 0.80 (0.16) 0.58-1.16  0.80 (0.15) 0.58-1.14 
 Avg. LD 7.33 (1.03) 5.63-10.05  7.33 (1.04) 5.62-10.09 
 Sys. LD 7.54 (1.05) 5.78-10.28  7.53 (1.06) 5.77-10.31 
 Dias. LD 7.14 (1.01) 5.50-9.86  7.14 (1.02) 5.50-9.90        
MA clips T1      
 Avg. CIMT  0.74 (0.12) 0.47-0.94  0.73 (0.12) 0.46-0.94 
 Sys. CIMT 0.72 (0.12) 0.48-0.97  0.71 (0.11) 0.46-0.95 
 Dias. CIMT 0.75 (0.12) 0.48-0.96  0.75 (0.12) 0.48-0.97 
 Avg. LD 7.65 (0.73) 6.09-8.99  7.63 (0.73) 6.07-8.95 
 Sys. LD 7.88 (0.75) 6.32-9.25  7.85 (0.73) 6.31-9.22   Dias. LD 7.45 (0.73) 5.89-8.73  7.43 (0.73) 5.87-8.70  
 
 
 
Table 5.2: Bland-Altman statistics for inter-reader variability for completely automatic (CA) and manual and 
automatic (MA) quality clips for observation times T1 and T2 
 
Inter-reader variability (R1 vs. R2) 
  Bias in mm (% of mean value)  SD in mm (% of mean value) 
  T1 T2  T1 T2 
CA clips 
 Avg. CIMT 0.002 (0.3 %) -0.004 (-0.5 %)  0.010 (1.2 %) 0.008 (1.0 %) 
 Sys. CIMT 0.000 (0.1 %) -0.003 (-0.4 %)  0.006 (0.8 %) 0.013 (1.6 %) 
 Dias. CIMT 0.006 (0.7 %) -0.007 (-0.9 %)  0.019 (2.4 %) 0.012 (1.5 %) 
 Avg. LD -0.003 (-0.0 %) -0.016 (-0.2 %)  0.025 (0.3 %) 0.019 (0.3 %) 
 Sys. LD -0.005 (-0.1 %) -0.016 (-0.2 %)  0.022 (0.3 %) 0.026 (0.3 %) 
 Dias. LD -0.001 (-0.0 %) -0.019 (-0.3 %)  0.034 (0.5 %) 0.025 (0.4 %) 
       
Ma clips 
 Avg. CIMT -0.004 (-0.5 %) -0.003 (-0.4 %)  0.010 (1.3 %) 0.010 (1.4 %) 
 Sys. CIMT -0.010 (-1.3 %) -0.017 (-2.3 %)  0.016 (2.2 %) 0.023 (3.2 %) 
 Dias. CIMT 0.000 (0.0 %) -0.005 (0.7 %)  0.026 (3.5 %) 0.037 (5.0 %) 
 Avg. LD -0.021 (-0.3 %) -0.015 (-0.2 %)  0.027 (0.4 %) 0.032 (0.4 %) 
 Sys. LD -0.030 (-0.4 %) -0.027 (-0.3 %)  0.039 (0.5 %) 0.041 (0.5 %) 
 Dias. LD -0.017 (-0.2 %) -0.011 (-0.1 %)  0.045 (0.6 %) 0.051 (0.7 %) 
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Figure 5.3: Bland-Altman plots for inter-reader variability for for completely automatic (CA) and manual and 
automatic (MA) datasets at evaluation time T1 (reader R1 vs. reader R2) 
 
 
 
 
Figure 5.4: Bland-Altman plots for intra-reader variability for completely automatic (CA) and manual and 
automatic (MA) data of reader R1 (time T1 vs. time T2) 
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The values for intra-reader variability are shown in Table 5.3 and Figure 5.4. The bias of R1 
for average CIMT measurements of CA clips was -0.003 mm and for MA clips 0.004 mm. 
Results for R2 were very similar. Regarding the SD for the average CIMT, identical results 
were observed for CA and MA clips: 0.007 mm (R1) and 0.008 mm (R2). Again, variability for 
the LD measurements was higher than the respective CIMT measurements.  
Table 5.4 lists inter-reader results for completely manual measurements. We can observe a 
bias of 0.048 mm (MA dataset, T2) to 0.061 mm (MA dataset, T1) for CIMT and 0.016 mm 
(MA dataset, T2) to 0.73 mm (CA dataset, T1) for LD measurements. The SD is in the range of 
0.028 mm (CA dataset, T2) to 0.042mm (CA dataset, T1) for CIMT and 0.038 mm (MA 
dataset, T2) to 0.068 mm (CA dataset, T1) for LD. 
 
 
Table 5.3: Bland-Altman statistics for intra-reader variability (R1 vs. R2) for completely automatic (CA) and 
manual and automatic (MA) clips 
 
Intra-reader variability (R1 vs. R2) 
  Bias in mm (% of mean value)  SD in mm (% of mean value) 
  R1 R2  R1 R2 
CA clips 
 Avg. CIMT -0.003 (-0.4 %) 0.003 (0.4 %)  0.007 (0.9 %) 0.008 (1.0 %) 
 Sys. CIMT 0.000 (0.1 %) 0.004 (0.6 %)  0.008 (1.1 %) 0.013 (1.7 %) 
 Dias. CIMT -0.008 (-0.9 %) 0.005 (0.6 %)  0.017 (2.2 %) 0.012 (1.5 %) 
 Avg. LD -0.003 (-0.0 %) 0.011 (0.1 %)  0.012 (0.2 %) 0.017 (0.2 %) 
 Sys. LD 0.001 (0.0 %) 0.012 (0.2 %)  0.017 (0.2 %) 0.017 (0.2 %) 
 Dias. LD -0.006 (-0.1 %) 0.013 (0.2 %)  0.019 (0.3 %) 0.020 (0.3 %) 
       
MA Clips 
 Avg. CIMT 0.004 (0.5 %) 0.002 (0.3 %)  0.007 (0.9 %) 0.008 (1.1 %) 
 Sys. CIMT -0.007 (-0.9 %) 0.000 (0.1 %)  0.027 (3.7 %) 0.017 (2.4 %) 
 Dias. CIMT 0.009 (1.2 %) 0.004 (0.5 %)  0.019 (2.6 %) 0.011 (1.5 %) 
 Avg. LD 0.009 (0.1 %) -0.003 (0.0 %)  0.012 (0.2 %) 0.014 (0.2 %) 
 Sys. LD 0.009 (0.1 %) 0.005 (0.1 %)  0.027 (0.3 %) 0.019 (0.2 %) 
 Dias. LD 0.009 (0.1 %) -0.003 (0.0 %)  0.038 (0.5 %) 0.012 (0.2 %) 
 
 
Table 5.4: Bland-Altman statistics for inter-reader variability for completely manually (CM) evaluated data 
for evaluation times T1 and T2 
 
Inter-reader variability (T1 vs. T2) for completely manually (CM) evaluated data 
  Bias in mm (% of mean value)  SD in mm (% of mean value) 
  T1 T2  T1 T2 
CA dataset – CM 
 Avg. CIMT 0.055 (7.7 %) 0.053 (7.3 %)  0.042 (5.8 %) 0.028 (3.9 %) 
 Avg. LD 0.073 (1.0 %) 0.057 (0.8 %)  0.068 (0.9 %) 0.066 (0.9 %) 
       
MA dataset – CM  
 Avg. CIMT 0.061 (9.2 %) 0.048 (7.1 %)  0.036 (5.5 %) 0.033 (4.9 %) 
 Avg. LD 0.056 (0.7 %) 0.016 (0.2 %)  0.052 (0.7 %) 0.038 (0.5 %) 
5 frames of each clip were either evaluated completely automatic (CA) or manual and automatic (MA). 
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Results for the inter-method analysis are given in Table 5.5. The bias / SD of CA to CM 
measurements are 0.057/0.031 mm (CIMT) and 0.077/0.061 mm (LD), respectively; for MA 
vs. CM measurements we obtain 0.064/0.027 mm (CIMT) and 0.049/0.048 mm (LD). 
Figure 5.5 shows a scatter plot of the percent change in LD versus the percent change in 
CIMT for each patient at each time. The patient-to-patient variation of strain measurements 
is approximately fivefold higher than the actual intra-reader variability (T1 vs. T2).  
Figure 5.6 shows the comparison of the virtual M-mode of the automatic tracing across one 
complete heart cycle (left side) and a completely manual tracing by an expert reader (right 
side). The more irregular line of the manual tracing is a clear indicator of the higher 
variability compared to the automatic tracing.  
 
 
 
Table 5.5: Bland-Altman statistics for inter-method variability (CA/MA vs. CM) 
 
Inter-method variability (CA/MA vs. CM) 
 CA vs. CM  MA vs. CM 
 Bias in mm  (% of mean) 
SD in mm  
(% of mean)  
Bias in mm 
(% of mean) 
SD in mm 
(% of mean) 
Avg. CIMT 0.057 (7.6 %) 0.031 (4.1 %)  0.064 (9.1 %) 0.027 (3.8 %) 
Avg. LD 0.077 (1.1 %) 0.061 (0.8 %)  0.049 (0.6 %) 0.048 (0.6 %) 
 
Bland-Altman statistics for completely automatic (CA) or manual and automatic (MA) measurements against a 
completely manual (CM) ground truth (average of manual tracings of R1 and R2 for times T1 and T2). 
 
 
 
 
 
 
Figure 5.5: Virtual M-mode showing the results of automatic vs. completely manual tracing 
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Figure 5.6: Examples for lumen diameter (LD) and carotid intima media thickness values (CIMT) for both 
readers and evaluation times over a heart cycle 
Vertical lines show the position of the diastole as determined by the respective readers. In the third row, the 
percentual changes of CIMT vs. LD are shown, together with the hypothetical relation when assuming 
conservation of vessel wall volume (black line). 
 
Discussion 
Changes of the CCA, especially an increase of the CIMT, enlargement of the LD and the 
reduction of the local compliance are accepted biomarkers for the atherosclerotic process of 
the arterial system and especially the CIMT is increasingly used in clinical trials, clinical 
practice and prediction of cardio-vascular events [1,27–29]. Automatic analyzing systems are 
attractive due to lower measurement variability compared to manual tracing of the CIMT 
[14,20,22]. However, two issues are not sufficiently addressed so far. These are the 
measurement of sectional CIMT and LD over the complete heart cycle in B-mode images and 
the handling of images with lower quality impeding the automatic measurement procedure.  
The presented novel analysis software DYARA targets to solve both issues. First, it is able to 
analyze the named structural and functional parameters of the CCA with high inter- and 
intra-reader consistency automatically across the complete heart cycle. In fact, the SD for 
the average CIMT are as good or better as the currently best system we are aware of: Faita 
et al. [20], SD for average CIMT, Operator 1 vs. Operator 2: ±0.010 mm. The implemented 
algorithm based on dual dynamic programming and enhanced features has shown highly 
consistent detection results. 
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Second, the software enables the reader to interact with the automatically traced lines if the 
result is not sufficient. Frames with echo dropouts or much noise do not have to be 
discarded in our system because of the possibility for manual editing of the traced lines. The 
resulting SD of the CIMT in MA clips is comparable to the CA results. Corrections could be 
executed in a highly consistent fashion by quickly comparing the results to other parts of the 
detected contours or neighboring frames. This is a clear advantage in large scale research 
studies with different centers. If large amounts of data are collected from several locations 
and examiners, it is likely that some frames are flawed. The combination of automatic and 
manual detection allows us to fully utilize the available data. 
The system is capable of analyzing the CIMT and the LD over the complete heart cycle, 
allowing studies that analyze the dynamic properties of the artery like Paini et al. [30] or 
Bianchini et al. [31]. This is an important issue since CIMT and LD changes across the heart 
cycle [18]. In our system, the end-systolic as well as end-diastolic frames are detected 
automatically by determination of the lowest and highest LD. Hence, the use of ECG markers 
for control of the heart cycle is dispensable. However, the values of the systolic and the 
diastolic LD and CIMT (in single frames) have a higher variability compared to the average 
CIMT and average LD. This is plausible since the averaged values contain all frames of the 
entire heart cycle, where as for the systolic/diastolic results only one single measurement is 
taken. 
The inter-reader analysis of the completely manual measurements showed a higher bias and 
SD than within the automatic method and thus the superiority of the (semi-)automatic 
system. When we compared the CA/MA measurements against a manual ground truth, we 
could show that the automatic methods detected on average the CIMT about 0.06 mm 
wider than human observers. A certain bias will most likely exist against other automatic 
systems and must be taken into consideration when comparing absolute CIMT and LD 
values. An automatic unbiasing procedure as proposed by Rossi et al. [11] could be a 
solution for this issue. The high variability of the manual tracings becomes visible when 
looking at a virtual M-mode in Figure 5.5. For human observers, it is difficult to meet exactly 
the same location in successive frames. The automatic tracing procedure provides more 
consistent results. 
The scatter of the percent changes in LD and CIMT between the patients is higher than the 
mean differences within repeated measurements of a reader (Figure 5.6). This offers the 
opportunity to analyze the strain relation of LD to CIMT based on our methodology. When 
assuming a conservation of vascular wall volume, the percent change for IMT should be 
nearly equal to the percent change in LD. This does not hold for all cases. The positive 
changes in CIMT are mainly due to measurement inaccuracies, and can thus serve as a 
quality check. The remaining values still do not all show this expected ratio. This has also 
been reported by others (e.g., Selzer et al. 2001 [18]) and might be investigated in future 
research. 
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Our system can offer reliable measurements from B-Mode ultrasound images, although the 
resolution of the underlying images (266 pixel per cm, i.e. 37.6 µm per measurement) is 
lower than in RF based methods, that are usually in the order of 21-23 µm per measurement 
[11,31]. The temporal resolution of both approaches is the same and dependant of the 
underlying US-equipment. Our data has a very high temporal resolution of 93 Hz, which is 
necessary if the CIMT and the LD should be measured accurately in the rapid transition from 
diastole to systole. 
The data for our study was acquired according to a standardized protocol and evaluated by 
expert readers. The results show the full capabilities of the system. The CIMT and LD 
measurements are affected by the location of the 1cm measurement range (see Mannheim 
Consensus). So an important factor for reproducible results is a good training of the readers. 
Excellent usability of the system and sophisticated visual control features help the users to 
place the bounding box at the right location. Further investigations will deal with an arbitrary 
setting of the bounding box and the effect of readers with different skill levels.  
In conclusion, DYARA is a highly precise detection system providing a combination of 
automated analysis together with manual interaction capabilities avoiding to discard images 
with poorer contour quality. Thus, it comes closer to cope with the varying quality of 
ultrasound images and clips in clinical practice as well as in research settings. 
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VARIABILITY AND REPRODUCIBILITY OF CAROTID STRUCTURAL AND FUNCTIONAL 
PARAMETERS ASSESSED WITH TRANSCUTANEOUS ULTRASOUND – RESULTS FROM THE 
SAPALDIA COHORT STUDY 
 
Abstract 
Objective: Carotid intima media thickness (CIMT) and local stiffness are vascular biomarkers 
of atherosclerotic burden. We investigated the variability and reproducibility of clinically 
relevant structural (CIMT, lumen diameter (LD)) and functional parameters (strain, 
distensibility, compliance, β-stiffness index, Peterson’s elastic modulus and Young’s elastic 
modulus) measured in B-mode ultrasound sequences of the common carotid artery (CCA) in 
the second follow-up of the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases 
In Adults (SAPALDIA 3). 
Methods: Ultrasound sequential images were examined twice over a 1 cm segment across at 
least one heart cycle in 165 SAPALDIA 3 participants. To assess variability and reproducibility 
of structural and functional parameters, individual coefficients of variation (CV), intraclass 
correlation (ICC), Bland-Altman plots and mixed effect regressions were used.  
Results: ICCs of repeated examinations ranged between 0.67 and 0.77 for blood pressure 
indices, between 0.87 and 0.97 for structural properties and between 0.75 and 0.79 for 
functional parameters. CV was lowest in structural parameters (1.6-4.6%), followed by blood 
pressure (5.1-7.9%) and functional indices (11.0-13.1%). Variations in all parameters were 
predominantly explained by subjects (>74% in functional, >82% in structural properties). 
Bland-Altman plots for functional indices showed mean and standard deviation of the 
respective mean value of 4.2(19.6)% for strain, 1.9(24.4)% for distensibility, 2.4(22.2)% for 
compliance, 3.0(24.4)% for β-stiffness index, 0.9(25.7)% for Peterson’s elastic modulus and 
1.2(27.9)% for Young’s elastic modulus. 
Conclusion: The results show that SAPALDIA 3 measurements of transcutaneous ultrasound 
examinations have an excellent reproducibility of structural parameters and a good 
reproducibility of functional indices. 
Key words: Common carotid artery; Ultrasound; Arterial stiffness; Intima media thickness; 
Diameter; Reproducibility 
 
Introduction 
CVD is a major cause of death [1]. The development and application of validated surrogate 
endpoints to identify risk and evaluate therapeutic intervention have become increasingly 
available in the last decades [2–5]. Based on numerous clinical studies non-invasive 
structural or functional endpoints as carotid intima media thickness (CIMT) and lumen 
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diameter (LD) assessed by B-mode ultrasound or aortic stiffness assessed by pulse wave 
velocity are now widely accepted as identifiers of the atherosclerotic status and predictors 
of atherosclerotic events, respectively [6–9]. Carotid functional indices such as distensibility 
are under discussion regarding their validity and sensitivity to predict cardiovascular events 
in the general population [9–12].  
The widespread availability of non-invasive high resolution ultrasound in combination with 
advanced automated reading software [13] allow the in-vivo evaluation and modelling of the 
haemodynamic effects and properties of the arterial wall in humans in cross-sectional and 
follow-up studies [14]. CIMT and LD describe the anatomic and structural properties of the 
CCA segment, whereas vascular function can be described by changes in CIMT and LD across 
the heart cycle.  
Accuracy and repeatability of CIMT and carotid LD measurements have a decisive impact on 
the sample sizes needed for cross-sectional and longitudinal risk identification and 
assessment of treatment efficacy. This implies that the evaluation of data quality needs a 
thorough methodical validation of all parameters used for future analyses within the same 
study setting. We therefore investigated the variability and reproducibility of carotid 
structural wall parameters (CIMT, LD) and the carotid functional indices strain, distensibility, 
compliance, β-stiffness index, Peterson’s elastic modulus and Young’s elastic modulus by 
means of repeated ultrasound scans. For our purposes a randomly selected sample of 
participants of the SAPALDIA 3 cohort, a general population study (second follow-up of the 
Swiss Cohort Study on Air Pollution and Lung and Heart Diseases In Adults), was selected 
and scanned a second time on top of the study visit. To better understand the significance of 
our reproducibility study, we additionally compared our results with different population 
based studies [9,15–22]. 
 
Methods 
Study design and subjects 
The SAPALDIA multicentre cohort study recruited in 1991 is a population-based random 
sample of adults (18-60 years) from eight areas of Switzerland representing rural and urban 
environmental conditions (Aarau, Basel, Davos, Genève, Lugano, Montana, Payerne, Wald) 
[23]. SAPALDIA 3 was executed in 2010/2011. It is the second follow-up of the SAPALDIA 
cohort after the previous survey’s in 2001/2003 and 1991 [23,24]. In SAPALDIA 3 carotid B-
mode ultrasound scans were performed in 3489 participants (49% males, 51% females) 
turning 50 years within the same year or older, mean age 63.9 (SD 8.1, range 50-81) years. A 
health screening questionnaire was applied before health examinations and participants 
were excluded partially or fully if a health risk for a clinical examination existed. Ethical 
approval had been granted by the respective Swiss cantonal ethical committees. Participants 
gave written informed consent according to their preferences either globally for all 
examinations or separately for single assessments.  
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To assess variability and reproducibility of carotid structural and functional parameters 
repeated scans were performed in a representative random sample of 165 SAPALDIA 3 
participants (see figure 6.1). Participants were examined on two different occasions, at least 
one night in between scans and within a maximum of three months. Sequential image 
analyses were consecutively performed within SAPALDIA 3 and all readers were blinded in 
terms of the initial and the repeat ultrasound examination date (intersession validation). 
 
 
 
Figure 6.1: Participation and feasibility flow chart 
 
Ultrasound examination 
Examinations were performed following a standardised ultrasound scan protocol. Eight 
standardised ultrasound instruments (Fukuda Denshi UF-870) equipped with an LA38 5-16 
MHz linear array transducers. The ultrasound temporal resolution was 10.47ms per frame. 
All sonographers were trained, certified prior to study entry and supervised by two 
collaborating vascular labs: the Department of Vascular Medicine at the Academic Medical 
Center/Imagelab, University of Amsterdam and Erichem, The Netherlands and the Division 
Sport and Exercise Medicine at the Institute of Exercise and Health Science, University of 
Basel, Switzerland. To guide sonographers through the scan procedures, all ultrasound 
instrumentation was equipped with the SAPALDIA 3 application protocol, jointly developed 
by Vascular Imaging/Imagelab, ISSW and Fukuda Denshi. 
Before start of the ultrasound examination, each individual rested in supine position for at 
least 10 minutes in a 22-25°C dimly lit room. During the bilateral carotid scans the head 
rested comfortably against a 45° foam wedge to standardise the horizontal and ear-to-ear 
angles of insolation of the four right and left distal CCA locations: In all CCA B-mode 
ultrasound scans the sonographer aimed to visualise the following standardised and 
predefined anatomic arterial wall structures: the lumen-intima to media-adventitia layer 
(CIMT) of the far wall and the media-adventitia interface of the far wall to the media-
adventitia interface of the near wall (outer LD) were assessed longitudinally in the CCA along 
the 1 cm arterial wall segment proximal to the carotid bifurcation for a duration of at least 
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three heart cycles (see figure 6.2) [25]. Furthermore, left and right brachial systolic (sBP) and 
diastolic blood pressure (dBP) were measured at the upper arm with a standard oscillometric 
device (OMRON 705IT, OMRON HEALTHCARE, Kyoto, Japan) immediately upon measuring 
CIMT on the respective side. 
 
 
 
Figure 6.2: Ultrasound images of the common carotid artery 
B-mode (left) and M-mode (right) ultrasound image of the common carotid artery with automatic contour 
detection lines (LD between adventitia far wall and adventitia near wall and CIMT as intima-media thickness of 
the far wall) over three heart cycles. 
 
All ultrasound examination data were saved as native format pooled per examination and 
transferred to the Swiss Tropical and Public Health Institute, Basel, Switzerland, which 
centrally administered the examined data. The native files were converted by a Fukuda 
Denshi extraction file program to a sequence of B-mode images in Portable Network 
Graphics (PNG) format. Afterwards, the image sequences were loaded into the B-mode 
image analysis program DYnamic ARtery Analysis (DYARA). The program interface shows the 
B-mode image sequences as x-y view on the left side and a virtual M-mode as y-z view on 
the right side (see figure 6.2) [13]. Validation for intra- and interreader variability is 
described in detail elsewhere [13]. 
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Sequential images analyses  
Data acquisition was conducted according to standardised SAPALDIA 3 protocols referring to 
Mannheim Consensus [25], thus plaque in the measurement region of the CCA and images 
with insufficient quality were excluded from analysis. In order to ensure reproducibility, 
expert ultrasound readers tagged the start of measurement systematically directly proximal 
to the opening of the carotid bifurcation in the B-mode DYARA user interface. Then, a 
bounding box of exactly 1 cm was generated by DYARA according to image resolution (266 
pixels per cm). The bounding box indicated the region of interest for automatic detection of 
the intimal and adventitial layer of the far wall and the media – adventitia interface of the 
near wall. The analysed sequential images started and ended in end-diastole containing one 
to three heart cycles (see figure 6.2). 
DYARA is advantageously reader independent, but it allows manual interaction as much as 
necessary whenever the measurement lacked information due to difficult ultrasound data 
quality. When the reading was finished (approximately 10 to 15 minutes per ultrasound 
scan), the raw data, contour detection results and calculated parameters were automatically 
saved in Hierarchical Data Format (HDF5). Simultaneously, a database was generated 
containing structural data (average, systolic and diastolic CIMT and LD, respectively). These 
were all based on the average of four location analyses (left and right CCA, each in ear to ear 
and horizontal view) of a 1 cm segment across at least one heart cycle (see table 6.1).  
 
Functional parameters 
In general, local functional indices reflect the local elasticity of the CCA. They are defined as 
the relation of blood pressure (BP) change (stress) to cyclic variation of structural indices. 
Hence, functional parameters are based on structural indices.  
Table 6.1 presents the structural definitions and functional parameter formulas used in 
SAPALDIA 3. Strain describes the relative carotid distension without considering any BP 
changes. It only considers the relative change of LD across heart cycles [14]. The 
distensibility coefficient (DC) represents the relative change of LD for a given pulse pressure 
and reflects the carotid elasticity [2,14]. The compliance coefficient (CC) measures the 
absolute change of the cross-sectional LD area for a given pressure change which displays 
the buffer capacity [2,14]. Peterson’s elastic modulus (EP) measures the needed pressure 
change for a given relative LD change [14]. Young’s elastic modulus (EINC) incorporates the 
wall thickness and therefore expresses a wall-dependent elasticity [8]. The β-stiffness index 
(Bstiff) describes the ratio between the logarithmized quotient of systolic and diastolic blood 
pressure to strain and therefore, it is dimensionless [26]. Lower values of strain, DC and CC 
and higher values of EP, EINC, and Bstiff correspond to a higher arterial stiffness.  
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Table 6.1: Structural and functional parameters based on a 1 cm detection segment 
 
Parameter unit Definition / formula  
aLD mm average of LD in all analysed ultrasound frames  
dLD mm average of the minimal LD in all analysed heart cycles  
sLD mm average of the maximum LD in all analysed heart cycles  
aCIMT mm average of CIMT in all analysed images across the heart cycle  
dCIMT mm average of CIMT measured in all analysed heart cycles at diastolic 
(minimal) LD 
 
sCIMT mm average of CIMT measured in all analysed heart cycles at systolic 
(maximal) LD 
 
deltaLD mm sLD-dLD  
Strain  % deltaLD / dLD [14] 
DC 1/kPa ((2 × deltaLD × dLD)+(deltaLD)2)/(PP× dLD2) [2] 
CC mm2/kPa π×((2× deltaLD × dLD)+(deltaLD)2)/(4×PP) [2] 
Bstiff no unit (ln(sBP/dBP))/(deltaLD/dLD)  [26] 
EP kPa dLD×PP/deltaLD [14] 
EINC kPa dLD/(aCIMT × DC) [8] 
 
a = average, d = diastolic, s = systolic, BP = blood pressure, PP = pulse pressure (sBP – dBP), deltaLD = delta 
lumen diameter, CIMT = carotid intima media thickness, LD = lumen diameter, DC = distensibility coefficient, CC 
= compliance coefficient, Bstiff = β-stiffness index, EP = Peterson’s elastic modulus, EINC = Young’s elastic 
modulus, ln = natural logarithm. 
 
Statistical analyses 
To assess differences in structural and functional carotid parameters between two 
ultrasound examinations (T1, T2), mean differences, 95% confidence interval (CI) and p-
values were calculated using paired t-tests. Functional parameters were log-transformed; p-
values <0.05 were considered as statistically significant. 
Furthermore, for each parameter, individual between-visit coefficients of variation (CV) 
defined as the ratio of the standard deviation to the mean of the two measurements of the 
respective subject, were determined and intraclass correlation coefficients (ICC) were 
computed using one-way analysis of variance models (according to McGraw and Wong 
ICC(1) [27] and Shrout and Fleiss ICC(1,1) [28]). In addition, Bland-Altman plots were 
generated showing mean differences and estimated limits of agreement of the examined 
carotid functional parameters [29].  
Finally, mixed linear models were used to quantify the different sources of total variation. 
Therefore, the model included a fixed factor distinguishing between the first and the second 
measurement and random intercepts were assigned to variables subject, sonographer, and 
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reader. Then, the contributions to the total variance of these random intercept factors and 
of uncontrolled influences at the level of individual measurements were estimated.  
All analyses were performed using the statistical software STATA (StataCorp, Release 12. 
Statistical Software, College Station, TX: StataCorp LPTexas, USA).  
 
Results 
Descriptive statistics of study population characteristics for both examinations (T1, T2) and 
the respective p-values of paired t-tests are shown in table 6.2. The analytic sample size 
included 165 SAPALDIA 3 subjects. 40.6% were men, with a mean age of 63.6(7.5) years, an 
age range of 50-80 years and a mean body mass index of 26.0(3.4) kg/m2. 59.4% were 
women, with a mean age of 61.0(6.9) years, an age range of 50-79 years and a mean body 
mass index of 23.7(3.5) kg/m2. On average, 19.3(18.1) days were between the two 
ultrasound examinations. 
 
 
Table 6.2: Descriptive characteristics of study population with number (N), mean value and standard 
deviation (SD) and the p-value for the difference of the two examinations (T1, T2) 
 
Parameter unit 
 T1 
 
T2  
p-value  
 N mean(SD) 
 
N mean(SD)  
sBP mmHg  165 131.93(17.63) 
 
165 127.03(15.20)  <0.001 
dBP mmHg  165 77.15(9.71) 
 
165 74.23(8.76)  <0.001 
PP mmHg  165 54.78(12.34) 
 
165 52.8(10.91)  0.001 
aCIMT mm  165 0.71(0.11)  165 0.71(0.12)  0.81 
sCIMT mm  165 0.68(0.11) 
 
165 0.68(0.12)  0.72 
dCIMT mm  165 0.73(0.12) 
 
165 0.74(0.12)  0.46 
aLD mm  165 7.34(0.78) 
 
165 7.29(0.80)  0.001 
sLD mm  165 7.54(0.78) 
 
165 7.48(0.82)  <0.001 
dLD mm  165 7.14(0.78) 
 
165 7.10(0.80)  0.002 
deltaLD mm  165 0.40(0.11)  165 0.38(0.11)  0.002 
strain %  165 5.63(1.67)  165 5.40(1.59)  0.016 
DC  10-3/kPa  165 16.64(6.31) 
 
165 16.33(5.63)  0.73 
CC  mm2/kPa  165 0.65(0.21) 
 
165 0.63(0.20)  0.25 
Bstiff  no unit  165 10.43(3.81) 
 
165 10.74(3.51)  0.016 
EP  kPa  165 143.07(59.51) 
 
165 141.84(53.37)  0.78 
EINC  kPa  165 708.33(306.64)  165 699.80(270.06)  0.95 
 
a = average, d = diastolic, s = systolic, BP = blood pressure, PP = pulse pressure,  
CIMT = carotid intima media thickness, LD = lumen diameter, DC = distensibility coefficient, CC = compliance 
coefficient, Bstiff = β-stiffness index, EP = Peterson’s elastic modulus, EINC = Young’s elastic modulus. 
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Table 6.3 shows means of ICCs and means of individual CVs with 95% CI. Additionally, table 
6.3 expresses how much of the variance of different examination variables is explained by 
the factors study subject, sonographer or reader and how much of the variance is 
unexplained. The ICCs were 0.71 for systolic BP, 0.67 for diastolic BP and 0.77 for PP 
between T1 and T2. ICCs for structural properties ranged between 0.87 and 0.91 for CIMT 
and between 0.96 and 0.97 for LD. Finally, ICCs of functional parameters ranged between of 
0.75 and 0.79. Measurement variability was lowest in LD (CV = 1.6-1.7%), followed by CIMT 
(CV = 3.7-4.6) and BP (CV = 5.08-7.87). Greater measurement variability was observed for 
functional indices (CV = 11.0-13.1%). For all parameters, most of the variance was explained 
by the factor subject (>71.1%), while the factors sonographer and reader accounted for less 
than 2.9% and 1.6%, respectively, of the total variance.  
 
 
Table 6.3: Mean ICC and mean CV with 95% confidence interval (CI) and percent variation explained by the 
factors study subject, sonographer, reader and residuals 
 
Para-
meter 
Mean ICC  
(95% CI) 
Mean CV  
(95% CI) [%] 
Variance 
explained 
by subject 
[%] 
Variance 
explained by 
sonographer 
[%] 
Variance 
explained 
by reader 
[%] 
Unexplained 
variance [%] 
sBP 0.71 (0.63-0.78) 5.08 (4.39-5.77) 74.44 0.00  25.56 
dBP 0.67 (0.59-0.75) 5.21 (4.48-5.94) 71.09 0.00  28.91 
PP 0.77 (0.70-0.83) 7.87 (6.87-8.86) 77.82 0.00  22.18 
aCIMT 0.89 (0.87-0.93) 3.98 (3.52-4.44) 86.28 2.66 1.25 9.81 
sCIMT 0.87 (0.84-0.91) 4.57 (4.00-5.14) 82.38 2.89 1.60 13.13 
dCIMT 0.91 (0.88-0.94) 3.70 (3.25-4.15) 89.42 1.51 0.81 8.25 
aLD 0.97 (0.96-0.98) 1.60 (1.40-1.80) 96.32 0.00 0.32 3.36 
sLD 0.96 (0.95-0.97) 1.67 (1.46-1.87) 96.12 0.00 0.32 3.56 
dLD 0.96 (0.96-0.98) 1.59 (1.39-1.80) 96.48 0.00 0.26 3.26 
deltaLD 0.77 (0.71-0.83) 11.16 (9.74-12.59) 75.04 0.00 0.21 24.75 
strain 0.77 (0.71-0.83) 10.99 (9.53-12.45) 77.71 0.00 0.00 22.29 
DC 0.77 (0.71-0.84) 12.14 (10.58-13.71) 80.73 0.00 0.00 19.27 
CC 0.75 (0.69-0.82) 12.11 (10.56-13.65) 74.27 0.00 0.01 25.72 
Bstiff 0.75 (0.68-0.82) 11.43 (9.81-13.06) 75.98 0.00 0.00 24.02 
EP 0.79 (0.73-0.85) 11.95 (10.42-13.49) 80.74 0.00 0.00 19.26 
EINC 0.77 (0.71-0.83) 13.07 (11.37-14.78) 78.47 0.00 0.00 21.53 
 
a = average, d = diastolic, s = systolic, BP = blood pressure, PP = pulse pressure,  
CIMT = carotid intima media thickness, LD = lumen diameter, DC = distensibility coefficient, CC = compliance 
coefficient, Bstiff = β-stiffness index, EP = Peterson’s elastic modulus, EINC = Young’s elastic modulus. 
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Bland-Altman plots for carotid function parameters with mean(SD) of the differences and 
the respective values in percentage of the mean were for strain 0.2(1.1) % and 4.2(19.6) %, 
for DC 0.3(4) 10-3/kPa and 1.9(24.4) %, for CC 0.0(0.1) mm2/kPa and 2.4(22.2) %, for 
Bstiff -0.3(2.6) and 3.0(24.4) %, for EP 1.2(36.6) kPa and 0.9(25.7) %, and for EINC 8.5(196.2) 
kPa and 1.2(27.9) % (see figure 6.3). In none of the parameters the Bland-Altman plot 
revealed a drift with increasing values thus indicating stable analysis across the complete 
range of analysed parameters within the cohort.  
 
 
 
Figure 6.3: Bland-Altman plots of functional parameters at two ultrasound examinations (T1, T2) with mean 
difference as thin black line and limits of agreement as bold black lines 
Legend: DC = distensibility coefficient, CC = compliance coefficient, stiffness = β-stiffness index, EP = Peterson’s 
elastic modulus, EINC = Young’s elastic modulus. 
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Discussion 
The main results of this validation study show that the structural parameters obtained from 
SAPALDIA 3 study have an excellent reproducibility and functional indices a good 
reproducibility. Measurement variability was lowest in structural parameters followed by 
functional indices and BP variables. To our knowledge this is the first epidemiological study 
which analysed reproducibility of all generally used parameters of carotid structure and 
function to describe risk for cardiovascular events within a representative sample of the 
total study cohort. 
To better understand the significance of our reproducibility study, we compared results of 
structural and functional reproducibility analyses of different population based studies with 
our data (see table 6.4). We chose these studies, because at least one structural and 
functional carotid parameter was used as a covariate or outcome. In general, reproducibility 
of structural parameters was higher than in the Rotterdam [22], Northern Manhattan 
Prospective Cohort Study (NOMAS) [20] and Hoorn Study [18] and in line with the Multi 
Ethnic Study of Atherosclerosis Study (MESA) [19]. Functional parameters showed higher 
ICCs than in the Atherosclerosis Risk In Communities Study (ARIC) [15] or slightly lower 
reproducibility compared to the Rotterdam [9,22], Hoorn [18] or MESA Study [19]. Overall, 
structural, functional and BP parameters were in good agreement with results reported in 
literature [9,15,18–22] (see table 6.4). However, comparisons of reproducibility results for 
structural and functional parameters within population based studies remain challenging 
due to three main aspects, namely differences in vascular measurement regions (e.g. near or 
far wall of CCA), in reproducibility aspects of study design (e.g. intra- and interreader, intra- 
and interobserver, intra- and intersession) and in statistical reproducibility analyses (e.g. 
Pearson and Spearman correlation coefficient, CV, ICC). 
From a methodological point of view, measurement variability depends on anatomical 
location [16,30,31]. Therefore, it is essential that only measurements relating to the same 
wall segments can be directly compared. Even the selected studies differ in calculating the 
CIMT (i.e. mean maximum or near plus far wall etc.) and thus are not one to one comparable 
according to reproducibility with our study and among each other.  
Further, a study design considering rereading a single ultrasound examination (inter- and 
intrareader) only reflects reading reproducibility but not the complete process including the 
sonographer’s contribution and the reading process. In order to investigate study data 
quality in a way relevant for the epidemiologic research, replicate ultrasound examinations 
and readings must be performed by the same technicians and their protocols and systems 
within the same study population to guarantee that data quality depends on population 
characteristics of the examined cohort such as age, sex, morbidities and other factors.  
From a statistical point of view, the use of different statistical methods for reproducibility 
assessment and interpretation has been recommended [32]. Reproducibility analysis by 
Pearson or Spearman correlation coefficient is still very common [16,17], but these 
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correlation measures cannot identify systematic errors [29,33]. CV is dimensionless, usually 
expressed in percent, and can directly be compared across different scales. However, these 
scales must be limited by zero since CV expresses the standard deviation as percentage of 
the mean [32]. ICC can assess reproducibility of one or more repeated measurements by 
expressing the relation of explained variance by subject to total variance [33]. But since 
there are several possibilities to calculate ICC, exact description of ICC formula is required 
[27,28,33]. Mixed model analysis has the advantage of determining the explained variance 
due to different factors and one can express each factor as percentage of explained 
variance. As a consequence, we examined reproducibility data by specified mixed linear 
models, ICC, CV, and Bland-Altman to give mean differences and estimated limits of 
agreement. This multi-parametric approach gives a thorough view into the quality of the 
reproducibility of the SAPALDIA 3 data being unique so far on the cohort level. 
In general, the total variability is the sum of the different components or sources of 
variability within a study and it should be as low as possible. In theory, the unexplained 
variance ideally should be zero and the remaining variability should be attributed to the 
subject. In real clinical practice, however, no measurement system is perfect and this is also 
true for our carotid ultrasound measurements within the SAPALDIA 3 study. Thus, the total 
variability of measurements can be explained by the population and its subjects, temporal 
effects, sonographers and readers. The mixed model analyses showed that less than 2.9% of 
the measurement variation was explained by sonographer or reader and the remaining 
variability of more than 74-81% for functional and 82-96% for structural parameters were 
explained by the subject. Within the presented population based studies only the ARIC study 
reported random effects analysis of variance [15], which best describes the distribution of 
different variability sources. Comparing ARIC and SAPALDIA 3, SAPALDIA 3 explained more 
variance by the factor subject for dLD, strain, EP and DC, while a slightly lower variance 
explained by subject was found for deltaLD and CC [15]. Thus, sample sizes needed for 
future SAPALDIA cross-sectional and longitudinal risk identification will be comparable or 
slightly lower than in ARIC providing a solid basis for the upcoming analysis with carotid 
structural and functional parameters as predictors or outcome.  
 
  
6 | Atherosclerosis. 2013 Dec;231(2):448–55. 
 
 
 
 
79 
Table 6.4: Overview of structural and functional reproducibility within population based studies 
 
Cohort 
and 
Referenc
e 
Cohort Reproducibility study 
N age [years] N 
age 
[years] ICC CV [%] Remarks 
ARIC 
[15] 
15800 Range:  45-64 36 
Range: 
45-64 
Interobserver 
dBP 
PP 
dLD 
deltaLD 
strain 
DC 
CC 
EINC 
 
0.57 
0.69 
0.65 
0.76 
0.67 
0.67 
0.77 
0.66 
Interobserver 
dBP 
PP 
dLD 
deltaLD 
strain 
DC 
CC 
EINC 
 
7# 
18# 
8# 
29# 
26# 
32# 
38# 
35# 
„No history of 
hypertension, angina 
pectoris or coronary heart 
disease“ [15]. 
#CV of between-person 
calculated by random 
effects analysis of 
variance [15]. 
CHS 
[16] 
5201 > 65 
N = 22 for 
aCIMT  
N = 24 for 
dLD 
Mean 
age: 
68.6  
SD: 1.2 
    
Interreader 
aCIMT 
dLD 
Spearman  
0.91 
0.85 
FOSC 
[17] 
5124 
Ultrasou
nd 
3377 
Mean 
age: 57.9 
SD: 9.6 
37 n.p.     
Interreader 
dCIMT 
sCIMT 
 
Pearson  
0.94 
0.93 
Hoorn 
Study 
[18] 
2484 
Ultrasou
nd 
822 
Range: 
50-74 10 
Mean 
age: 
58.2 
SD: 9.5 
  
Intraobserver  
aCIMT 
aLD 
deltaLD 
DC 
CC 
EINC 
 
10.9 
2.9 
5.3 
7.0 
6.0 
11.6 
 
MESA 
[19] 
6814 Range:  45-84 
Intraobserver 
N=31 for 
CIMT 
N=211 for DC 
and EINC  
Interobserver 
N=10 for DC 
and EINC  
intrareader 
N=71 for 
CIMT 
N=204 for DC 
and EINC  
Interreader 
N=77 for 
CIMT 
 
Not 
publish
ed 
Intraobserver 
CIMT 
DC 
EINC 
 
Interobserver 
DC 
EINC 
 
Intrareader 
CIMT 
DC 
EINC 
 
Interreader 
CIMT 
 
0.95 
0.71 
0.69 
 
 
0.85 
0.84 
 
 
0.98 
0.68 
0.80 
 
 
0.87 
  
CIMT is the average of 
maximal CIMT in near and 
far wall [19]. 
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Table 6.4 continued 
 
Cohort 
and 
Referenc
e 
Cohort Reproducibility study 
N age [years] N 
age 
[years] ICC CV [%] Remarks 
NOMAS 
[20,21]  
3298 
Ultrasou
nd 
1133 
Mean 
age : 65.4 
SD : 8.8 
88  n.p.   
Intrareader 
CIMT 
Interreader 
CIMT 
 
 
5.4 
 
7.5 
 
 
Intrareader  
CIMT 
Interreader 
CIMT 
Correlation 
coefficient 
0.94 
 
0.77 
CIMT is the average of the 
near and the far wall of 
the maximal CCA CIMT, 
the maximal bifurcation 
CIMT, and the maximal ICA 
CIMT [21]. 
Rotterda
m 
[9,22] 
7983 > 50 47 n.p. 
CIMT 
DC 
0.74 
0.8 
  
CIMT is the average of the 
near and far wall CIMT 
[23]. 
SAPALDI
A  
(current 
article) 
3489 
Range:  
50-81 
Mean 
age: 
63.90 
SD: 8.07 
165 
Range: 
50-80 
Mean 
age: 
62.1 
SD:7.3 
intersession 
dBP 
sBP 
PP  
aCIMT  
dCIMT 
sCIMT 
aLD 
dLD 
sLD 
deltaLD 
strain 
DC 
CC 
Bstiff 
EP 
EINC 
 
0.67 
0.71 
0.77 
0.89 
0.91 
0.87 
0.97 
0.96 
0.96 
0.77 
0.77 
0.75 
0.75 
0.75 
0.79 
0.77 
intersession 
dBP 
sBP 
PP  
aCIMT  
dCIMT 
sCIMT 
aLD 
dLD 
sLD 
deltaLD 
strain 
DC 
CC 
Bstiff 
EP 
EINC 
5.21 
5.08 
7.87 
3.98 
3.70 
4.57 
1.60 
1.59 
1.67 
11.16 
10.99 
12.14 
12.11 
11.43 
11.95 
13.07 
  
 
a = average, d = diastolic, s = systolic, BP = blood pressure, PP = pulse pressure, CIMT = carotid intima media 
thickness, LD = lumen diameter, DC = distensibility coefficient, CC = compliance coefficient, Bstiff = β-stiffness 
index, EP = Peterson’s elastic modulus, EINC = Young’s elastic modulus, ARIC = Atherosclerosis Risk in 
Communities, CHS = the Cardiovascular Health Study, FOSC = Framingham offspring study, Hoorn = Hoorn 
Study, MESA = Multi Ethnic Study of Atherosclerosis, NOMAS = Northern Manhattan Prospective Cohort Study, 
Rotterdam = Rotterdam study, SAPALDIA = Swiss Cohort Study on Air Pollution and Lung and Heart Diseases In 
Adults, n.p. = not published, Interobserver = two ultrasound visits and minimal two different readers, 
Intraobserver = two ultrasound visits and the same reader, Interreader = one ultrasound visit and minimal two 
different readers, Interreader = one ultrasound visit and the same reader, intersession = two ultrasound visits 
with randomised reading procedure.  
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Conclusion and perspectives 
In summary, in order to investigate study data quality for further epidemiologic research, we 
evaluated the reproducibility and sources of variability of structural and functional distal CCA 
wall and lumen ultrasound measurements in a representative random sample of participants 
in the multicentre SAPALDIA 3 cohort. Structural parameters have an excellent 
reproducibility and functional indices a good reproducibility. This will provide a solid basis 
for the exploratory SAPALDIA 3 ultrasound data analyses to assess the early and late 
consequences of atherosclerosis progression and to evaluate the associations of preventive 
or prognostic determinants and carotid ultrasound structural and functional parameters 
which may help to improve cardiovascular risk stratification by using carotid ultrasound in 
clinical practice. 
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Paper abbreviations 
· BP = blood pressure 
o dBP = diastolic blood pressure 
o sBP = systolic blood pressure 
o PP = pulse pressure = systolic blood pressure – diastolic blood pressure 
 
· CCA = common carotid artery 
· DYARA = DYnamic ARtery Analysis 
 
· Functional parameters 
o DC = distensibility coefficient 
o CC = compliance coefficient 
o Bstiff = β-stiffness index 
o EP = Peterson’s elastic modulus 
o EINC = Young’s elastic modulus 
 
· Structural parameters 
o CIMT = carotid intima media thickness 
§ aCIMT = average carotid intima media thickness 
§ dCIMT = diastolic intima media thickness 
§ sCIMT = systolic intima media thickness 
o LD = lumen diameter 
§ aLD = average lumen diameter 
§ dLD = diastolic lumen diameter 
§ sLD = systolic lumen diameter 
§ deltaLD = systolic lumen diameter – diastolic lumen diameter  
 
· Statistical terms 
o CI = confidence interval 
o CV = coefficient of variation 
o ICC = intraclass coefficient 
o SD = standard deviation 
o ln = natural logarithm 
 
· Studies acronyms 
o ARIC = Atherosclerosis Risk in Communities 
o CHS = the Cardiovascular Health Study 
o FOSC = Framingham offspring study 
o Hoorn = Hoorn Study 
o MESA = Multi Ethnic Study of Atherosclerosis 
o NOMAS = Northern Manhattan Prospective Cohort Study 
o Rotterdam = Rotterdam study 
o SAPALDIA = Swiss Cohort Study on Air Pollution and Lung and Heart Diseases In 
Adults 
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SEX-SPECIFIC ASSOCIATIONS OF CARDIOVASCULAR RISK FACTORS WITH CAROTID 
STIFFNESS – RESULTS FROM THE SAPALDIA COHORT STUDY 
 
Abstract 
Objective: Manifestation of cardiovascular disease (CVD) occurs with clear sex differences. 
Carotid stiffness parameters are increasingly used for CVD risk assessment but the sex 
specific association with CVD risk factors as well as association patterns between carotid 
stiffness parameters are largely unknown, which we investigated in SAPALDIA population-
based cohort participants. 
Methods: Risk factors of 2545 participants without clinically manifest disease were 
evaluated in 2001 2003 and different carotid stiffness parameters were assessed in carotid 
ultrasound scans in 2010-2011. Stratified and non-stratified mixed linear models and 
multivariate regression analyses were used to examine sex specific associations, differences 
and association patterns of single risk factors and carotid stiffness parameters. 
Results: High-density lipoprotein cholesterol (HDL-C) was the only significant protective 
determinant of reduced carotid stiffness for both sexes (ranges of carotid stiffness 
parameters: -3.7; -0.8% of changes in geometric mean per 1SD of the risk factor on an 
inverted scale) and significant adverse risk factors were body mass index (BMI) (-0.5; 4.7%), 
systolic (-1.23; 4.7%) and diastolic blood pressure (1.4; 4.4%), heart rate (2.7; 7.9%), C-
reactive protein (0.6; 3.3%) and smoking ( 2.82; 1%), all p-values of multivariate analyses 
were < 0.01. Sex differences with stiffer carotid stiffness parameters in men were observed 
for increased heart rate (p=0.001) and low-density lipoprotein cholesterol (LDL-C) (p<0.001) 
and in women for triglyceride (p<0.003). Similar association patterns were found for most 
carotid stiffness parameters. 
Conclusion: Sex-specific associations of cardiovascular risk factors may reflect a sex-specific 
burden of atherosclerotic risk factors and similar association patterns across different 
carotid stiffness parameters within men and women may allow the use of carotid stiffness 
parameters in an exchangeable manner.  
 
Introduction 
Six major cardiovascular risk factors, hypertension, smoking, elevated blood glucose and 
cholesterol, physical inactivity and obesity cause 42.1% of total mortality worldwide and 
60.2% in high-income countries [1]. An early assessment of cardiovascular risk might 
therefore support the implementation of preventive or therapeutic interventions in 
asymptomatic but at risk subjects to reduce the economic burden of cardiovascular disease 
(CVD) [2]. Risk prediction today is generally based on risk scores like Framingham, PROCAM, 
HEART or ASCVD [3,4]. Substantial disadvantages of the score systems are that they account 
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only for specific risk factors at one time point, not reflecting risk factor burden longitudinally 
[3]. Vascular imaging biomarkers may overcome this disadvantage since the vasculature may 
indicate accumulated risk at an initial state, expressed by the deterioration of vascular 
function, and later on by structural changes in shape of arteriosclerosis and/or 
atherosclerosis [5,6]. 
Among non-invasive imaging biomarkers carotid stiffness has been increasingly examined in 
recent years. Novel software applications facilitate the analysis of single ultrasound images 
and of sequential images over several heart cycles [7–13]. Carotid stiffness parameters 
derived from such analyses are local measures of arterial stiffness [14] and encompass 
strain, distensibility, compliance, β-stiffness index, Peterson’s elastic modulus and Young’s 
elastic modulus [15–19]. Shared pathophysiological mechanisms (e.g. blood pressure (BP) or 
vascular diameter) among carotid stiffness parameters should theoretically result in similar 
associations with risk factors. However, this has not been tested neither in both sexes nor 
separately within men and women [18–26]. Further, we noticed that some studies used 
more than one carotid stiffness parameter, and reported more or less divergent associations 
of risk factors and carotid stiffness parameters in their results [18–22]. In addition, some 
investigators did not use the same statistical approach consistently for all carotid stiffness 
parameters, which impairs the comparability of the results [20,21]. The gained impressions 
indicate that differences in associations between these six carotid stiffness measurements 
may exist and should be tested. Moreover, sex differences in subclinical CVD measured with 
carotid ultrasound were not yet investigated. 
However, sex- and age-related cardiovascular morbidity and mortality risk and vascular 
remodeling, respectively, have been reported [22–25]. Women have a lower incidence of 
cardiovascular morbidity and mortality in middle age with an approximation after age 45 
years [22] and on the vascular level, carotid stiffness parameters have been shown to stiffen 
with age in both sexes, but with greater impact in older women compared to men [23,24]. 
Studies among measurements of regional or systemic arterial stiffness such as carotid-
femoral or aortic pulse wave velocity have shown to predict cardiovascular events and 
mortality [14,26]. Aortic stiffness was independently associated with different cardiovascular 
risk factors in men [27]. Moreover, a large prospective study reported sex-specific different 
associations of risk factors on aortic stiffness [28]. In contrast, negligible sex differences 
were shown for hemodynamic parameters and age investigating reference values [29]. 
However, conclusions have been shown to depend on sex and arterial segment [30]. On this 
background and focusing on local measurement of arterial stiffness, it is not clear yet 
whether cardiovascular risk factors and their cardiovascular burden result in identical 
vascular changes for men and women in the common carotid artery (CCA). 
This study intends to deepen the understanding of the long-term associations and patterns 
between several classical CVD risk factors and different carotid stiffness parameters, 
separately for men and women initially free of CVD diagnosis based on the SAPALDIA cohort 
study (Swiss Cohort Study on Air Pollution And Lung and Heart Diseases In Adults).  
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Methods 
Study design and subjects 
SAPALDIA baseline assessments were conducted in 1991 in a random population sample of 
adults aged 18-60 years (N=9651) from eight rural and urban areas of Switzerland (Aarau, 
Basel, Davos, Genève, Lugano, Montana, Payerne, Wald) [31]. The original focus of the study 
was on air pollution and respiratory health. In the follow-up surveys in 2001-2003 (SAPALDIA 
2, N=8047) and in 2010-2011 (SAPALDIA 3, N=6087) the focus was extended to 
cardiovascular health [32]. In SAPALDIA 2, cardiovascular risk factors were assessed in 6190 
subjects (49% male, 51% females) and medical treatment was collected by means of self-
report, asking for intake of antihypertensive drugs, lipid lowering agents, glucose lowering 
agents and beta-blocker within the last 30 days. In SAPALDIA 3, sequential B-mode 
ultrasound images of the CCA were obtained from 3489 participants (49% male, 51% 
females) with an age range between 50-80 years at the time of the examination.  
A total of 3410 subjects participated in both follow-up examinations. After excluding 
subjects with missing data on anthropometric parameters, classical risk factors, heart rate 
and doctor diagnosed diabetes, stroke or myocardial infarction, 2545 participants were 
available for analysis (see figure 1). Excluded SAPALDIA participants were more likely to be 
male, smokers and less physically active, had slightly higher weight, blood pressure, lipids 
and inflammatory markers compared to the study sample. The respective Swiss cantonal 
ethical committees granted the ethical approval and participants gave written informed 
consent according to their preferences either globally for all examinations or separately for 
single assessments. 
 
Measurements of risk factors at SAPALDIA 2 
The following CVD risk factors of SAPALDIA 2 were considered in the analyses: height, 
weight, body mass index (BMI), systolic BP, diastolic BP, pulse pressure, heart rate, 
creatinine, C-reactive protein (CRP), total cholesterol, triglyceride, high-density lipoprotein 
cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), pack years of smoking and 
physical activity (PA). Methods of SAPALDIA 2 are described elswhere [32]. In short, weight 
was measured without heavy clothes with a calibrated digital electronic scale (TERRAILLON, 
Bradford, MA, USA). Height was assessed by a permanently fixed telescopic scale (SECA, 
Hamburg, Germany). All BP measurements were performed in sitting position twice after a 
rest of at least 10 minutes with a standard oscillometric device (OMRON 705 CP, Tokyo, 
Japan) at the left upper arm. The second measurement was executed within three minutes. 
Venous blood samples of the antecubital vein were drawn in sitting position, centrifuged and 
the serum fractioned within four hours, stored at -80° Centigrade. Pack years of smoking and 
PA state were self-reported using questionnaires. Moderate PA was defined as activity 
causing breathlessness or sweating and totalling at least two hours per week. 
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Figure 7.1: Analytic sample - flow chart of subject inclusion 
Exclusion criteria are presented as numbers and as percentage of participants in both follow-ups. 
 
Measurements of carotid stiffness parameters at SAPALDIA 3 
Centrally trained and certified sonographers performed ultrasound examinations in all eight 
centres using the same standardised ultrasound instruments (UF-870 machine LA38 5-16 
MHz array transducer, Fukuda Denshi, Japan) and scan protocol. Bilateral sequential B-mode 
ultrasound scans of predefined anatomic CCA structures (distal intimal and adventitial layer 
of the far wall and adventitial layer of the near wall) were accomplished in supine position 
after at least 10 minutes rest with the neck rotated to either the right or left side 
standardised by a 45° foam wedge. Immediately after ultrasound examination BP was 
measured with a standard oscillometric device (OMRON 705IT, OMRON HEALTHCARE, 
Kyoto, Japan) at the left and right upper arm. Mean arterial pressure was calculated as one-
third of the pulse pressure added to the diastolic BP [15]. 
For ultrasound data analyses, a full automatic and validated B-mode image analysis program 
was used [13,33]. Expert readers traced intimal and adventitial layer of the far wall and 
media-adventitia interface of the near wall directly proximal of the carotid bifurcation over 
exactly one centimetre across at least one heart cycle in each predefined ultrasound angle. 
Whenever detection of wall layers lacked information due to insufficient ultrasound image 
quality, manual correction was done as much as necessary. Detection results and raw data 
were automatically saved and a database with single results of carotid intima media 
thickness (CIMT) in maximum systole and end-diastole and the average over heart cycles 
was generated. Outer lumen diameter was assessed simultaneously. From this data, carotid 
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stiffness parameters namely strain, distensibility, compliance, β-stiffness index, Peterson’s 
elastic modulus and Young’s elastic modulus were calculated (see supplement table 7.4). 
Lower values of strain, distensibility and compliance and higher values of Peterson’s elastic 
modulus, Young’s elastic modulus and β-stiffness index, respectively, correspond to an 
increased carotid stiffness.  
The variability and reproducibility of all carotid stiffness parameters were investigated 
previously in 165 SAPALDIA 3 participants [33]. Intraclass correlation coefficients (ICC) of 
replicate ultrasound measurements ranged between 0.75-0.79 for carotid stiffness indices. 
Coefficients of variation (CV) ranged between 11.0-13.1% [33]. 
 
Statistical analyses 
Sex-specific descriptive analyses of the study population characteristics and cardiovascular 
risk factors at SAPALDIA 2 and hemodynamic parameters at SAPALDIA 3 were performed. 
Sex differences were assessed by the two sample t-test. Carotid stiffness parameters got 
close to normally distributed after log transformation. Statistical significance was defined as 
p<0.05. The Bonferroni-Holm method was used to assess statistical significance in multiple 
comparisons. 
To investigate sex-specific associations between SAPALDIA 2 cardiovascular risk factors and 
SAPALDIA 3 carotid stiffness parameters and to appropriately deal with multiple comparison 
issues we performed stratified multivariate regression analyses considering all carotid 
stiffness parameters as six-dimensional outcome and included each CVD risk factor 
separately along with age, education level (obligatory school education, higher education 
and college education) and medication information (antihypertensive, lipid lowering, glucose 
lowering treatment) at SAPALDIA 2, mean arterial BP and study centres at SAPALDIA 3. The 
raw p-value of each risk factor was calculated using an F-test with 6 numerator degrees of 
freedom. The statistically significant risk factors were determined using the Bonferroni-Holm 
method. For the graphical illustration we calculated sex-stratified mixed linear models 
considering the same covariates as above but study centres were now treated as random 
intercepts to account for regional clustering.  
To investigate sex differences, we performed multivariate regression analyses for each CVD 
risk factor separately including interaction terms of sex with the respective risk factor and all 
covariates. The raw p-value of the sex-risk factor interaction was calculated using an F-test 
with 6 numerator degrees of freedom, and the statistically significant sex-risk factor 
interactions were determined using the Bonferroni-Holm method.  
To investigate sex-specific association patterns and to assess potential heterogeneity of the 
effects of a given risk factor on the different log-transformed carotid stiffness parameters, all 
risk factors were first z-standardised separately for men and women, enabling each effect 
estimate to be interpreted as percentage change in the geometric mean of the respective 
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carotid stiffness parameter associated with an increase in the respective risk factor by one 
standard deviation [34]. To have higher values of carotid stiffness parameters correspond to 
a stiffer artery, strain, compliance and distensibility were multiplied by minus one (labelled 
as inverted scale). Sex-stratified multivariate regressions and mixed linear models and were 
conducted considering standardised risk factors and the same covariates as in the sex-
specific association analyses. To quantify the degree of heterogeneity in the associations of a 
given risk factor with the 6 carotid stiffness parameters, we performed F-tests with 5 
numerator degrees of freedom testing the null hypothesis of equal regression coefficients. 
Based on these analyses and to explore heterogeneity, five different multivariate carotid 
stiffness models were defined. All analyses were performed using the statistical software 
STATA (StataCorp 12, Statistical Software, College Station, TX: StataCorp LPTexas, USA). 
 
Results  
Sex-specific characteristics of the study population with respect to cardiovascular risk factors 
assessed in SAPALDIA 2 and carotid stiffness and hemodynamic parameters assessed in 
SAPALDIA 3 are shown in table 7.1.  
 
Sex-specific associations and sex differences 
Detailed sex-specific adjusted association estimates between different carotid stiffness 
parameters and non-standardised cardiovascular risk factors are reported in the 
supplement table 7.5. According to the multivariate analyses with subsequent Bonferroni-
Holm correction of p-values, significant associations for both sexes were found for height, 
weight, body mass index, systolic and diastolic BP, pulse pressure, heart rate, CRP, HDL-C 
and smoking, as well as for total cholesterol and LDL-C in men and for creatinine and 
triglyceride in women (table 7.2). Multivariate analyses with interaction terms and 
subsequent Bonferroni-Holm correction of p-values showed significant sex differences for 
LDL-C, heart rate and triglyceride (table 7.2). Adjusted associations of log transformed 
carotid stiffness parameters with z-standardised risk factors are displayed in figure 7.2 and 
detailed estimates are presented in the supplement table 7.6. 
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Table 7.1: Characteristics of study population with respect to cardiovascular risk factors assessed in 
SAPALDIA 2 and carotid stiffness and hemodynamic parameters assessed in SAPALDIA 3, for men and 
women 
 
Characteristics Units 
 Men (N=1211)  Women (N=1334)  p-
value*  Mean(SD)  Mean(SD)  
SA
PA
LD
IA
 2
 
Age years  55.08(7.99)  55.22(8.00)  0.66 
Height cm  175.37(6.31)  162.62(6.11)  <0.001 
Weight kg  81.36(11.33)  65.50(11.56)  <0.001 
Body mass index kg/m2  26.45(3.34)  24.77(4.22)  <0.001 
Systolic BP mmHg  132.93(17.10)  121.49(18.37)  <0.001 
Diastolic BP mmHg  83.44(10.67)  77.44(10.27)  <0.001 
Pulse pressure mmHg  49.49(10.88)  44.05(11.89)  <0.001 
Heart rate bpm  69.45(10.70)  70.67(9.50)  0.002 
Creatinine μmol/l  94.43(10.55)  81.81(9.20)  <0.001 
CRP mg/l  1.99(3.34)  1.95(2.61)  0.75 
Total cholesterol mmol/l  6.16(1.08)  6.16(1.12)  0.96 
Triglyceride mmol/l  2.10(1.24)  1.55(0.90)  <0.001 
HDL-C mmol/l  1.35(0.37)  1.72(0.43)  <0.001 
LDL-C mmol/l  3.85(0.99)  3.74(1.04)  0.005 
Smoking pack years  12.98(20.19)  7.56(13.84)  <0.001 
Physical activity %  38.1  23.1  <0.001 
 Medication intake %   18.7  13.4  <0.001 
 Anti-hypertensive %  13.8  10.9  0.03 
 Lipid-lowering %  8.1  3.4  <0.001 
 Glucose-lowering %  0.0  0.1†  0.3 
         
SA
PA
LD
IA
 3
 
Systolic BP mmHg  137.88(16.94)  132.42(18.92)  <0.001 
Diastolic BP mmHg  79.94(9.46)  76.53(9.18)  <0.001 
Pulse pressure mmHg  57.94(12.04)  55.88(14.22)  <0.001 
Mean arterial BP mmHg  99.25(11.09)  95.16(11.42)  <0.001 
        
Stiffness 
parameters Units  
Geometric mean  
(95% CI)  
Geometric mean  
(95% CI)  
p-
value 
Strain %  5.13 (5.04; 5.23)  5.25 (5.16; 5.34)  <0.001 
Compliance  mm2/kPa  0.65 (0.64; 0.66)  0.57 (0.56; 0.58)  <0.001 
Distensibility 10-3/kPa  0.0139 (0.0136; 0.0142)  0.0149 (0.0146; 0.0152)  <0.001 
β-stiffness index no unit  10.48 (10.28; 10.69)  10.23 (10.03; 10.43)  <0.001 
Peterson’s EM kPa  147.5 (144.4; 150.7)  137.9 (134.9; 141.0)  <0.001 
Young’s EM kPa  744.3 (728.0; 761.0)  660.4 (645.8; 675.4)  <0.001 
 
CI = confidence interval, N = number, SD = standard deviation, BP = Blood pressure, CRP = C-reactive protein, 
EM = elastic modulus HDL-C = high-density lipoprotein cholesterol, LDL-C = low-density lipoprotein cholesterol, 
Medication intake = anti-hypertensive or lipid- or glucose-lowering medication, *p-value for differences 
between men and women, † self-reported glucose lowering medication but no self-reported doctor diagnosed 
diabetes. 
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Table 7.2: Significance of the associations of single cardiovascular risk factors (per unit) across all six carotid 
stiffness parameters (log-transformed) separately for men, women and for the respective sex differences 
 
Risk factors  Men p-value  
Women 
p-value  
Sex difference 
p-value 
Height  <0.001 †  <0.001 †  0.74  Weight  <0.001 †  <0.001 †  0.20  Body mass index  <0.001 †  <0.001 †  0.02  Systolic blood pressure  <0.001 †  <0.001 †  0.41  Diastolic blood pressure  0.01 †  <0.001 †  0.04  Pulse pressure  <0.001 †  <0.001 †  0.04  Heart rate  <0.001 †  <0.001 †  0.001 † 
Creatinine  0.05   0.007 †  0.67  C-reactive protein  0.006 †  <0.001 †  0.06  Total cholesterol  <0.001 †  0.03   0.016  Triglyceride  0.03   <0.001 †  0.003 † HDL-C  <0.001 †  <0.001 †  0.58  LDL-C  <0.001 †  0.04   <0.001 † Smoking  <0.001 †  0.001 †  0.51  Physical activity  0.79   0.57   0.84   
P-values were based on multivariate regression analyses with a subsequent F-test performed.  
† = Significant after Bonferroni-Holm correction, HDL-C = high-density lipoprotein cholesterol, LDL-C = low-
density lipoprotein cholesterol. 
 
Sex-specific association patterns 
Association patterns of carotid stiffness parameters with standardised risk factors are 
visualised in the figure 7.3, separately for men and women. Overall, strong mutual 
correlations were found for Young’s elastic modulus, Peterson’s elastic modulus, β-stiffness 
index and distensibility (│r│ = 0.89-0.99) while compliance and strain were less strongly 
correlated among themselves (with r = 0.76) and with the other carotid stiffness parameters 
(│r│ = 0.74-0.88).  
Multivariate analyses showed significant heterogeneity in association patterns within 
different standardised risk factors (supplement table 7.7). Homogeneous association 
patterns across all carotid stiffness parameters were found for PA in both sexes, for diastolic 
BP, creatinine and triglyceride in men and for cholesterol and LDL-C in women. Pairwise 
comparisons showed that associations of compliance with height, weight, body mass index, 
pulse pressure, creatinine, HDL-C and smoking strongly differed from those of other carotid 
stiffness parameters for both sexes and with systolic BP and heart rate in women. Moreover, 
associations of strain with systolic and pulse pressure differed from those of the other 
carotid stiffness parameters in both sexes and for diastolic BP and heart rate in women. 
Further sub analyses showed that heterogeneity in LDL-C and total cholesterol was removed 
in a model without Young’s elastic modulus in men (data not shown). The ranges of 
estimated effects of standardised risk factors on carotid stiffness parameters are presented 
in the table 7.3. Association patterns are shown in figure 7.2 and figure 7.3 and detailed 
information are presented in supplement table 7.6-7.7. 
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Figure 7.2: Sex-specific associations of single cardiovascular risk factors (per 1 SD) for each carotid stiffness parameter (log-transformed). Women = grey line, men = black line 
Association estimates were based on mixed linear regression analyses adjusted for age, education level, medication, mean arterial pressure and study centre. Physical activity is a 
binary variable. BP = blood pressure, Cholesterol = total cholesterol, CRP = C-reactive protein, HDL-C = high density lipoprotein cholesterol, LDL-C = low density lipoprotein 
cholesterol, SD = standard deviation. 
7 | Atherosclerosis 2014 Jun;235(2):576-84 
 
 
 
 
95 
Discussion 
Our analyses provide estimates of long-term adverse effects of cardiovascular risk factors 
assessed in SAPALDIA 2 on carotid stiffness parameters assessed ten years later in SAPALDIA 
3. To our knowledge, this is the first population-based study in elderly Caucasians 
investigating the sex-specific associations, sex differences and carotid stiffness association 
patterns of established CVD risk factors with several carotid stiffness parameters. While we 
find a high agreement for the effects of most CVD risk factors in men and women (strongest 
for anthropometrics and hemodynamic parameters), the analyses reveal effects of different 
size in men and women for heart rate, LDL-C and triglyceride. The only long-term 
determinant showing consistent protective associations with all carotid stiffness parameters 
in both sexes was HDL-C. The hypothesis of similar association patterns between carotid 
stiffness parameters and risk factors was partially rejected. Despite the high to medium 
mutual correlations of carotid stiffness parameters, their associations with some of the risk 
factors showed partially significant heterogeneity. Associations of compliance with 
anthropometric variables were different from those of the other carotid stiffness 
parameters and strain showed a distinct association pattern with the BP variables.  
 
Sex differences in associations of risk factors and carotid stiffness parameters 
Increased heart rate was more strongly associated with stiffer arteries across all carotid 
stiffness parameters in men as compared to women. This association is pathophysiologically 
important since an enhanced mechanical load induces vascular smooth muscle cell growth 
and collagen deposition, processes potentially associated with arterial stiffening [15]. An 
association between increased heart rate and increased carotid stiffness has been reported 
in a cross-sectional analysis in normotensive as well as in hypertensive subjects in a clinical 
setting [35,36]. Further, increase of heart rate by ventricular pacing caused reduced 
distensibility of the carotid artery [37]. Moreover, it has been shown that an increased heart 
rate is related to increased incidence of CVD and mortality [38]. 
Further sex differences in association estimates were observed for LDL-C and triglyceride. 
Since the basic lipid profile also includes HDL-C and total cholesterol beside LDL-C and 
triglyceride [39], a discussion of the whole panel is needed. HDL-C was the only determinant 
significantly associated with less carotid stiffness in both sexes. Triglyceride was significantly 
associated with increased carotid stiffness in women, but not in men. The exact opposite 
was found for LDL-C and total cholesterol, although the sex-difference for total cholesterol 
lost its statistical significance after Bonferroni-Holm correction. A recent study concluded 
that lower non-HDL-C concentration in women was related to lower cholesterol synthesis 
and absorption [40]. Values of total cholesterol in SAPALDIA 2 did not differ between men 
and women. Nevertheless, the meta-analysis of ‘prospective Studies Collaboration’ has 
shown that a reduction of 1 mmol/l of total cholesterol was associated with a reduction of 
ischaemic heart disease by one sixth to one third in participants aged 50 years or older [41]. 
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Similarly, in our study, a 1 mmol/l increase of total cholesterol was associated with 
significant increases carotid stiffness of |1.5 to 1.8%| in the geometric means of strain, 
distensibility, β-stiffness index and Peterson’s elastic modulus in men, but not in women 
(supplement table 7.5).  
Overall, the observed sex differences in the associations of carotid stiffness-parameters with 
heart rate, triglyceride and LDL-C were statistically significant. This is potentially relevant to 
clinical treatment and preventive strategies.  
 
Carotid stiffness parameter patterns 
Multivariate analyses using z-standardized risk factors showed very similar association 
patterns across risk factors for Peterson’s elastic modulus, β-stiffness index and distensibility 
and this suggests that they could be used in an exchangeable manner. With the exception of 
few risk factors, this extends to strain and Young’s elastic modulus. The question arises 
whether all carotid stiffness parameters need to be measured in future clinical studies. 
Strain differed from other stiffness parameters solely in its positive association with BP 
values. At a first glance, this positive association seems implausible, since we would expect 
an inverse association. Lower values of strain corresponding to a stiffer artery and, on the 
opposite, high strain values are an expression of an improved vascular function as shown for 
HDL-C. However, BP and especially pulse pressure have a direct mechanical impact on 
diameter change resulting in increased strain values since strain is only the relative change 
of the diameter without accounting for BP values (supplement table 7.4). Investigation of 
multiple risk factors may result in divergent associations with strain and therefore we 
recommend using and interpreting the respective results with caution. In case of Young’s 
elastic modulus, different associations were observed for LDL-C and total cholesterol. One 
must keep in mind that its formula includes CIMT and therefore reflects the atherosclerotic 
process in a slightly different way.  
Compliance showed deviating association patterns with a range of risk factors. This might be 
due to the fact that the mathematical formula of compliance is the only one containing the 
cross-sectional area, instead of the diameter of the CCA (supplement table 7.4). Since most 
of the risk factor are associated with increased carotid diameter, as shown also by Polak et 
al. [42], their impact might be stronger for compliance than for the other carotid stiffness 
parameters. Based on our results we question whether compliance is a suitable parameter 
for cardiovascular risk assessment.  
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Table 7.3: Ranges of association estimates of cardiovascular risk factors on carotid stiffness parameters for 
different models 
 
 Risk factors 
Model 1: 
All CS 
parameters 
(min; max) 
Model 2:  
All CS 
parameters 
except 
compliance 
(min; max) 
Model 3: 
All CS 
parameters 
except strain  
(min; max) 
Model 4:  
All CS 
parameters 
except 
compliance and 
strain 
(min; max) 
Model 5: 
All CS 
parameters 
except 
compliance, 
strain and 
Young’s elastic 
modulus 
(min; max) 
M
en
 
Height (-3.16; 0.89) (0.03; 0.89) (-3.16; 0.89) (0.03; 0.89) (0.03; 0.04) 
Weight (-1.07; 4.39) (3.93; 4.39) (-1.07; 4.23) (3.93; 4.23) (3.93; 3.99) 
Body mass index (0.51; 4.67) (4.31; 4.67) (0.51; 4.56) (4.31; 4.56) (4.46; 4.56) 
Systolic blood 
pressure (-1.23; 3.33) (-1.23; 3.33) (1.44; 3.33) (3.05; 3.33) (3.10; 3.33) 
Diastolic blood 
pressure (3.38; 4.12) (3.83; 4.12) (3.38; 4.00) (3.83; 4.00) (3.83; 3.89) 
Pulse pressure (-5.41; 1.20) (-5.41; 1.20) (-1.00; 1.20) (0.72; 1.20) (0.91; 1.20) 
Heart rate (6.14; 7.88) (6.92; 7.88) (6.14; 7.88) (6.92; 7.88) (6.92; 7.26) 
Creatinine (-0.23; 1.79) (-0.23; 0.58) (-0.23; 1.79) (-0.23; 0.04) (0.02; 0.04) 
C-reactive protein (0.61; 2.42) (0.81; 2.42) (0.61; 2.42) (1.81; 2.42) (1.81; 1.90) 
Total cholesterol (0.37; 1.93) (0.37; 1.93) (0.37; 1.93) (0.37; 1.93) (1.88; 1.93) 
Trigyceride (0.32; 2.00) (1.15; 2.00) (0.32; 2.00) (1.88; 2.00) (1.88; 1.92) 
HDL-C (-3.71; -0.78) (-3.71; -2.30) (-3.30; -0.78) (-3.30; -2.30) (-3.30; -3.12) 
LDL-C (0.16; 2.50) (0.16; 2.50) (0.16; 2.24) (0.16; 2.24) (2.22; 2.24) 
Smoking (-2.82; 1.00) (-0.51; 1.00) (-2.82; 0.08) (-0.51; 0.08) (0.07; 0.08) 
Physical activity (-1.04; 1.53) (-1.04; 0.01) (-0.37; 1.53) (-0.37; 0.01) (-0.05; 0.01) 
       
W
om
en
 
Height (-4.01; -0.26) (-1.26; -0.26) (-4.01; -0.26) (-1.26; -0.26) (-1.26; -1.17) 
Weight (-2.10; 2.22) (1.64; 2.22) (-2.10; 2.02) (1.64; 2.02) (1.64; 1.69) 
Body mass index (-0.43; 2.67) (2.36; 2.67) (-0.43; 2.45) (2.36; 2.45) (2.39; 2.45) 
Systolic blood 
pressure (0.13; 4.68) (0.13; 4.68) (1.96; 4.68) (3.27; 4.68) (4.41; 4.68) 
Diastolic blood 
pressure (1.41; 4.37) (1.92; 4.37) (1.41; 2.03) (1.92; 2.03) (1.96; 2.03) 
Pulse pressure (-3.71; 4.71) (-3.71; 4.71) (1.48; 4.71) (2.82; 4.71) (4.32; 4.71) 
Heart rate (2.74; 4.77) (2.74; 4.77) (2.74; 4.26) (2.74; 2.86) (2.74; 2.81) 
Creatinine (-1.40; 0.64) (-1.40; 0.37) (-1.40; 0.64) (-1.40; -0.67) (-0.73; -0.67) 
C-reactive protein (2.18; 3.27) (3.05; 3.27) (2.18; 3.27) (3.22; 3.27) (3.22; 3.26) 
Total cholesterol (-1.70; 0.11) (-1.70; -0.55) (-1.70; 0.11) (-1.70; -0.55) (-0.57; -0.55) 
Trigyceride (1.97; 3.69) (1.97; 3.69) (1.97; 3.23) (1.97; 3.23) (3.19; 3.23) 
HDL-C (-3.47; -1.71) (-3.47; -2.40) (-3.25; -1.71) (-3.25; -2.40) (-3.25; -3.07) 
LDL-C (-1.51; 0.06) (-1.51; -0.47) (-1.51; 0.06) (-1.51; -0.47) (-0.48; -0.47) 
Smoking (-2.82; -0.82) (-1.01; -0.82) (-2.82; -0.82) (-0.96; -0.82) (-0.86; -0.82) 
Physical activity (-1.46; -0.14) (-1.46; -0.91) (-1.46; -0.14) (-1.46; -0.91) (-1.46; -1.39) 
 
Values are expressed as percent change in geometric mean per 1 SD increment. Association estimates were 
based on mixed linear regression models adjusted for age, education level, medication, mean arterial pressure 
and study centre. Scales for strain, compliance and distensibility were inverted. Physical activity is a binary 
variable. CRP = C-reactive protein, HDL-C = high-density lipoprotein cholesterol, LDL-C = low-density lipoprotein 
cholesterol, SD = standard deviation. 
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Figure 7.3: Association patterns of cardiovascular risk factors (per 1 SD) and six carotid stiffness parameters 
(log-transformed) separately for men and women 
Association estimates were based on mixed linear regression analyses adjusted for age, education level, 
medication, mean arterial pressure and study centre. Scales for strain, compliance and distensibility were 
inverted. Physical activity is a binary variable. BP = blood pressure, Cholesterol = total cholesterol, CRP = C-
reactive protein, EM = elastic modulus, HDL-C = high-density lipoprotein cholesterol, LDL-C = low-density 
lipoprotein cholesterol, SD = standard deviation.  
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Strengths and limitations 
The highly standardised procedures of biomarker and ultrasound assessment, image 
analyses and validation combined in a large cohort are clear strengths of this study. It 
allowed us to investigate the longitudinal associations of CVD risk factors assessed in 
SAPALDIA 2 with carotid stiffness parameters obtained in SAPALDIA 3 for the first time. 
However, the study population is primarily Caucasian and the age range is limited to 50-80 
years at the last examination we measured brachial instead of central BP which may have 
overestimated carotid stiffness [14]. Although the difference of brachial and central pulse 
pressure decreases with advancing age [15], it’s not clear how this variability - which is also 
dependent on heart rate - affects the association estimates, especially if the differences vary 
in males and females [43]. Furthermore, some cardiovascular diagnoses are based on self-
report and we could not investigate the longitudinal change in carotid stiffness itself since 
carotid stiffness was measured only in SAPALDIA 3. Therefore, it is not possible to infer a 
causal relationship between risk factors and carotid stiffness parameters. Prior studies have 
documented the predictive power of single carotid stiffness parameters [18,44,45], but did 
not compare the sensitivity and predictability of carotid stiffness parameters among each 
other. Although we found very similar association pattern for most of the carotid stiffness 
parameters, we recommend to investigate all these carotid stiffness parameters in 
correlation with hard cardiovascular endpoints in order to confirm our results and to 
precisely figure out whether similarities justify exchangeability of different carotid stiffness 
parameters.  
 
Conclusion and perspectives  
This first investigation of long-term associations of cardiovascular risk factors assessed in 
2001-2003 with several common carotid stiffness parameters measured ten years later in an 
elderly population without diagnosed CVD shows sex differences in association estimates for 
heart rate, LDL-C and triglyceride. Increased heart rate was more strongly associated with 
stiffer arteries across all carotid stiffness parameters in men than in women. LDL-C was 
significantly associated with carotid stiffness only in men and triglyceride only in women. 
These results emphasize the importance of clarifying and estimating sex-specific associations 
of atherosclerotic risk factors. We were able to show comparable CVD risk association 
patterns for distensibility, β-stiffness index, Peterson’s elastic modulus and partially Young’s 
elastic modulus in men and women, suggesting that these carotid stiffness parameters might 
be used in an exchangeable manner. Since transcutaneous ultrasound measurement and 
their reproducible automated image analyses become increasingly available, a simplification 
of the use and interpretation of carotid stiffness parameters might facilitate implementation 
of these instruments in clinical practice.  
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Supplement Table 7.4: Formulas of carotid stiffness parameters based on a one centimetre detection 
segment 
 
Parameter Unit Formula  
Strain % deltaLD / dLD [15] 
Distensibility 1/kPa ((2 × deltaLD × dLD)+(deltaLD)2)/(PP× dLD2) [17] 
Compliance mm2/kPa π×((2× deltaLD × dLD)+(deltaLD)2)/(4×PP) [17] 
β-stiffness index no unit (ln(sBP/dBP))/(deltaLD/dLD)  [16] 
Peterson’s elastic modulus kPa dLD×PP/deltaLD [15] 
Young’s elastic modulus kPa dLD/(aCIMT × distensibility) [18] 
 
aCIMT = average carotid intima media thickness across heart cycle, deltaLD = delta lumen diameter, dLD = 
diastolic lumen diameter, dBP= diastolic blood pressure, sBP = systolic blood pressure, PP = pulse pressure (sBP 
– dBP), ln = natural logarithm. 
 
 
 
Supplement Table 7.5: Sex-specific associations of cardiovascular risk factors (per unit) with six CS 
parameters for men, women and for the respective sex differences 
 
 
risk factors units 
men  women  
sex 
differences  
p-value 
 
Change in geometric 
mean (CI) [%] 
p-
value 
 
Change in geometric 
mean (CI) [%] 
p-
value 
 
 
St
ra
in
 [%
] 
height 10 cm -1.01 (-3.81 ; 1.87) 0.49  0.81 (-1.75 ; 3.44) 0.54  0.35 
weight 10 kg -3.89 (-5.35 ; -2.40) 0.00  -1.93 (-3.22 ; -0.61) 0.00  0.05 
BMI 5 kg/m2 -6.91 (-9.34 ; -4.42) 0.00  -3.16 (-4.96 ; -1.33) 0.00  0.02 
systolic BP 10 mmHg 0.72 (-0.48 ; 1.93) 0.24  -0.07 (-1.09 ; 0.96) 0.89  0.33 
diastolic BP 10 mmHg -3.87 (-5.64 ; -2.07) 0.00  -4.26 (-5.89 ; -2.59) 0.00  0.76 
pulse pressure 10 mmHg 4.96 (3.16 ; 6.78) 0.00  3.11 (1.59 ; 4.66) 0.00  0.13 
heart rate 10 bpm -6.96 (-8.41 ; -5.49) 0.00  -5.01 (-6.50 ; -3.50) 0.00  0.07 
creatinine 1 μmol/l -0.06 (-0.22 ; 0.11) 0.51  -0.04 (-0.21 ; 0.13) 0.63  0.90 
CRP 1 mg/l -0.24 (-0.76 ; 0.27) 0.36  -1.18 (-1.76 ; -0.59) 0.00  0.02 
cholesterol 1 mmol/l -1.51 (-3.09 ; 0.09) 0.07  0.75 (-0.66 ; 2.18) 0.30  0.04 
triglyceride 1 mmol/l -0.93 (-2.32 ; 0.47) 0.19  -4.10 (-5.76 ; -2.42) 0.00  0.00 
HDL-C 1 mmol/l 10.33 (5.32 ; 15.59) 0.00  8.24 (4.47 ; 12.13) 0.00  0.52 
LDL-C 1 mmol/l -2.53 (-4.24 ; -0.79) 0.00  0.84 (-0.66 ; 2.37) 0.27  0.00 
smoking pack years -0.05 (-0.14 ; 0.04) 0.26  0.07 (-0.04 ; 0.18) 0.20  0.09 
moderate PA  yes/no 1.04 (-2.56 ; 4.77) 0.57  1.26 (-2.40 ; 5.06) 0.50  0.93 
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Supplement Table 7.5 continued 
 
 
risk factors units 
men  women  
sex 
differences  
p-value 
 
Change in geometric 
mean (CI) [%] 
p-
value 
 
Change in geometric 
mean (CI) [%] 
p-
valu
e 
 
 
Co
m
pl
ia
nc
e 
[m
m
2/
kP
a]
 
height 10 cm 5.05 (1.79 ; 8.41) 0.00  6.65 (3.70 ; 9.69) 0.00  0.48 
weight 10 kg 0.95 (-0.77 ; 2.69) 0.28  1.82 (0.34 ; 3.32) 0.02  0.46 
BMI 5 kg/m2 -0.77 (-3.65 ; 2.20) 0.61  0.51 (-1.54 ; 2.60) 0.63  0.49 
systolic BP 10 mmHg -0.85 (-2.14 ; 0.47) 0.21  -1.07 (-2.18 ; 0.05) 0.06  0.80 
diastolic BP 10 mmHg -3.17 (-5.15 ; -1.15) 0.00  -1.38 (-3.22 ; 0.51) 0.15  0.20 
pulse pressure 10 mmHg 0.92 (-1.01 ; 2.88) 0.35  -1.24 (-2.85 ; 0.39) 0.14  0.09 
heart rate 10 bpm -5.75 (-7.39 ; -4.08) 0.00  -4.48 (-6.13 ; -2.81) 0.00  0.29 
creatinine 1 μmol/l -0.17 (-0.35 ; 0.01) 0.07  -0.07 (-0.25 ; 0.11) 0.45  0.44 
CRP 1 mg/l -0.18 (-0.75 ; 0.39) 0.53  -0.84 (-1.49 ; -0.19) 0.01  0.14 
cholesterol 1 mmol/l -0.68 (-2.44 ; 1.11) 0.45  -0.10 (-1.63 ; 1.46) 0.90  0.63 
triglyceride 1 mmol/l -0.26 (-1.79 ; 1.30) 0.74  -2.21 (-4.06 ; -0.31) 0.02  0.12 
HDL-C 1 mmol/l 2.12 (-3.03 ; 7.54) 0.43  4.02 (0.03 ; 8.16) 0.05  0.58 
LDL-C 1 mmol/l -0.93 (-2.85 ; 1.03) 0.35  -0.06 (-1.70 ; 1.61) 0.94  0.51 
smoking pack years 0.14 (0.04 ; 0.23) 0.00  0.20 (0.08 ; 0.32) 0.00  0.41 
moderate PA  yes/no -1.53 (-5.39 ; 2.50) 0.45  0.14 (-3.75 ; 4.19) 0.94  0.56  
           
Di
st
en
sib
ilit
y [
10
-3
/k
Pa
] 
height 10 cm -0.07 (-2.82 ; 2.76) 0.96  2.06 (-0.57 ; 4.76) 0.12  0.28 
weight 10 kg -3.47 (-4.91 ; -2.01) 0.00  -1.47 (-2.79 ; -0.12) 0.03  0.05 
BMI 5 kg/m2 -6.61 (-8.98 ; -4.17) 0.00  -2.90 (-4.73 ; -1.03) 0.00  0.02 
systolic BP 10 mmHg -1.87 (-3.00 ; -0.73) 0.00  -2.45 (-3.46 ; -1.44) 0.00  0.46 
diastolic BP 10 mmHg -3.60 (-5.34 ; -1.82) 0.00  -1.98 (-3.70 ; -0.23) 0.03  0.20 
pulse pressure 10 mmHg -0.97 (-2.64 ; 0.73) 0.26  -3.71 (-5.15 ; -2.25) 0.00  0.02 
heart rate 10 bpm -6.48 (-7.90 ; -5.04) 0.00  -2.93 (-4.49 ; -1.35) 0.00  0.00 
creatinine 1 μmol/l 0.00 (-0.16 ; 0.16) 0.97  0.08 (-0.09 ; 0.25) 0.36  0.49 
CRP 1 mg/l -0.57 (-1.07 ; -0.07) 0.03  -1.24 (-1.84 ; -0.65) 0.00  0.09 
cholesterol 1 mmol/l -1.79 (-3.32 ; -0.23) 0.02  0.51 (-0.92 ; 1.96) 0.49  0.03 
triglyceride 1 mmol/l -1.54 (-2.88 ; -0.19) 0.03  -3.55 (-5.24 ; -1.82) 0.00  0.07 
HDL-C 1 mmol/l 9.16 (4.32 ; 14.23) 0.00  7.70 (3.90 ; 11.65) 0.00  0.65 
LDL-C 1 mmol/l -2.27 (-3.94 ; -0.57) 0.01  0.47 (-1.06 ; 2.01) 0.55  0.02 
smoking pack years 0.00 (-0.09 ; 0.08) 0.92  0.06 (-0.05 ; 0.17) 0.28  0.35 
moderate PA  yes/no 0.01 (-3.47 ; 3.62) 0.99  1.42 (-2.30 ; 5.29) 0.46  0.59 
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Supplement Table 7.5 continued 
 
 
risk factors units 
men  women  
sex 
differences  
p-value 
 
Change in geometric 
mean (CI) [%] 
p-
value 
 
Change in geometric 
mean (CI) [%] 
p-
valu
e 
 
 
β-
st
iff
ne
ss
 in
de
x [
no
 u
ni
t] 
height 10 cm 0.04 (-2.65 ; 2.81) 0.98  -1.91 (-4.38 ; 0.62) 0.14  0.30 
weight 10 kg 3.47 (1.96 ; 4.99) 0.00  1.42 (0.09 ; 2.77) 0.04  0.05 
BMI 5 kg/m2 6.83 (4.18 ; 9.55) 0.00  2.84 (0.94 ; 4.77) 0.00  0.02 
systolic BP 10 mmHg 1.80 (0.65 ; 2.96) 0.00  2.38 (1.35 ; 3.42) 0.00  0.47 
diastolic BP 10 mmHg 3.63 (1.80 ; 5.50) 0.00  1.93 (0.19 ; 3.71) 0.03  0.19 
pulse pressure 10 mmHg 0.83 (-0.83 ; 2.52) 0.33  3.62 (2.11 ; 5.16) 0.00  0.02 
heart rate 10 bpm 6.77 (5.19 ; 8.38) 0.00  2.96 (1.35 ; 4.60) 0.00  0.00 
creatinine 1 μmol/l 0.00 (-0.16 ; 0.16) 0.98  -0.07 (-0.24 ; 0.09) 0.38  0.52 
CRP 1 mg/l 0.54 (0.05 ; 1.04) 0.03  1.24 (0.64 ; 1.83) 0.00  0.08 
cholesterol 1 mmol/l 1.74 (0.19 ; 3.31) 0.03  -0.49 (-1.88 ; 0.91) 0.49  0.04 
triglyceride 1 mmol/l 1.51 (0.17 ; 2.88) 0.03  3.61 (1.84 ; 5.42) 0.00  0.07 
HDL-C 1 mmol/l -8.26 (-12.24 ; -4.11) 0.00  -7.02 
(-10.23 ; -
3.70) 0.00  0.64 
LDL-C 1 mmol/l 2.25 (0.55 ; 3.98) 0.01  -0.45 (-1.93 ; 1.04) 0.55  0.02 
smoking pack years 0.00 (-0.08 ; 0.09) 0.93  -0.06 (-0.17 ; 0.05) 0.27  0.35 
moderate PA  yes/no -0.05 (-3.45 ; 3.47) 0.98  -1.46 (-5.00 ; 2.20) 0.43  0.58  
           
Pe
te
rs
on
’s 
el
as
tic
 m
od
ul
us
 [k
Pa
]  
height 10 cm 0.05 (-2.65 ; 2.82) 0.97  -1.99 (-4.46 ; 0.56) 0.12  0.28 
weight 10 kg 3.51 (2.00 ; 5.04) 0.00  1.45 (0.11 ; 2.80) 0.03  0.05 
BMI 5 kg/m2 6.90 (4.24 ; 9.63) 0.00  2.90 (1.00 ; 4.84) 0.00  0.02 
systolic BP 10 mmHg 1.94 (0.78 ; 3.10) 0.00  2.52 (1.48 ; 3.57) 0.00  0.46 
diastolic BP 10 mmHg 3.64 (1.80 ; 5.51) 0.00  1.91 (0.16 ; 3.69) 0.03  0.18 
pulse pressure 10 mmHg 1.11 (-0.56 ; 2.80) 0.20  3.94 (2.42 ; 5.49) 0.00  0.01 
heart rate 10 bpm 6.75 (5.16 ; 8.36) 0.00  2.89 (1.27 ; 4.53) 0.00  0.00 
creatinine 1 μmol/l 0.00 (-0.16 ; 0.16) 0.98  -0.08 (-0.24 ; 0.09) 0.34  0.48 
CRP 1 mg/l 0.57 (0.07 ; 1.06) 0.02  1.24 (0.64 ; 1.84) 0.00  0.09 
cholesterol 1 mmol/l 1.78 (0.23 ; 3.36) 0.02  -0.49 (-1.88 ; 0.91) 0.49  0.03 
triglyceride 1 mmol/l 1.55 (0.20 ; 2.92) 0.02  3.58 (1.80 ; 5.40) 0.00  0.08 
HDL-C 1 mmol/l -8.20 (-12.19 ; -4.03) 0.00  -6.99 
(-10.21 ; -
3.65) 0.00  0.65 
LDL-C 1 mmol/l 2.27 (0.56 ; 4.00) 0.01  -0.45 (-1.93 ; 1.05) 0.56  0.02 
smoking pack years 0.00 (-0.08 ; 0.09) 0.93  -0.06 (-0.17 ; 0.05) 0.28  0.37 
moderate PA  yes/no 0.01 (-3.40 ; 3.54) 1.00  -1.39 (-4.95 ; 2.30) 0.46  0.58 
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Supplement Table 7.5 continued 
 
 
risk factors units 
men  women  
sex 
differences  
p-value 
 
Change in geometric 
mean (CI) [%] 
p-
value 
 
Change in geometric 
mean (CI) [%] 
p-
value 
 
 
Yo
un
g’
s e
la
st
ic 
m
od
ul
us
 [k
Pa
] 
height 10 cm 1.42 (-1.67 ; 4.59) 0.37  -0.43 (-3.20 ; 2.42) 0.77  0.39 
weight 10 kg 3.72 (2.02 ; 5.46) 0.00  1.75 (0.27 ; 3.25) 0.02  0.09 
BMI 5 kg/m2 6.53 (3.53 ; 9.62) 0.00  2.81 (0.71 ; 4.95) 0.01  0.05 
systolic BP 10 mmHg 1.77 (0.47 ; 3.09) 0.01  1.77 (0.63 ; 2.92) 0.00  1.00 
diastolic BP 10 mmHg 3.75 (1.66 ; 5.87) 0.00  1.87 (-0.06 ; 3.84) 0.06  0.20 
pulse pressure 10 mmHg 0.67 (-1.21 ; 2.58) 0.49  2.37 (0.70 ; 4.06) 0.01  0.19 
heart rate 10 bpm 7.35 (5.54 ; 9.18) 0.00  3.01 (1.23 ; 4.83) 0.00  0.00 
creatinine 1 μmol/l -0.02 (-0.20 ; 0.16) 0.81  -0.15 (-0.34 ; 0.03) 0.10  0.31 
CRP 1 mg/l 0.72 (0.16 ; 1.28) 0.01  1.24 (0.59 ; 1.90) 0.00  0.24 
cholesterol 1 mmol/l 0.34 (-1.39 ; 2.10) 0.70  -1.52 (-3.03 ; 0.01) 0.05  0.11 
triglyceride 1 mmol/l 1.61 (0.09 ; 3.16) 0.04  2.20 (0.26 ; 4.19) 0.03  0.64 
HDL-C 1 mmol/l -6.09 (-10.70 ; -1.24) 0.01  -5.49 (-9.11 ; -1.73) 0.00  0.85 
LDL-C 1 mmol/l 0.16 (-1.73 ; 2.09) 0.87  -1.45 (-3.07 ; 0.18) 0.08  0.21 
smoking pack years -0.03 (-0.12 ; 0.07) 0.59  -0.07 (-0.19 ; 0.05) 0.25  0.57 
moderate PA  yes/no -0.37 (-4.20 ; 3.61) 0.85  -0.91 (-4.86 ; 3.20) 0.66  0.85 
 
Values are expressed as percentage change in the geometric mean per unit increment. Association estimates 
were based on mixed linear regression models adjusted for age, education level, medication, mean arterial 
pressure and study centre. Physical activity is a binary variable.  CI = confidence interval, p = p value, BMI = 
body mass index, BP = blood pressure, cholesterol = total cholesterol, CRP = C-reactive protein, HDL-C = high 
density lipoprotein cholesterol, LDL C = low density lipoprotein cholesterol, PA = physical activity, SD = standard 
deviation. 
 
*Sex-specific associations in effect estimates per unit increment between men and women for single risk 
factors and CS parameters were calculated based on sex-stratified mixed linear models adjusted for age, 
education level, medication, mean arterial pressure and study centre. Sex-difference p-values were calculated 
based on sex-stratified log-estimates using the following formulas:  
Sex- difference with 95% CI: (coefficientwomen - coefficientmen) ± 1.96×ඥܵܧሺݓ݋݉݁݊ሻଶ ൅ ܵܧሺ݉݁݊ሻଶ 
p-value: 1 – F[(coefficientwomen - coefficientmen)2 / ((standard errorwomen)2 + (standard errormen)2)], where F = Chi2-
distribution function with 1 degree of freedom. 
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Supplement Table 7.6: Sex-specific associations of cardiovascular risk factors (per 1 SD) with six CS 
parameters for men, women and for the respective sex differences 
 
 
Risk factors 
Men  Women 
 
Change in geometric 
mean (CI) per 1SD [%] 
p  
Change in geometric 
mean (CI) per 1SD [%] 
p 
St
ra
in
 [%
] 
Height -0.64 (-2.42; 1.17) 0.49  0.50 (-1.07; 2.09) 0.54 
Weight -4.39 (-6.04; -2.72) 0.00  -2.22 (-3.72; -0.70) 0.00 
Body mass index -4.67 (-6.34; -2.97) 0.00  -2.67 (-4.20; -1.12) 0.00 
Systolic blood pressure 1.23 (-0.81; 3.32) 0.24  -0.13 (-2.00; 1.78) 0.89 
Diastolic blood pressure -4.12 (-6.01; -2.20) 0.00  -4.37 (-6.05; -2.66) 0.00 
Pulse pressure 5.41 (3.45; 7.40) 0.00  3.71 (1.89; 5.56) 0.00 
Heart rate -7.43 (-8.97; -5.87) 0.00  -4.77 (-6.18; -3.33) 0.00 
Creatinine -0.58 (-2.30; 1.17) 0.51  -0.37 (-1.88; 1.16) 0.63 
CRP -0.81 (-2.52; 0.92) 0.36  -3.05 (-4.54; -1.54) 0.00 
Total Cholesterol -1.63 (-3.33; 0.10) 0.07  0.84 (-0.74; 2.44) 0.30 
Triglyceride -1.15 (-2.86; 0.58) 0.19  -3.69 (-5.18; -2.17) 0.00 
HDL-C 3.71 (1.94; 5.52) 0.00  3.47 (1.90; 5.05) 0.00 
LDL-C -2.50 (-4.18; -0.78) 0.00  0.88 (-0.69; 2.46) 0.27 
Smoking -1.00 (-2.71; 0.74) 0.26  1.01 (-0.51; 2.55) 0.20 
Physical activity 1.04 (-2.56; 4.77) 0.57  1.26 (-2.40; 5.06) 0.50  
        
Co
m
pl
ia
nc
e 
[m
m
2/
kP
a]
 
Height 3.16 (1.12; 5.23) 0.00  4.01 (2.24; 5.81) 0.00 
Weight 1.07 (-0.87; 3.06) 0.28  2.10 (0.39; 3.85) 0.02 
Body mass index -0.51 (-2.45; 1.47) 0.61  0.43 (-1.30; 2.19) 0.63 
Systolic blood pressure -1.44 (-3.64; 0.80) 0.21  -1.96 (-3.97; 0.09) 0.06 
Diastolic blood pressure -3.38 (-5.49; -1.22) 0.00  -1.41 (-3.31; 0.52) 0.15 
Pulse pressure 1.00 (-1.10; 3.14) 0.35  -1.48 (-3.38; 0.47) 0.14 
Heart rate -6.14 (-7.88; -4.36) 0.00  -4.26 (-5.83; -2.67) 0.00 
Creatinine -1.79 (-3.66; 0.12) 0.07  -0.64 (-2.28; 1.04) 0.45 
CRP -0.61 (-2.49; 1.31) 0.53  -2.18 (-3.84; -0.50) 0.01 
Total Cholesterol -0.73 (-2.63; 1.20) 0.45  -0.11 (-1.83; 1.64) 0.90 
Triglyceride -0.32 (-2.22; 1.62) 0.74  -1.98 (-3.65; -0.28) 0.02 
HDL-C 0.78 (-1.14; 2.73) 0.43  1.71 (0.01; 3.44) 0.05 
LDL-C -0.92 (-2.81; 1.02) 0.35  -0.06 (-1.77; 1.67) 0.94 
Smoking 2.82 (0.87; 4.81) 0.00  2.82 (1.14; 4.54) 0.00 
Physical activity -1.53 (-5.39; 2.50) 0.45  0.14 (-3.75; 4.19) 0.94 
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Supplement table 7.6 continued 
 
 
Risk factors 
Men  Women 
 
Change in geometric 
mean (CI) per 1SD [%] 
p  
Change in geometric 
mean (CI) per 1SD [%] 
p 
Di
st
en
sib
ilit
y [
10
-3
/k
Pa
] 
Height -0.04 (-1.79; 1.73) 0.96  1.26 (-0.35; 2.88) 0.12 
Weight -3.93 (-5.54; -2.28) 0.00  -1.69 (-3.22; -0.14) 0.03 
Body mass index -4.46 (-6.09; -2.80) 0.00  -2.45 (-4.00; -0.87) 0.00 
Systolic blood pressure -3.18 (-5.08; -1.24) 0.00  -4.46 (-6.26; -2.62) 0.00 
Diastolic blood pressure -3.83 (-5.69; -1.94) 0.00  -2.03 (-3.79; -0.24) 0.03 
Pulse pressure -1.05 (-2.87; 0.79) 0.26  -4.39 (-6.09; -2.66) 0.00 
Heart rate -6.92 (-8.43; -5.39) 0.00  -2.79 (-4.27; -1.28) 0.00 
Creatinine -0.04 (-1.72; 1.67) 0.97  0.73 (-0.82; 2.30) 0.36 
CRP -1.89 (-3.53; -0.23) 0.03  -3.22 (-4.72; -1.68) 0.00 
Total Cholesterol -1.93 (-3.58; -0.25) 0.02  0.57 (-1.03; 2.20) 0.49 
Triglyceride -1.91 (-3.56; -0.24) 0.03  -3.19 (-4.71; -1.64) 0.00 
HDL-C 3.30 (1.58; 5.06) 0.00  3.25 (1.66; 4.86) 0.00 
LDL-C -2.24 (-3.89; -0.57) 0.01  0.48 (-1.10; 2.09) 0.55 
Smoking -0.08 (-1.76; 1.63) 0.92  0.86 (-0.68; 2.42) 0.28 
Physical activity 0.01 (-3.47; 3.62) 0.99  1.42 (-2.30; 5.29) 0.46 
 
        
β-
st
iff
ne
ss
 in
de
x [
no
 u
ni
t] 
Height 0.03 (-1.68; 1.76) 0.98  -1.17 (-2.69; 0.38) 0.14 
Weight 3.94 (2.23; 5.68) 0.00  1.64 (0.10; 3.21) 0.04 
Body mass index 4.51 (2.77; 6.28) 0.00  2.39 (0.80; 4.01) 0.00 
Systolic blood pressure 3.10 (1.12; 5.12) 0.00  4.41 (2.49; 6.37) 0.00 
Diastolic blood pressure 3.88 (1.92; 5.88) 0.00  1.99 (0.20; 3.81) 0.03 
Pulse pressure 0.91 (-0.90; 2.75) 0.33  4.32 (2.51; 6.16) 0.00 
Heart rate 7.26 (5.56; 8.99) 0.00  2.81 (1.28; 4.36) 0.00 
Creatinine 0.02 (-1.63; 1.69) 0.98  -0.67 (-2.16; 0.84) 0.38 
CRP 1.81 (0.15; 3.50) 0.03  3.25 (1.69; 4.85) 0.00 
Total Cholesterol 1.88 (0.20; 3.58) 0.03  -0.55 (-2.10; 1.01) 0.49 
Triglyceride 1.88 (0.21; 3.57) 0.03  3.23 (1.65; 4.84) 0.00 
HDL-C -3.15 (-4.73; -1.54) 0.00  -3.09 (-4.54; -1.61) 0.00 
LDL-C 2.22 (0.54; 3.93) 0.01  -0.47 (-2.00; 1.08) 0.55 
Smoking 0.08 (-1.57; 1.75) 0.93  -0.84 (-2.31; 0.66) 0.27 
Physical activity -0.05 (-3.45; 3.47) 0.98  -1.46 (-5.00; 2.20) 0.43 
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Supplement table 7.6 continued 
 
 
Risk factors 
Men  Women 
 
Change in geometric 
mean (CI) per 1SD [%] 
p  
Change in geometric 
mean (CI) per 1SD [%] 
p 
Pe
te
rs
on
’s 
el
as
tic
 m
od
ul
us
 [k
Pa
] 
Height 0.03 (-1.68; 1.77) 0.97  -1.22 (-2.75; 0.34) 0.12 
Weight 3.99 (2.27; 5.73) 0.00  1.67 (0.12; 3.25) 0.03 
Body mass index 4.56 (2.81; 6.33) 0.00  2.45 (0.84; 4.07) 0.00 
Systolic blood pressure 3.33 (1.35; 5.36) 0.00  4.68 (2.74; 6.65) 0.00 
Diastolic blood pressure 3.89 (1.92; 5.89) 0.00  1.96 (0.16; 3.79) 0.03 
Pulse pressure 1.20 (-0.61; 3.05) 0.20  4.71 (2.88; 6.56) 0.00 
Heart rate 7.24 (5.53; 8.97) 0.00  2.74 (1.20; 4.30) 0.00 
Creatinine 0.02 (-1.63; 1.70) 0.98  -0.73 (-2.23; 0.79) 0.34 
CRP 1.90 (0.24; 3.60) 0.02  3.26 (1.68; 4.86) 0.00 
Total Cholesterol 1.93 (0.25; 3.64) 0.02  -0.55 (-2.10; 1.02) 0.49 
Triglyceride 1.92 (0.25; 3.62) 0.02  3.21 (1.61; 4.83) 0.00 
HDL-C -3.12 (-4.70; -1.51) 0.00  -3.07 (-4.53; -1.59) 0.00 
LDL-C 2.24 (0.55; 3.95) 0.01  -0.47 (-2.00; 1.09) 0.56 
Smoking 0.07 (-1.58; 1.75) 0.93  -0.82 (-2.31; 0.69) 0.28 
Physical activity 0.01 (-3.40; 3.54) 1.00  -1.39 (-4.95; 2.30) 0.46 
 
        
Yo
un
g’
s e
la
st
ic 
m
od
ul
us
 [k
Pa
]  
Height 0.89 (-1.05; 2.87) 0.37  -0.26 (-1.97; 1.47) 0.77 
Weight 4.23 (2.29; 6.21) 0.00  2.02 (0.31; 3.76) 0.02 
Body mass index 4.31 (2.34; 6.32) 0.00  2.36 (0.60; 4.16) 0.01 
Systolic blood pressure 3.05 (0.81; 5.34) 0.01  3.27 (1.16; 5.43) 0.00 
Diastolic blood pressure 4.00 (1.77; 6.28) 0.00  1.92 (-0.06; 3.95) 0.06 
Pulse pressure 0.72 (-1.32; 2.81) 0.49  2.82 (0.84; 4.85) 0.01 
Heart rate 7.88 (5.94; 9.86) 0.00  2.86 (1.16; 4.58) 0.00 
Creatinine -0.23 (-2.09; 1.66) 0.81  -1.40 (-3.04; 0.26) 0.10 
CRP 2.42 (0.53; 4.34) 0.01  3.27 (1.53; 5.04) 0.00 
Total Cholesterol 0.37 (-1.50; 2.27) 0.70  -1.70 (-3.38; 0.02) 0.05 
Triglyceride 2.00 (0.11; 3.92) 0.04  1.97 (0.23; 3.75) 0.03 
HDL-C -2.30 (-4.11; -0.46) 0.01  -2.40 (-4.03; -0.75) 0.00 
LDL-C 0.16 (-1.71; 2.06) 0.87  -1.51 (-3.18; 0.19) 0.08 
Smoking -0.51 (-2.36; 1.37) 0.59  -0.96 (-2.60; 0.70) 0.25 
Physical activity -0.37 (-4.20; 3.61) 0.85  -0.91 (-4.86; 3.20) 0.66 
 
Values are expressed as percentage change in the geometric mean per 1 SD increment. Association estimates 
were based on mixed linear regression models adjusted for age, education level, medication, mean arterial 
pressure and study centre. Continuous risk factors were standardised. CI = confidence interval, p = p value, BMI 
= body mass index, BP = blood pressure, cholesterol = total cholesterol, CRP = C-reactive protein, HDL-C = high 
density lipoprotein cholesterol, LDL C = low density lipoprotein cholesterol, PA = physical activity, SD = standard 
deviation.  
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P-values for heterogeneity were tested for each risk factor based on the null hypothesis of equal regression coefficients across all six CS parameters using an F-test with 5 
numerator degrees of freedom. Pairwise comparisons of effect estimates of CS parameters were performed using F-tests with 1 numerator degree of freedom. †= 
significant after Bonferroni-Holm correction, Bstiff = β-stiffness index, Comp = compliance, Dist = distensibility, Youngs = Young’s elastic modulus, EP = Peterson’s elastic 
modulus, BP = blood pressure, CRP = C-reactive protein, HDL-C = high density lipoprotein cholesterol, LDL C = low density lipoprotein cholesterol. 
Supplement Table 7.7: Significance of heterogeneity in the associations of single cardiovascular risk factors (per 1 SD) across all six CS parameters (log-transformed) 
separately for men, women 
 Risk factors 
Hetero-
geneity 
Strain 
vs 
Comp 
Strain 
vs 
Dist 
Strain 
vs Bstiff 
Strain 
vs 
EP 
Strain 
vs 
Youngs 
Comp 
vs 
Dist 
Comp 
vs Bstiff 
Comp 
vs 
EP 
Comp 
vs 
Youngs 
Dist 
vs Bstiff 
Dist 
vs 
EP 
Dist 
vs 
Youngs 
Bstiff vs 
EP 
Bstiff vs 
Youngs 
EP 
vs 
Youngs 
M
en
 
Height <0.001† <0.001† 0.14 0.13 0.15 0.75 <0.001† <0.001† <0.001† <0.001† 0.82 0.73 0.05 0.99 0.05 0.05 
Weight <0.001† <0.001† 0.27 0.15 0.19 0.54 <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† 0.80 0.18 0.56 0.63 
Body mass index <0.001† <0.001† 0.68 0.44 0.53 0.36 <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† 0.38 0.14 0.60 0.53 
Systolic BP <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† 0.01 0.02 0.01 0.10 <0.001† 0.07 0.67 <0.001† 0.94 0.60 
Diastolic BP 0.02 0.38 0.55 0.42 0.45 0.71 0.57 0.67 0.67 0.65 0.02† <0.001† 0.93 0.87 0.78 0.79 
Pulse pressure <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† 0.00† 0.00† <0.001† 0.05 <0.001† <0.001† 0.48 <0.001† 0.72 0.32 
Heart rate <0.001† 0.04 0.21 0.10 0.10 0.87 0.13 0.22 0.24 0.09 <0.001† <0.001† 0.29 0.42 0.15 0.14 
Creatinine 0.03 0.08 0.16 0.14 0.16 0.15 0.00† 0.00† 0.00† 0.01† 0.63 0.37 0.53 0.93 0.56 0.57 
CRP 0.00† 0.75 0.01† 0.02 0.02 0.01† 0.02 0.03 0.02 0.02 <0.001† 0.29 0.25 0.00† 0.16 0.23 
Total Cholesterol <0.001† 0.18 0.47 0.59 0.53 0.04 0.03 0.05 0.04 0.62 0.01 0.10 <0.001† 0.13 <0.001† <0.001† 
Triglyceride 0.02 0.20 0.09 0.12 0.11 0.18 0.00† 0.01† 0.01† 0.03 0.04 0.18 0.89 0.18 0.75 0.83 
HDL-C <0.001† <0.001† 0.39 0.32 0.31 0.03 <0.001† <0.001† <0.001† 0.04 0.13 <0.001† 0.02 0.41 0.03 0.04 
LDL-C <0.001† 0.02 0.61 0.49 0.54 <0.001† 0.02 0.02 0.02 0.32 0.04 0.02 <0.001† 0.58 <0.001† <0.001† 
Smoking <0.001† <0.001† 0.02 0.02 0.02 0.01 <0.001† <0.001† <0.001† 0.00† 0.86 0.47 0.16 0.76 0.17 0.18 
Physical activity 0.69 0.09 0.28 0.29 0.28 0.68 0.24 0.22 0.24 0.25 0.63 0.62 0.60 0.39 0.63 0.58 
                  
W
om
en
 
Height <0.001† <0.001† 0.10 0.13 0.12 0.68 <0.001† <0.001† <0.001† <0.001† 0.04 0.23 0.00† 0.14 0.01 0.01† 
Weight <0.001† <0.001† 0.24 0.17 0.21 0.66 <0.001† <0.001† <0.001† <0.001† 0.02 0.02 0.37 0.34 0.26 0.31 
Body mass index <0.001† <0.001† 0.63 0.45 0.54 0.52 <0.001† <0.001† <0.001† <0.001† <0.001† 0.00† 0.71 0.09 0.97 0.84 
Systolic BP <0.001† 0.01 <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† 0.14 <0.001† 0.70 0.00† <0.001† 0.01 0.00† 
Diastolic BP <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† 0.41 0.50 0.54 0.65 0.04 <0.001† 0.78 0.42 0.94 1.00 
Pulse pressure <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† 0.08 <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† 
Heart rate <0.001† 0.33 <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† <0.001† 0.02 0.12 <0.001† 0.95 0.03 0.82 0.67 
Creatinine 0.00† 0.61 0.02 0.02 0.02 <0.001† 0.00† 0.00† 0.00† <0.001† 0.13 0.62 0.03 0.05 0.02 0.03 
CRP 0.01† 0.11 0.72 0.82 0.82 0.83 0.02† 0.02 0.02 0.09 0.05 0.00† 0.88 0.88 0.97 0.98 
Total Cholesterol 0.03 0.09 0.55 0.52 0.53 0.12 0.12 0.13 0.13 0.00† 0.69 0.40 <0.001† 0.92 <0.001† <0.001† 
Triglyceride <0.001† 0.00† 0.29 0.23 0.23 <0.001† 0.01 0.01 0.02 0.88 0.10 <0.001† <0.001† 0.49 <0.001† <0.001† 
HDL-C <0.001† 0.00† 0.66 0.55 0.55 0.07 <0.001† 0.00† 0.00† 0.22 0.08 <0.001† 0.02 0.61 0.04 0.05 
LDL-C 0.06 0.10 0.38 0.36 0.37 0.25 0.21 0.22 0.22 0.01† 0.74 0.42 0.00† 0.88 0.00† 0.00† 
Smoking <0.001† 0.00† 0.74 0.72 0.70 0.97 <0.001† <0.001† <0.001† 0.00† 0.74 0.18 0.70 0.62 0.68 0.64 
Physical activity 0.75 0.76 0.79 0.74 0.80 0.92 0.51 0.48 0.52 0.84 0.47 0.78 0.60 0.35 0.55 0.62 
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CAROTID STIFFNESS AND PHYSICAL ACTIVITY IN ELDERLY – RESULTS FROM THE SAPALDIA 3 
COHORT STUDY 
 
Abstract 
Introduction: Regular physical activity has been shown to reduce cardiovascular disease risk 
in the general population. While smaller studies in specified groups (highly trained versus 
untrained individuals) indicate a certain dose-dependent effect of physical activity on 
reduction of carotid stiffness - which is an indicator of subclinical vascular disease - it is 
unclear whether this association is present in a representative sample. Thus, we investigated 
this question cross-sectionally in participants from the population-based SAPALDIA cohort 
study. 
Methods: Self-reported total, moderate and vigorous physical activity and distensibility as a 
measure of local arterial stiffness among 1636 participants aged 50 to 81 years without 
clinically manifest diseases were evaluated. Mixed regression models and pathway analyses 
were used to examine associations of physical activity intensity with distensibility.  
Results: Vigorous physical activity, but not total nor moderate physical activity, was 
significantly associated with increased distensibility (= reduced carotid stiffness) in univariate 
analyses (percent change in the geometric mean and 95% confidence interval per 
10min/week increase in vigorous physical activity = 0.11 (0.03-0.19), p<0.01; in total physical 
activity = 0.03 (0.00-0.06), p=0.08; in moderate physical activity = 0.02 (-0.02-0.06), p=0.45). 
These associations disappeared when we additionally adjusted for age. Pathway analyses 
showed that age (standardised beta -0.48) was the strongest predictor of distensibility 
followed by mean arterial blood pressure (standardised beta -0.35) and heart rate 
(standardised beta -0.18). All pathways of vigorous physical activity (direct or intermediate) 
were marginal and statistically non-significant.  
Conclusion: We found no evidence for an association of physical activity with carotid 
stiffness in the general middle-age to elderly population adjusted for most important 
confounders and risk factors. 
 
Introduction 
Physical inactivity is a generally accepted cardiovascular risk factor which causes 
cardiovascular disease (CVD) and a high percentage of global mortality [1–3]. Therefore, 
being regularly physically active can improve health at all ages by different pathways (e.g. 
enhancing cardiorespiratory, metabolic or mental health) resulting in a reduced CVD risk and 
mortality [3–8]. CVD begins with structural and functional changes of the arterial system 
commonly known as the atherosclerotic process [9,10]. The vascular damage accumulated 
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over time can be assessed as arterial stiffness, which can be directly measured in the 
common carotid artery (CCA) [11].  
While regular physical activity (PA) has been shown to reduce CVD risk in the general 
population, results of inverse associations between an increased PA level and a reduced 
carotid stiffness were mostly limited to two or three healthy groups with specific group 
characteristics such as highly trained versus untrained subjects [12–19]. Although these 
reports suggest a certain dose-dependent effect of PA on carotid stiffness [12–19], the 
specific group distinctions constrict a more generalizable conclusion. In addition, there is no 
consent on how different types and intensities of PA influence different parameters of 
arterial stiffness across the lifespan, since arterial stiffness varies in different arterial 
segments along the arterial tree with age.  
Thus, the aim of this study was to assess whether an increasing amount of self-reported 
total, moderate and vigorous PA is associated with reduced carotid stiffness in a general 
middle-aged and elderly population without a diagnosis of CVD from the SAPALDIA cohort 
(Swiss Cohort Study on Air Pollution And Lung and Heart Diseases In Adults).  
 
Methods 
Study design and subjects 
The SAPALDIA cohort study is an ongoing multicentre cohort study with a population-based 
random sample of adults from eight rural and urban areas of Switzerland (Aarau, Basel, 
Davos, Genève, Lugano, Montana, Payerne, Wald) with baseline assessment in 1991 and first 
follow-up assessment in 2001-2003 [20,21]. This study is based on the second follow-up 
assessment (SAPALDIA 3) which was conducted in 2010-2011. Sequential B-mode ultrasound 
images of the CCA were assessed in 3489 participants (51% female) aged between 50-81 
years at the time of examination. PA was assessed using the long form of the International 
Physical Activity Questionnaire (IPAQ). Data from 1636 participants were available for 
analyses after exclusion of individuals with doctor diagnosed diabetes, stroke, myocardial 
infarction, angina pectoris, heart failure at time of ultrasound examination or missing 
ultrasound, IPAQ or additional covariate data (figure 8.1).  
The study complies with the declaration of Helsinki and ethical clearance was obtained and 
approved from the respective cantonal ethical committees (Aargau, Basel, Geneva, Grisons, 
Ticino, Valais, Vaud and Zurich) and participants gave written informed consent according to 
their preferences either globally for all examinations or separately for single assessments. 
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Figure 8.1: Flow chart of subject inclusion 
IPAQ = International Physical Activity Questionnaire, PA = physical activity, affected adjustments = body mass 
index, mean arterial pressure, heart rate, smoking. 
 
Carotid stiffness – distensibility  
Ultrasound B-mode scans of the CCA were performed by centrally trained and certified 
sonographers in all eight centres. The same standardised ultrasound instruments (UF-870 
machine LA385-16 MHz array transducer, Fukuda Denshi, Japan) and scan protocol were 
used. Participants’ common carotid arteries were bilaterally examined in supine position 
after a rest of at least 10 minutes with the neck rotated by 45° to either right or left side 
standardized with a foam wedge. Blood pressure (BP) was measured immediately after 
ultrasound examination with a standard oscillometric device (OMRON 705IT, OMRON 
HEALTHCARE, Kyoto, Japan) at the left and right upper arm. Mean arterial pressure was 
defined as diastolic BP added to one-third of the pulse pressure [22].  
Ultrasound scans were analysed offline by the fully automatic ultrasound program DYARA 
(DYnamic ARtery Analysis program) [23,24]. Expert readers tagged the carotid structure 
directly proximal of the carotid bifurcation over exactly one centimetre and analysed the 
intimal and adventitial layer of the carotid wall and adventitia layer of the near wall for a 
duration of at least one heart cycle [23,24]. Detailed information about the reading process 
and DYARA algorithm are described elsewhere [23,24]. Distensibility was calculated as 
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([1/kPa] = ((2 × deltaLD × dLD)+(deltaLD)2)/(PP× dLD2)) [25], where deltaLD is the systolic-
diastolic lumen diameter difference, dLD the diastolic lumen diameter and PP the pulse 
pressure. Lower values of distensibility correspond to an increased carotid stiffness. 
The variability and reproducibility of carotid stiffness parameters were evaluated in 165 
participants of the SAPALDIA 3 population within the identical study setting [24]. The 
coefficient of variation of replicate ultrasound measurements was 12.14% for distensibility 
with an intraclass correlation coefficient (ICC) of 0.77 [24]. 
 
Physical activity parameters 
Self-reported PA was assessed using the validated IPAQ long form [26,27]. IPAQ data 
cleaning and item analysis were conducted according to the IPAQ protocol for data 
processing and analysis [28]. In short, moderate and vigorous continuous values expressed 
as min/week were derived from 27 items and four domains (work, transport, 
domestic/garden, leisure time) [28]. Values of moderate or vigorous intensity were only 
considered if at least 10 minute bouts were obtained. Values above 1260 min/week 
(3hours/day) were truncated [28]. The sum of moderate and vigorous PA intensity was 
calculated and defined as the total PA. 
 
Table 8.1: Characteristics of the study population by sex described by numbers (N) and percentages (%), 
mean value and standard deviation (SD) or median and interquartile range (p25, p75) 
 
Characteristics    Units   Men  Women 
N participants  N (%)  712 (43.5)  924 (56.5) 
No medication intake  N (%)  463 (39.9)  696 (60.1) 
Medication intake  N (%)  249 (52.2)  228 (47.8) 
       Age  Mean (SD) years  63.0 (7.6)  63.0 (7.8) 
Height  Mean (SD) cm  175.1 (6.3)  162.0 (6.3) 
Weight  Mean (SD) kg  81.8 (11.9)  65.7 (12.3) 
Body mass index  Mean (SD) kg/m2  26.7 (3.5)  25.1 (4.6) 
Diastolic BP  Mean (SD) mmHg  80.1 (9.4)  76.5 (9.1) 
Systolic BP  Mean (SD) mmHg  137.5 (17.3)  131.5 (17.9) 
Mean BP  Mean (SD) mmHg  99.2 (11.2)  94.8 (11.1) 
Pulse pressure  Mean (SD) mmHg  57.4 (12.1)  55.1 (13.1) 
Heart rate  Mean (SD) bpm  68.1 (10.6)  69.1 (9.2) 
       Smoking  Median (p25, p75) pack years  2.5 (0, 24)  0 (0, 12) 
Distensibility   Median (p25, p75) 10
-3/kPa  14.5 (11.4, 18.1)  15.8 (12.0, 20.1) 
Total PA  Median (p25, p75) min/week  510 (180, 1105)  590 (240, 1195) 
Moderate PA  Median (p25, p75) min/week  360 (120, 00)  510 (193, 1080) 
Vigorous PA   Median (p25, p75) min/week   25 (0, 225)  0 (0, 113) 
 
BP = blood pressure, PA = physical activity 
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Statistical analysis 
Descriptive analyses of the study population characteristics and hemodynamic parameters 
were performed. Box plots of distensibility values and moderate and vigorous PA stratified 
by potential confounders (sex and age) were generated (figure 8.2). Distensibility was 
skewed on the original scale and was normalised by log-transformation. Statistical 
significance was defined for p-values <0.05. 
To examine the associations of distensibility with PA, an a priori directed acyclic graph (DAG) 
was generated considering potential confounder variables and referring to the indirect 
effects of PA via intermediate endpoints. Based on the defined variables in the DAG, a 
stepwise forward and backward selection using the likelihood ratio test was used to define 
the final set of variables for analyses. The same procedure was repeated to check for 
potential interaction and non-linearity terms of covariates. Education level (obligatory school 
education, higher education and college education) did not reach the inclusion significance 
level of 0.2. The final DAG pathways for vigorous PA are shown in figure 8.3.  
Considering the final different pathways of the DAG (figure 8.3), the univariate, the total and 
the direct effect estimates of moderate and vigorous PA on distensibility were calculated 
using different multiple mixed linear regression models. Model 1 was an univariate model of 
distensibility and PA determinants; model 2 additionally adjusted for potential confounders 
sex and age; model 3 included possible mediators like heart rate, body mass index (BMI), 
mean arterial BP and smoking and was further adjusted for medication (yes/no: 
antihypertensive, lipid lowering, and kidney disease treatment) and the different study 
centres as random intercept to account for regional clustering (table 8.2). In a further 
approach, we pre-specified possible interactions of variables presented in the DAG, namely 
sex-age, sex-BMI and sex-mean arterial pressure, and interactions between PA and sex or 
age and calculated the respective mixed linear regression models according to model 3 
adding these interactions (model 4 in table 8.2).  
We performed pathway analyses to describe the single hypothesised pathway direction 
presented in the DAG (figure 8.2). All pathway analyses were adjusted for study centre 
(treated as fixed effect factor) and association estimates between vigorous PA intensity, 
distensibility and the covariates were presented as standardised betas.  
We repeated the main analyses considering other carotid stiffness parameters, namely beta 
stiffness index, Peterson’s elastic modulus and Young’s elastic modulus to investigate 
whether the conclusions were consistent among carotid stiffness parameters. Therefore, we 
performed multivariate regression analyses with a four-dimensional outcome using the 
same predictor variables as in the model for distensibility and treating study centre as a fixed 
effect. For a description of the additional mentioned carotid stiffness parameters and the 
methodology of these analyses we refer to previous extensive analyses [29]. The conclusions 
drawn from these combined indices did not differ from distensibility and therefore only the 
analyses on distensibility - an often used carotid stiffness measure - are presented in this 
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article. All analyses were performed using the statistical software STATA (StataCorp, Release 
12. Statistical Software, College Station, TX: StataCorp LPTexas, USA). The analytical data set 
and the statistical code are available from the corresponding author upon request, since ethics 
approval and participants consent does not allow public sharing of data. 
 
 
 
Figure 8.2: Box plots of carotid distensibility values and amount of moderate and vigorous physical activity 
(PA) for both sexes across three 10-year age categories  
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Results 
Descriptive analyses  
Characteristics of the study participants for males and females are shown in table 8.1. Box 
plots of distensibility values and moderate and vigorous PA for both sexes and across three 
10-year age categories from 50 to 81 years are presented in figure 8.2. Compared to the 
youngest age group, distensibility and vigorous PA were lower in older age groups for both 
sexes (p<0.05). Moderate PA did not show an age-associated decline. Within each age group, 
vigorous PA was significantly lower in women than in men (p<0.05). No differences for 
distensibility and moderate PA values were found in the oldest age group for both sexes 
(p>0.1). In the youngest and middle age groups, women had on average a higher 
distensibility and moderate PA compared to men (p<0.05). 
 
Multiple linear models 
Detailed estimates of the associations between PA intensities and distensibility from 
different mixed linear models (models 1-4) are depicted in table 8.2. We found significant 
univariate associations (model 1) between vigorous PA and distensibility, but not for total PA 
and moderate PA (percent change in the geometric mean per 10min/week increase in 
vigorous PA = 0.11, p<0.01; in total PA = 0.03, p=0.08; in moderate PA = 0.02, p=0.45). In all 
mixed linear regression analyses, associations of different PA determinants with 
distensibility disappeared when age was included in the model (data not shown, see also 
model 2 adjusted for age and sex, and other PA determinants p>0.7). Significant associations 
between confounders or mediators of distensibility and distensibility were found for age, 
mean arterial BP, BMI, heart rate, smoking and medication intake across all different PA 
determinants (model 3). Including further interaction terms (model 4), we observed a 
significant interaction between sex and BMI (p<0.01). Based on the 95% confidence interval, 
a trend was found for the interactions of sex with age and sex with mean arterial BP. We 
found no interactions between physical activity intensities and sex or age (p>0.8). 
 
Pathway analyses  
The strongest predictor of distensibility was age (standardised beta = -0.48) followed by 
mean arterial BP (standardised beta = -0.35) and heart rate (standardised beta = -0.18). All 
direct or intermediate pathways of vigorous PA were marginal and statistically non-
significant. Detailed results can be found in the DAG presented in figure 8.3.  
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Parameter Units 
Model 1  Model 2  Model 3  Model 4 
CGM (95% CI) [%] p-value 
 CGM (95% CI)  
[%] 
p-
value 
 CGM (95% CI)  
[%] 
p-
value 
 CGM (95% CI)  
[%] 
p-
value 
M
od
er
at
e 
PA
 
Moderate PA 10 min/week 0.02 (-0.02; 0.06)  0.45  0.00 (-0.03; 0.04)  0.83  0.01 (-0.02; 0.04)  0.54  0.01 (-0.02; 0.04)  0.49 
Sex female vs male    8.27 (5.01; 11.63)  <0.01  2.56 (-0.15; 5.34)  0.06  
18.76 (-13.05; 
62.19)  0.28 
Age years    -2.68 (-2.87; -2.49)  <0.01  -2.32 (-2.49; -2.15)  <0.01  -2.16 (-2.41; -1.91)  <0.01 Medication yes vs no*       -6.57 (-9.36; -3.69)  <0.01  -6.19 (-8.99; -3.29)  <0.01 Mean arterial BP mmHg       -1.15 (-1.26; -1.03)  <0.01  -1.02 (-1.20; -0.85)  <0.01 BMI kg/m2       -0.66 (-0.98; -0.34)  <0.01  -1.28 (-1.85; -0.71)  <0.01 Heart rate bpm       -0.72 (-0.85; -0.59)  <0.01  -0.71 (-0.84; -0.58)  <0.01 Smoking packyears       0.14 (0.07; 0.20)  <0.01  0.13 (0.07; 0.20)  <0.01 Interaction sex-age female age          -0.28 (-0.61; 0.05)  0.10 Interaction sex-bpmap female bpmap          -0.21 (-0.45; 0.03)  0.08 Interaction sex-bmi female bmi          0.91 (0.22; 1.59)  <0.01 
Vi
go
ro
us
 P
A 
Vigorous PA 10 min/week 0.11 (0.03; 0.19)  <0.01  -0.01 (-0.08; 0.06)  0.76  -0.02 (-0.08; 0.03)  0.43  -0.02 (-0.07; 0.04)  0.51 
Sex female vs male    8.24 (4.98; 11.61)  <0.01  2.51 (-0.21; 5.29)  0.07  
19.14 (-12.75; 
62.69)  0.27 
Age years    -2.69 (-2.88; -2.50)  <0.01  -2.33 (-2.50; -2.16)  <0.01  -2.17 (-2.42; -1.91)  <0.01 Medication yes vs no*       -6.65 (-9.44; -3.78)  <0.01  -6.28 (-9.08; -3.39)  <0.01 Mean arterial BP mmHg       -1.14 (-1.26; -1.03)  <0.01  -1.02 (-1.20; -0.85)  <0.01 BMI kg/m2       -0.66 (-0.98; -0.34)  <0.01  -1.27 (-1.84; -0.70)  <0.01 Heart rate bpm       -0.72 (-0.85; -0.59)  <0.01  -0.71 (-0.84; -0.58)  <0.01 Smoking packyears       0.13 (0.07; 0.20)  <0.01  0.13 (0.06; 0.20)  <0.01 Interaction sex-age female age          -0.29 (-0.62; 0.05)  0.09 Interaction sex-bpmap female bpmap          -0.21 (-0.44; 0.03)  0.09 Interaction sex-bmi female bmi          0.89 (0.20; 1.57) 0.01 
 
Table 8.2: Estimates of associations between different PA determinants and carotid distensibility adjusted for different covariates 
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Parameter Units 
Model 1 
CGM (95% CI) 
[%] 
p-
value  
Model 2 
CGM (95% CI) 
[%] 
p-
value  
Model 3 
CGM (95% CI) 
[%] 
p-
value  
Model 4 
CGM (95% CI) 
[%] 
p-
value 
M
od
er
at
e 
an
d 
vig
or
ou
s P
A 
Moderate PA 10 min/week 0.18 (-3.89; 4.42) 0.93  0.55 (-2.87; 4.09) 0.76  1.27 (-1.65; 4.28) 0.40  1.34 (-1.58; 4.34) 0.37 
Vigorous PA 10 min/week 0.01 (0.00; 0.02) <0.01  -0.00 (-0.01; 0.01) 0.71  -0.00 (-0.01; 0.00) 0.33  -0.00 (-0.01; 0.00) 0.39 
Sex female vs male    8.17 (4.87; 11.56) <0.01  2.36 (-0.37; 5.16) 0.09  18.46 (-13.26; 61.79) 0.29 
Age years    -2.69 (-2.88; -2.50)  <0.01  -2.33 (-2.50; -2.16) <0.01  -2.17 (-2.43; -1.92) <0.01 Medication yes vs no*       -6.58 (-9.37; -3.70) <0.01  -6.20 (-9.01; -3.31) <0.01 Mean arterial BP mmHg       -1.15 (-1.26; -1.03) <0.01  -1.03 (-1.20; -0.85) <0.01 BMI kg/m2       -0.66 (-0.98; -0.34) <0.01  -1.28 (-1.84; -0.71) <0.01 Heart rate bpm       -0.72 (-0.85; -0.59) <0.01  -0.71 (-0.84; -0.58) <0.01 Smoking packyears       0.14 (0.07; 0.20) <0.01  0.13 (0.07; 0.20) <0.01 Interaction sex-age female age          -0.28 (-0.61; 0.05) 0.10 Interaction sex-bpmap female bpmap          -0.21 (-0.44; 0.03) 0.08 Interaction sex-bmi female bmi          0.90 (0.21; 1.58) <0.01 
To
ta
l P
A 
Total PA 10 min/week 0.03 (0.00; 0.06) 0.08  0.00 (-0.03; 0.03) 0.96  0.00 (-0.02; 0.03) 0.86  0.00 (-0.02; 0.03) 0.77 
Sex female vs male    8.30 (5.06; 11.65) <0.01  2.63 (-0.07; 5.40) 0.06  19.09 (-12.80; 62.64) 0.27 
Age years    -2.68 (-2.87; -2.49) <0.01  -2.32 (-2.49; -2.15) <0.01  -2.16 (-2.41; -1.91) <0.01 Medication yes vs no*       -6.61 (-9.40; -3.73) <0.01  -6.22 (-9.03; -3.33) <0.01 Mean arterial BP mmHg       -1.15 (-1.26; -1.03) <0.01  -1.02 (-1.20; -0.85) <0.01 BMI kg/m2       -0.66 (-0.98; -0.34) <0.01  -1.28 (-1.85; -0.71) <0.01 Heart rate bpm       -0.72 (-0.85; -0.59) <0.01  -0.71 (-0.84; -0.58) <0.01 Smoking packyears       0.14 (0.07; 0.20) <0.01  0.13 (0.07; 0.20) <0.01 Interaction sex-age female age          -0.28 (-0.62; 0.05) 0.10 Interaction sex-bpmap female bpmap          -0.21 (-0.45; 0.03) 0.08 Interaction sex-bmi female bmi          0.90 (0.22; 1.59) <0.01 
 
Results are expressed as percentage change in the geometric mean (CGM) per unit increase in the respective parameter with 95% confidence interval (CI), interactions 
between physical activity parameters and sex or age were not significantly associated p>0.8 (data not shown), *second mentioned = reference group, BMI = body mass index, 
bpmap = mean arterial blood pressure 
 
Table 8.2 continued 
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Figure 8.3: Pathway analyses based on the Directed Acyclic Graph (DAG) of vigorous physical activity (PA) and distensibility using standardised betas 
BMI = body mass index, PA = physical activity, arrows = hypothesised effect directions; dashed lines = mediator pathways of PA, * p<0.05, † p<0.01, ‡ p<0.001 
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Discussion 
We observed no association of self-reported PA with distensibility in individuals aged 50 to 
81 years of the SAPALDIA cohort free of CVD diagnosis. Only vigorous PA was significantly 
associated with reduced carotid stiffness in univariate analyses. However, these associations 
disappeared after adjustment for age.  
We used an a priori generated DAG to disentangle the complex interrelation of PA and 
distensibility with several classical risk factors, sex and age. Based on plausible physiological 
and clinical assumptions the DAG helped to unravel directions and strengths of associations 
between potentially influencing factors. The pathway analyses presented in figure 8.3 clearly 
identifies age as the dominant determinant of carotid stiffness (-0.48) followed by 
hemodynamic variables (-0.18 for heart rate and -0.35 for mean arterial pressure) and all 
remaining classical risk factors (< 0.08) including vigorous PA.  
Age is a well-known strong determinant of carotid stiffness [10,22,30,31]. Nevertheless, it is 
challenging to distinguish between age as a classical cardiovascular risk factor, e.g. 
representing the accumulation of life-style risks, and age as a normal physiological process 
known as ‘vascular ageing’ [10]. The concept of ‘vascular ageing’ reflects changes of the 
arterial wall properties, on one hand due to normal vascular remodelling with advancing age 
and on the other hand also due to changes due to an early exposure to risk factors [10]. The 
influence of age treated as a risk factor (e.g. time to unavoidable strain such as normal heart 
rate) might change over lifetime and arterial segment [32]. Thus, it is not clear whether PA 
has a comparable impact on arterial stiffness at different ages. More precisely, does PA 
influence carotid stiffness differently in elderly subjects compared to children and young 
adults since vascular ageing is already advanced in elderly people. However, since we found 
no interaction between PA and age, our results suggest that there are no specific differences 
in the effect of PA on arterial stiffness in individuals above an age of 50 years.  
Our results are principally in line with a report of ‘The Atherosclerosis Risk in Community’ 
(ARIC) cohort study also cross-sectionally investigated [19]. They found no association of PA 
with carotid stiffness in the overall population. Only in a sub analysis vigorous PA was weakly 
associated with reduced carotid stiffness independent of risk factors and age [19]. In 
contrast, cross-sectional studies with far smaller study samples seemed to show much 
stronger inverse associations of increased PA with reduced carotid stiffness parameters [13–
19]. However, these findings were mostly obtained by comparing extremes of PA. Thus, 
middle-aged to older trained athlete swimmers, runners and rowers showed reduced 
stiffness assessed as compliance and beta-stiffness index compared with aged-matched 
sedentary peers [14,15]. Beta-stiffness index even lost significance after adjustment for 
heart rate [15]. Middle-aged to older trained male athletes exercising vigorously had a lower 
carotid compliance and beta-stiffness index while light to moderately exercise was 
associated only with favourable carotid compliance compared to their sedentary peers [16]. 
Furthermore, carotid stiffness in postmenopausal women at a similar age as our cohort was 
correlated with moderate to vigorous PA but not with light PA [18]. These studies indicate a 
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certain dose-dependent reduction of carotid stiffness with more vigorous PA even at older 
age [16,18]. However, the fact that some of the very strong effects were found in small 
studies raises concern about publication bias. Furthermore, some differences in baseline 
fitness level between sedentary and trained people were very large, e.g. maximal oxygen 
consumption were ~30 ml/kg/min for untrained and 34-50 ml/kg/min for trained individuals, 
equivalent to a percentage difference of 13 to 66% [14,16]. The expected gain of maximal 
oxygen consumption by training is as much as 25% on average [33], so that it is questionable 
whether these differences could be achieved by exercise training alone. Instead, exercise 
capacity and arterial stiffness are likely determined by genetic differences. Overall, except 
for ARIC, these small studies with highly selected samples probably do not reflect the 
general population, limiting the transfer of their results from athletes to normal individuals. 
Based on extensive evidence from the literature on favourable mechanisms of PA on 
vascular function via the nitric oxide pathway [34–37] and conserving effect on elastin and 
collagen content against adverse wall remodelling [37,38], we were convinced to find a clear 
independent favourable contribution of PA on carotid stiffness described in the DAG. 
Positive effects of PA on cardiovascular risk factors and CVD were already widely 
investigated [3–8] and different plausible associations of cardiovascular risk factors and 
carotid stiffness were shown by our group [29]. Even more, we were astonished that we 
were not able to show any effect of PA on arterial stiffness in contrast to previous findings. 
 
Strengths and limitations  
This study performed ultrasound examinations to assess carotid stiffness in a large sample 
size with highly standardised procedures and investigated its association with PA assessed by 
IPAQ. The IPAQ was already validated with objective measurements describing a moderate 
reasonable agreement between accelerometry and questionnaire [26,27]. A separate IPAQ 
validation within the SAPALDIA 3 setting including also middle age to elderly individuals 
confirmed the previous findings (paper submitted). However, self-reported PA over the last 
seven days might lead to bias since PA intensity is based on subjective assessment. People 
might consider themselves active based on their life-long activity level, which may has 
changed with age. Overall, the degree of misclassification might be strong enough to prevent 
small effects of PA from being detected. However, measurement of PA in a large sample is 
challenging and costly and a validated questionnaire often seems to be the only feasible 
solution to assess PA in a cohort. In line with other larger studies investigating PA and 
carotid stiffness, our study was limited by its cross-sectional design. Although we generated 
a DAG emphasising to reduce bias by identifying a priori possible confounders, the presented 
DAG and the cross-sectional design do not solve the challenge of possible reverse causality. 
Even though we excluded participants with known pre-existing CVD, there is still the chance 
that an unknown unfavourable health status affects the association between PA and carotid 
stiffness. Thus, to addressing reverse causality, we suggest to assess PA activity 
longitudinally before measuring carotid stiffness 
8 | submitted to PLOS ONE
 
 
 
 
 
124 
Conclusion and perspectives 
This is only the second epidemiological study investigating the associations of PA, risk factors 
and age on carotid stiffness assessed in an ageing population without diagnosed CVD. 
Although we hypothesized an independent beneficial effect of PA on arterial stiffness in the 
CCA, only an increasing amount of vigorous PA (and not total or moderate PA) was 
associated with reduced carotid stiffness and the association was no longer present after 
adjusting for age. Among the classical risk factors of vascular health, age had the dominant 
effect on carotid stiffness followed by mean arterial pressure and heart rate. Since only very 
small intervention studies not representative for the general population showed a beneficial 
effect of PA on carotid stiffness, we recommend to investigate PA determinants in 
correlation with carotid stiffness longitudinally including a representative study sample.  
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Vascular damage plays a key role in the development of atherosclerosis and cardiovascular 
disease (CVD). Therefore, we measured carotid structure and function (carotid stiffness) as 
markers of vascular damage. A summary of the background and a detailed description of the 
respective goals can be found in chapter 2. This thesis aimed to summarise the state of the 
art of ultrasound measurements of the common carotid artery (CCA) and the respective 
relevance for the atherosclerotic risk management; to validate a new ultrasound analysis 
program; to investigate the reproducibility of structural and functional parameters of the 
CCA; to clarify the single associations between different cardiovascular risk factors and 
carotid stiffness indices; and to elucidate the multifarious relationship between physical 
activity (PA), distensibility and cardiovascular risk factors (chapter 4-8).  
 
SUMMARY OF THE MAIN RESULTS  
Carotid intima media thickness (CIMT) is an established biomarker of subclinical 
atherosclerosis. However, standardised preparation, performance and evaluation of CIMT 
measurements are essential (methods) to generate valid and reproducible results and thus 
also for the evaluation and interpretation of the predictive values and subsequent potential 
treatment options (chapter 4). Our first review outlined the state of the art of CIMT 
measurements using ultrasound. Aside from homogeneous external conditions such as 
lying- or head-position, image acquisition needs to be done by trained sonographers in 
pre-specified regions, ideally using sequential-based records across several heart cycles or at 
least three images during the end-diastolic phase in which the the structure of the carotid 
artery is depicted with sufficient visibility. Image analysis using automatic or semiautomatic 
software enhance reproducibility of measurements, especially if landmarks such as the 
opening of the bulb of the CCA were used to tag the start of ultrasound measurements. 
Overall, valid measurements are essential for distinguishing between normal and 
pathological structures. CIMT has been shown to be a suitable approach to improve risk 
stratification in subjects with intermediate risk. Despite the positive findings, using CIMT to 
assure or reclassify CVD risk stratification in daily clinical practice is still under discussion. 
Based on the gained knowledge, we performed standardised measurements of CIMT and 
lumen diameter (LD) in sequential images across the complete heart cycle using an 
automatic analysing system called DYARA (DYnamic ARtery Analysis), which also allows 
manual interaction (chapter 5). To validate the system, all measurements were analysed 
twice. The intra- and inter-reader results were highly consistent with slightly higher bias for 
analyses with manual interactions compared to the automatic detection. Among the carotid 
structure parameters (average CIMT and LD across heart cycle, single images in diastole and 
systole), average CIMT and LD showed lowest variability between the two analyses, with 
smaller relative differences in the latter one (LD). DYARA tackles the challenge of being able 
to analyse ultrasound images of variable quality and therefore can be recommended for 
epidemiological research, diagnostics and clinical practice on grounds of its high precision.  
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The new validated DYARA program was then used to investigate carotid structure and 
function of participants from the SAPALDIA cohort. To assess the quality of the study data, 
we evaluated the reproducibility and the factors attributing to variability of structural and 
functional parameters in a representative sample of 165 SAPALDIA 3 participants (for details 
see chapter 6). Apart from the fact that we can report a good to excellent reproducibility for 
structural and functional indices, our results revealed that the subject itself is the source of 
greatest ultrasound measure variability. In addition, the use of different statistical 
approaches and the relatively large sample size was unique compared to other population-
based studies within the same research field. On the grounds of these results, we can 
provide a solid data basis for further research on vascular health.  
Focusing on carotid function, the first step was to examine associations between several 
cardiovascular risk factors assessed within the first SALPALDIA follow-up period 
(SALPALDIA 2, 2001-2003) and parameters for carotid stiffness, assessed in the SALPALDIA 3 
study period (2010-2011), separately for men and women (chapter 7). In both sexes, most 
cardiovascular risk factors in SAPALDIA 2 were associated with increased carotid stiffness ten 
years later, except PA and high-density lipoprotein cholesterol (HDL-C). HDL-C was the only 
protective vascular determinant and no relation was observed for PA. Sex differences were 
found for heart rate, low-density lipoprotein cholesterol (LDL-C) and triglyceride with stiffer 
arteries in men compared to women for the former two risk factors and in women for the 
latter one. This might suggest a sex-specific burden of atherosclerotic risk factors that might 
be worthwhile to investigate it in more detail.  
In a second step, we examined whether the effects of a given risk factor on carotid stiffness 
were heterogenic among the six carotid stiffness parameters. The analyses suggested 
comparable effects for distensibility, β-stiffness index and Peterson’s elastic modulus across 
the different cardiovascular risk factors. Young’s elastic modulus differed in associations with 
lipids, strain with hemodynamic parameters and compliances with various cardiovascular 
risk factors. While the mathematical formulas of Young’s elastic modulus and strain might 
explain the resulting deviances in some association patterns, we question whether 
compliance is a comparable parameter for cardiovascular risk assessment compared to the 
other carotid stiffness indices.  
Given the results that most carotid stiffness parameters could be used in an interchangeable 
manner, we used only distensibility for further analyses. Although we had already found out 
that PA in SAPALDIA 2 was not significantly associated with carotid stiffness, we assumed 
that health changes within the ten years of the first and the second follow-up might have 
masked the positive effect of PA on carotid stiffness. However, PA assessed in SAPALDIA 3 
showed no beneficial effect on distensibility (see chapter 8). This was the second population-
based study reporting null-results for PA and since protective reports were mostly found in 
smaller studies, this raises the concern of publication bias. Overall, detailed pathway 
analyses between PA, distensibility and cardiovascular risk factors indicated that age was the 
strongest predictor for distensibility, followed by mean arterial pressure and heart rate.  
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SYNTHESIS AND GENERAL DISCUSSION 
The outlined results were based on a well-conceived framework within the SAPALDIA cohort. 
An intensive planning phase lead to high procedural standardisations in ultrasound 
measures, the collection of other biological biomarkers and questionnaire based 
assessments, which emphasised to increase the SAPALDIA data quality. However, it is at 
least as important to investigate and communicate the study data quality in a transparent 
manner [1]. The TREND, the CONSORT, the PRISMA or the STROBE statements and the 
Cochrane Collaboration provide very important information for improved reporting quality 
for clinical trials, observational study designs, systematic reviews and meta-analyses [2–7]. 
However, study data quality does not only reflect methodological issues and procedures (as 
intensively discussed in chapter 4); it also includes the reporting of validity and reliability 
tests for instruments (chapter 5 and 6) [8]. This leads to the question, which is the 
appropriate way to assess the study data quality. Although some of the statements might be 
transferable to validation or reliability studies, a general guideline for assessing the study 
data quality is missing (e.g. number of needed observations, possible statistical methods). 
Although we did not develop a guideline, (data) quality management is a fundamental 
SAPALDIA principle, since data quality has a considerable impact on a proper interpretation 
of the results and thus on the strength of recommendations [1].  
 
Establish a solid data base for carotid stiffness parameters – tasks and duties 
Since DYARA was a newly developed ultrasound analysis program, validating the new 
research tool was inevitable. However, we were not able compare DYARA to another 
system, since there is no gold-standard in analysing ultrasound images and manual tracing 
has been a common way to validate new analysis programs [9,10]. Although automatic 
devices would have been preferable (as outlined in chapter 4), we either could not afford 
costly automatic systems or devices were not compatible with our native format of 
ultrasound images. Since there was no data set from a former validation study available, we 
compared our system to completely manually traced ultrasound images. Results showed a 
far smaller bias for automatic and semiautomatic tracings compared to manual traced clips. 
Thus, we accurately measured what we intended to measure (validity) and increased the 
measurement precision (reliability). We provide our entire validation data set free of charge 
upon request to enable a comparison with all existing and future systems based on the very 
same data from the same patients, ultrasound equipment, and sonographers as described in 
chapter 5.  
In addition to the validation study, we performed the reproducibility study in a relatively 
large subsample of the SAPALDIA cohort (chapter 6) to establish the reliability of the whole 
ultrasound examination process (not only the reading part). Therefore, we visualised 
different concepts of variability and reliability (e.g. dispersion or precision) by depicting 
Bland-Altman plots. Even though relevant information provided by Bland-Altman plots 
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depends on subjective decisions and judgment [11], they deliver much valuable information 
about the investigated data set (e.g systematic bias or heteroscedasticity). However, none of 
the population-based studies mentioned in chapter seven, presented Bland-Altman plots 
[12–19].  
Overall, comparison of reliability measures remains challenging not only due to different 
statistical approaches, but also due to initially specified study methods and study designs 
(e.g. differences in vascular measurement regions or missing study sample description and 
different reader or observer comparisons, see overview in table 6.4). In order to address the 
adjustable issues and to enhance comparability with other reliability studies, we used 
different statistical approaches to assess the reproducibility (mixed model analysis to 
determine the sources of variability, coefficient of variation (CV) and intraclass correlation 
coefficient (ICC)). Since the precision of obtained estimates also influences the interpretation 
of the results, we presented ICC and CV as average estimate with 95% confidence interval 
[20]. Figure 9.1 illustrates the 95% confidence area for the reproducibility of carotid 
structural and functional parameters schematically. Although the degree of precision is 
fundamental, we were the only population-based study within our research area reporting 
confidence intervals for reproducibility results [12–19]. 
 
 
Figure 9.1: Illustrational diagram of the 95% confidence area for the intraclass correlation coefficients (ICC) of 
structural and functional parameters 
To increase the quality of reported reliability studies, official validation and reliability 
guidelines addressing the outlined issues are needed. In addition, journals should promote 
publishing validation and reliability studies and assure that at least the characteristics of the 
validation sample, point estimates and confidence interval of the analyses are described.  
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Different carotid stiffness parameters – do they provide similar information? 
While the reliability study results indicated that reproducibility is comparable across the 
different carotid stiffness parameters (figure 9.1) and while most cardiovascular risk factors 
were highly associated with carotid stiffness (see chapter 7), it is unknown whether all 
carotid stiffness parameters are similarly strong associated within each cardiovascular risk 
factor. This merits particular attention, since we have noticed that some studies, which used 
two or more carotid stiffness indices, rendered more or less divergent results of associations 
between carotid stiffness parameters and cardiovascular risk factors [21–23] or CVD events 
[24,25]. Even more questionable was the fact that the presented results of several carotid 
stiffness parameters within the same study were based on different statistical approaches 
[22,23].  
Investigating this question for the first time in general, correlation analyses yielded a 
moderate to high correlation across the different carotid stiffness indices (chapter 7). More 
detailed analyses showed similar association patterns across cardiovascular risk factors for 
Peterson's elastic modulus, β-stiffness index, distensibility and with exception to certain risk 
factors also for strain and Young’s elastic modulus, but not for compliance (figure 7.3). The 
reported deviances of association patterns might be attributed to parameter omission or 
amendment in the different carotid stiffness parameter formulas and/or to mathematical 
formula modifications (table 6.1). Summarising the formulas, all carotid stiffness parameters 
contain information about the diameter change in diastole and systole and the respective 
blood pressure (BP) values (except strain) to describe the (in)ability of the arterial structure 
to adapt to pressure changes [26]. Carotid wall thickness is only included by Young’s elastic 
modulus [21]. Since strain does not account for BP values [26], hemodynamic parameters 
have a direct mechanical impact on LD change and this clarifies the strong associations of BP 
values on strain (figure 7.3).  
The discrepancy in the association of Young’s elastic modulus and lipids might be explained 
by the inclusion of CIMT and therefore describes the vascular remodelling of the arterial 
structure in a slightly different manner. As outlined in the introduction, the underlying 
mechanisms of atherosclerotic wall alterations involve multiple processes, which are 
complex and interrelated [27]. The interaction between lipid accumulation and their 
inflammatory response is beside other triggers such as endothelial dysfunction or direct 
mechanical stress an established atherosclerotic characterisation [28–30].  
Among all carotid stiffness parameters, results of association patterns of compliance suggest 
partially strong heterogeneity in many cardiovascular risk factors with greatest deviances in 
anthropometric parameters. Based on the formulas, compliance provides as solely 
parameter a two dimensional information of the CCA (cross-sectional area of LD instead of 
the diameter as one-dimensional parameter) [31]. Since the diameter is affected by many 
cardiovascular risk factors and especially by the body morphology [32], this might explain 
the apparent heterogeneity of compliances compared to the other carotid stiffness indices. 
However, the heterogeneity in compliance association estimates is current in many 
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cardiovascular risk factors compared to the other carotid stiffness indices. Thus, it is 
questionable whether statements based on compliance investigations can be generalised as 
carotid stiffness conclusions. 
In conclusion, regarding the association patterns between carotid stiffness and different 
cardiovascular risk factors, we were the first to document existing heterogeneity among 
specific association estimates. However, beside these defined association estimates, most 
carotid stiffness parameters yielded very similar directions in association estimates within 
each cardiovascular risk factor for both sexes, this indicates that most carotid stiffness 
parameters could be used in an exchangeable manner (with certain exceptions e.g. strain 
and hemodynamic parameters). 
 
Associations of cardiovascular risk factors and carotid stiffness in men and women – 
differences or similarities? 
Comparing not only methodological issues, carotid stiffness as a marker of vascular damage 
might offer additional information about cardiovascular risk beyond classical risk factors 
[33]. It is acknowledged that cardiovascular morbidity and mortality are highly dependant on 
an adverse risk factor profile [34]. We showed that most unfavourable cardiovascular risk 
factors were associated with increased carotid stiffness in both sexes, even in the long-term. 
These findings are widely established by various research studies, at least in the short term, 
as already outlined in the introduction (figure 1.1) [16,35–37]. However, manifest CVD and 
lifetime risk are higher among middle-aged men than among women with a comparable risk 
factor profile [38,39].  
We aimed to determine sex differences in carotid stiffness as a possible biomarker of CVD 
risk, since they might indicate a sex-specific susceptibility to certain cardiovascular risk 
factors. Therefore, we investigated possible sex-interactions of cardiovascular risk factors 
across all six carotid stiffness parameters and significant sex-specific discrepancies in effect 
sizes were found for heart rate, LDL-C and triglycerides (table 7.2 and figure 7.2). Increased 
heart rate and LDL-C was more strongly associated with increased carotid stiffness among 
men than women while the opposite was the case for triglycerides. However, comparisons 
of sex-specific results in the literature were hindered, since sex-specific interactions of 
cardiovascular risk factors and carotid stiffness have rarely been investigated. Although 
different studies examined the direct pathways of major cardiovascular risk factors and 
carotid stiffness (figure 1.1), the majority of these studies either investigated only in male or 
female study populations [40–42], adjusted for sex as a possible confounder or performed 
stratified analyses, but they did not investigate sex-specific interactions [36,37,43–47]. This 
leads to the paradoxial situation that a similar database might be present, but specific 
results needed for literature comparisons are not available due to different research aims. 
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Lipids, the metabolic syndrome and cardiovascular diseases in men and women 
Among all cardiovascular determinants in SAPALDIA 2, HDL-C was the only predictor, which 
was significantly associated with reduced carotid stiffness in both sexes. Looking at the 
determinants of the basic lipid profile, our results showed that increased LDL-C and 
triglyceride were sex-specifically related to stiffer carotid arteries. Women seem to absorb 
and synthesize less cholesterol than men resulting in a lower non-HDL-C concentration [48].  
With regard to the metabolic syndrome, HDL-C and triglyceride are two of the five 
components to establish the diagnosis [49]. Groupings of at least three parameters of the 
metabolic syndrome have been shown to be associated with increased carotid stiffness in 
participants without clinical CVD [49]. These analyses were adjusted for sex (amongst other 
carotid stiffness parameters), but did not investigate sex-risk factor interactions [49]. A 
similar study observed a significant increase in carotid stiffness with increasing number of 
metabolic syndrome risk factors only in women [35]: sex only modified the association of 
glucose and carotid stiffness [35]. Glucose might play an important role as an intermediate 
phenotypic trait of diabetes mellitus and according to other studies, the diabetes-related 
influence on cardiovascular risk is elevated in women compared to men due to a stronger 
sex-specific impact of high BP, low HDL-C and high triglycerides [50]. However, it has already 
been shown that diabetes, stroke and myocardial infarction differently influence the 
cardiovascular risk in men and women [37,38,51]. Even though the sex-specific 
predisposition of triglycerides is partly reproduced through our findings, since carotid 
stiffness is a predictor of CVD [52], we decided at the beginning of our study to exclude 
individuals with clinically manifest CVD to avoid additional modification effects. 
 
Heart rate, blood pressure and underlying pathways 
Beside LDL-C and triglyceride, sex differences were also found for heart rate, which remains 
a major risk factor for cardiovascular events and mortality [53]. In the general population, 
increased heart rate is associated with increased carotid stiffness [36]. These analyses were 
amongst other parameters adjusted for sex, but they did not report results for the 
adjustments [36]. Nevertheless, enhanced heart rate due to increased pacing has been 
shown to be a direct modulator of carotid stiffness independent of BP changes [54]. The 
underlying pathways are multifactorial and reflect the complex interplay between heart rate, 
BP and carotid stiffness. Although they are not yet fully understood, this section aims to 
focus on possible functional interactions by heart rate.  
Heart rate pacing studies could offer the opportunity to elucidate the underlying short-term 
mechanisms by heart rate alone. Heart rate pacing at rest showed a reduced stroke volume 
and a relatively constant cardiac output with increasing heart rate [55]. At the same time, 
central venous pressure was slightly reduced, pulmonary mean pressure was unchanged and 
mean arterial pressure was increased [55]. This indicates that heart rate modulates the 
stroke volume by reducing the cardiac preload resulting in a reduced end-diastolic volume 
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[55,56]. Although an increased heart rate might to some extent compensate for the reduced 
stroke volume to maintain the cardiac output [54], the raised mean arterial pressure 
indicates an increased cardiac afterload [55]. The underlying mechanisms might be explained 
by the left-ventricular ejection fraction and the resulted pulse wave [37]. Each ejection 
results in a pulse wave, which travels along the arterial tree and is reflected when arteries 
bifurcate [37]. Even though a higher heart rate reduces the stroke volume and might 
therefore reduce the magnitude of the forward pulse wave, the time spent in end-diastolic 
phase is also shorter [37]. This relates together with stiffer arteries to the circumstances that 
the reflected pulse wave overlap in an earlier phase of the forward travelling pulse wave 
resulting in increased amplitude in the systolic phase while at the same time the diastolic 
pressure is not augmented (increased pulse pressure) [37]. In the short-term, the increased 
pulse pressure affects the direct myogenic response of the artery also called Bayliss effect to 
counteract the mechanical impact [26]. Therefore, an increased mean arterial pressure 
suggests an interplay between a shorter diastolic phase and/or an increased vascular 
resistance due to vasoconstriction based on enhanced cyclic stress [54].  
However, the interrelationships between heart rate, cardiac output, BP and carotid stiffness 
might occur differently based on divergent physiological needs and responses [55]. 
Interestingly, these results during exercise in general agree with the previous findings 
[55,56]. As expected, cardiac output increased with enhancing intensity of PA, but cardiac 
output did not differ with or without atrial pacing [55,56]. In contrast to the findings at rest, 
mean arterial pressure was maintained [55,56] probably due to higher availability of 
endothelial vasodilators, since PA affects the endothelial function [57]. In both, pacing and 
non-pacing exercise interventions, stroke volume increased to about 40% of the maximal 
work load with a subsequent steady state and a following decrease [56]. Thus, it seems to be 
reasonable that heart rate modifies the interaction between stroke volume and carotid 
stiffness to control for BP values and to maintain the homeostasis [55,56]. To compensate 
for the smaller stroke volume [58,59] and in line with our results, heart rate is higher among 
women than among men. This possibly explains the stronger relative effect of heart rate 
among men compared to women.  
There is evidence that BP values differ between men and women during all stages of life, but 
differences are reduced with advancing age (especially in systolic BP) [60]. In line with the 
literature, men showed higher BP values than women (table 7.1). Therefore, one could 
assume that associations to carotid stiffness might also differ by sex. We found no significant 
sex differences for continuous variables in multivariate analyses with additional Bonferroni-
Holm correction. However, in sub-analyses investigating the five BP categories according to 
the hypertension management guidelines [61], women in the optimal category 
(systolic/diastolic BP lower than 120/80 mmHg, respectively) had a significantly reduced 
carotid stiffness compared to men in the same category [62]. While carotid stiffness was 
increasing with increasing BP category, no further sex differences were found for all other 
categories [62]. This suggests that the impact of increased BP on vascular function is similar 
among men and women.   
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Other explanations and possible mechanisms of sex-differences? 
To our knowledge, we were the first to investigate the long-term associations and sexual 
dimorphisms of prior single cardiovascular risk factors and carotid stiffness measured about 
ten years later in a population-based study in elderly. This population based observation 
revealed sex differences in CVD risk occurrence assessed by carotid stiffness but this might 
be not enough to explain the complex underlying mechanisms themselves. Reasons for 
sexual dimorphisms of atherosclerotic diseases may lie in the hormonal status, but 
investigations of sex differences particularly with respect to hormonal and menopausal 
status were beyond the scope of this thesis. Nevertheless, the possible impact of hormonal 
status on the atherosclerotic process will be outlined briefly. Beside the differential exposure 
to risk factors leading to a lower cumulative risk factor burden in women, which might 
explain sexual dimorphisms in cardiovascular risk, it might be plausible that sex hormones 
have a direct effect on pathophysiological changes in vascular function [63]. The question 
rises whether hormonal status might be responsible for the differences in lipid absorption. 
Wang et al. concluded that the lipid mechanism is only partially dependent on hormonal 
status and cannot sufficiently explain sex differences [64]. Other possible anti-
atherosclerotic benefits of oestrogen have been shown by regulating NO activity especially 
in the premenopausal stage, but the protective effect attenuated or disappeared with 
advancing age in postmenopausal women [63]. This results in an increased vascular 
remodelling independent of cardiovascular risk factors [65,66] and leads to an assimilation 
of the carotid atherosclerosis in men and women [67]. In the second SAPALDIA follow-up 
survey, 75% of all female study participants were over 56 years old and 50% older than 63 
years. This means that women were most likely in the post-menopausal phase and thus, the 
pre-menopausal effect might be minimized.  
Another sex-specific pathway might be due to medication intake [68]. It has been shown 
that women are more likely to be under-estimated in risk assessment or under-treated in 
pharmacotherapy in comparison with men [68]. Therefore, we generally adjusted for 
medication intake (antihypertensive, lipid lowering, and glucose lowering treatment) in all 
analyses to avoid confounding by medication. Medication intake in SAPALDIA 2 includes two 
different sources. First of all, participants reported the specific drug names and secondly, 
information is derived from the health care matrix, which included general answers to 
medication intake for detailed doctor diagnosed diseases or symptoms (e.g. high BP). Both 
sources together enhance the completeness of medication intake information and enable 
the correct adjustment for confounding. According to the descriptive analyses, women took 
less medication than men (see table 7.1). When we investigated the sex differences between 
risk factors and carotid stiffness, we additionally included a sex-medication interaction term 
to adjust for possible sex differences in association of carotid stiffness and medication intake 
(data not shown). Based on our data, we cannot support the hypothesis that the described 
sex differences were based on prescribed medications.  
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Which is the most important trigger of carotid stiffness?  
Extending the aim of long-term associations and looking at the complex interrelationship of 
different cardiovascular risk factors as presented in figure 1.2, the atherosclerotic burden 
seemed to be more than a cumulative load of single cardiovascular exposures. Therefore, we 
investigated the direct associations and thus, the particular strengths of single risk factors on 
vascular changes.  
Our results revealed that age was the strongest predictor of increased carotid stiffness 
(standardised betas are displayed in directed acyclic graph (DAG) in figure 8.3). This 
suggested that vascular changes were predominantly based on a normal physiological 
process. Looking at the direct pathways of risk factors and distensibility, mean arterial BP 
and heart rate were beside age the strongest predictors. To set the normal physiological 
process and the direct associations of other risk exposures into relation, which might help to 
interpret the relevance of the findings, the relative proportions of each mean standardised 
risk factor estimate and age are presented here. The strength of direct association of mean 
arterial pressures was 27% smaller compared to the direct association of age on 
distensibility, heart rate was 62% smaller, and all other parameters were more than 83% 
smaller, respectively. However, the strength of direct association of age might be 
overestimated since age is the time being alive and possibly exposed to other influences. 
Therefore, age as a covariate might also account for the burden of other unmeasured 
exposures (mediators). Nevertheless, these results impressively demonstrate the high direct 
impact of age compared to the other risk factors. 
Since age induces remodelling of the carotid artery based on a normal vascular process, we 
presumed that the association of different risk factors might differ with advancing age. 
However, we found no indication for an interaction between age and different risk factors 
on distensibility in further analyses and therefore we suggested that there are no specific 
interaction effects on distensibility in individuals aged 50 years or more. Whether 
accumulation of risk exposure differently affects the arterial system in children or younger 
adults compared to the elderly population remains to be investigated in trans-generational, 
longitudinal study designs.  
Interestingly, the adjusted R2 of the pathway analyses model investigating the direct effect 
estimates on distensibility was 0.52 (data not shown). This is rather high for an 
epidemiological study, but given the fact that age alone already explains 30% of the variation 
in univariate analysis, this might explain the high R2 in the final model (data not shown). The 
univariate analysis for age seemed to be appropriate to investigate the overall effect 
estimate of age on distensibility since age can be assumed as an un-confounded exposure. 
Thus, this underlines that vascular changes assessed by carotid stiffness is predominantly 
affected by age, which might reflect the atherosclerotic and/or arteriosclerotic progression. 
Nevertheless, age is an immutable exposure and other assessed cardiovascular risk factors 
contributed to the prediction of carotid stiffness, which might affect the application of 
further treatment (further information see ‘outlook and perspectives’).  
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Focus physical activity - disentangle the complex cardiovascular risk factor relationship 
We will shortly return to the long-term analyses analysis (chapter 7). In contrast to most 
other cardiovascular risk factors, increased PA in SAPALDIA 2 based on the short questions 
was not significantly associated with reduced carotid stiffness in SAPALDIA 3. The self-
reported short questions were related to duration, intensity (“a bit out of breath” and “out 
of breath or sweat”), and frequency of PA and might be not capable to identify small 
differences in carotid stiffness. The failure to detect a significant association might 
additionally be due to the fact that PA behaviour may have changed between the two 
surveys. However, sub-analyses investigating the longitudinal effect of PA behaviour on 
carotid stiffness yielded in the same conclusion (data not shown). Being physically active or 
inactive in either surveys or getting active or inactive from SAPALDIA 2 to SAPALDIA 3 was 
not significantly associated with carotid stiffness. 
Returning to the pathway analyses based on SAPALDIA 3 data (chapter 8): We calculated not 
only the direct pathways of different risk factors and carotid stiffness, but also focused on 
the complex interrelationship of PA and distensibility. PA was assessed with the long form of 
the International PA Questionnaire (IPAQ) in SAPALDIA 3, which promised more detailed 
information on PA compared to the short questions. However, age confounded the 
association between vigorous PA and distensibility substantially.  
As discussed in chapter 8, we have expected to find associations based on previous findings, 
although most of the studies were based on a small sample size, or researchers investigated 
trained versus age-matched sedentary peers and not a population-based sample [47,69]. 
Even though the general results of ‘The Atherosclerosis Risk in Community’ Study’ (ARIC) 
were comparable to our findings [70], in contrast to ARIC we found no indication of any 
associations in further sub-group analyses (data not shown). Comparing the lowest to the 
highest tertiles of PA, total PA and also intensity stratified analyses lead to the same 
inference.  
Since PA is an acknowledged modifier of cardiovascular risk factors [71], the relative overall 
impact of PA on carotid stiffness might be attenuated. Nevertheless, the other possible 
pathways were also non-significant. Time effects, long-term lifestyle modifications and 
influence of prior or present risk factors are potential modifiers of carotid stiffness (other 
limitations regarding the PA assessment are discussed in the methodological section). 
Although our pathway analyses showed very nicely the different relationships between and 
within the cardiovascular risk factors and distensibility (figure 8.3), directions were based on 
a DAG, which in turn relied on a priori-defined hypothesis. The cross-sectional design does 
not allow drawing causal conclusions and it does not solve the issue of reverse causality [72]. 
The latter one is especially true for BP. 
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Reverse causality – blood pressure and carotid stiffness 
Even though BP and vascular changes were longitudinally investigated in normotensive 
subjects [73], there is no evidence, whether the development of hypertension may have 
occurred due to an increased arterial stiffness or the other way around (‘Chicken-or-the-Egg’ 
question) [74]. Figure 9.2 shows the modified carotid stiffness circle originally generated by 
McEniery and Wilkinson [75] referring to the challenge of reverse causation of vascular 
function and BP leading to atherosclerosis and/or arteriosclerosis. Even though BP always 
has a short-term direct mechanical impact on carotid stiffness (action and reaction), it re-
affects BP itself [26], either by auto regulation (e.g. in terms of the Bayliss effect) and/or by 
acute effects as it can be induced by exercise interventions [76,77]. Short-term changes are 
assumed to be reversible and aim to maintain blood flow and to preserve homeostasis 
within the artery. In the long-term, cyclic stress induced by heart rate might adapt the 
cardiac and arterial structure and function (e.g. left ventricular mass or the cardiac 
contractility and CIMT, LD or the carotid function) and other main factors (e.g. cardiac pre- 
and afterload or BP) [75,78].  
 
 
Figure 9.2: Modified circular adaption of the common carotid artery (McEniery & Wilkinson, 2013) [68] 
The circular adaption of BP and vascular function covers the determination of the cause and 
the consequence. The interpretation is additionally aggravated due to possible varying 
circumstances (interactions of preventive factors and risk factors). For instance, the impact 
of heart rate differs from short-term to long-term. While heart rate is a short term modifier 
of BP, which in turn induces a mechanical stress, in the long-term it is a direct risk factor of 
carotid stiffness since it reflects the extent of exposure to mechanical stress (cyclic stress) 
[79].   
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METHODOLOGICAL ISSUES – DECISIONS, POSSIBILITIES AND CHALLENGES 
Research is always a balancing act between optimal and feasible scientific research. 
Statistical analyses rely on models, which aim to reflect the real situation, but also rely on 
certain assumptions. Although our research is based on solid research using highly 
standardised and validated methods and our findings are reasonable in the light of current 
literature, some research methodology restrict the generalisation of the results and need to 
be discussed. 
 
Central versus brachial blood pressure 
Even though the difference between brachial and central BP decreases with advancing age 
[26], and it has been shown that brachial BP can be used to calculate carotid stiffness 
parameters in elderly people [52], pulse pressure might differ between central and 
peripheral locations [80]. The difference between central and brachial BP not only depends 
on the process of arterial stiffening based on arteriosclerosis and atherosclerosis, but also on 
the vessel properties (e.g. radius), blood flow (e.g. density and velocity), and determinants of 
the cardiac function [81–83]. Since vessel function changes along the arterial tree 
characterised by higher elastic wall properties and lager diameter in central arteries 
compared to the periphery, blood flow is reduced in the latter one and resistance is 
increased, respectively (Hagen-Poiseuille equation and Laplace’s law) [26]. To overcome the 
higher flow resistance, a higher pressure difference is needed in the periphery compared to 
the central pulse pressure [26].  
The underlying parameters, which cause differences between the central and brachial BP 
values additionally vary between sexes and may modify to some extent the sex-specific 
associations of cardiovascular risk factors and carotid stiffness [32,59,84,85]. In agreement 
with literature, we found that body and diameter size, BP values and all carotid stiffness 
parameters were reduced among women compared to men while heart rate was contrarily 
increased (see table 7.1, diameter size not shown) [59,60,85–87]. As outlined before, heart 
rate has an additional impact on BP. Increased heart rate reduces the time of the cardiac 
cycle due to a shorter end-diastolic phase [37]. In combination with stiffer arteries, the 
superposition of the forward and backward pulse wave is more likely to be in the systolic 
phase, which leads to higher pulse pressure, especially in the periphery [37]. Thus, the pulse 
pressure amplification between the brachial and central pulse pressure is also dependent on 
heart rate [82].  
By using brachial BP for carotid stiffness, investigations may overestimate carotid stiffness. 
Also, the question whether sex-specific variability of BP values has an impact on our 
estimates, is not clarified [88,89]. Since we have not measured central BP, this might affect 
the outlined investigations and it should be implemented in future carotid stiffness 
examinations. 
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Carotid parameters 
Whenever a plaque occurred in the measurement region of interest, we excluded this 
specific observation. We did not implement plaque as an additional criterion for 
atherosclerosis because the sonographers were not trained to detect plaque occurrence in 
the carotid artery and we would therefore have implemented a detection bias. This is also 
reflected by our descriptive statistics. Inclusion of plaque might have added important 
additional information on atherosclerosis, since plaque always reflects a pathological 
atherosclerotic process, while an increased intima media thickness does not necessarily [90]. 
The resulting blood flow reduction of plaques is dependent on the stage of atherosclerotic 
stenosis [91]. However, focal narrowing induces blood flow reduction, but it is not 
necessarily associated with ischemic neurological symptoms [91]. But plaques still induce 
blood flow disturbance and reduction [91].  
SAPALDIA ultrasound examinations were performed in 3489 participants. Data of 65 
participants (1.9%) could not be analysed due to poor ultrasound data quality. A plaque was 
only found in 174 participants (5%), whereby the expected prevalence in middle to older 
populations would be assumed to lie above 50% (increasing prevalence with advancing age) 
[92]. Thus, all conclusions in this thesis are based on plaque-free detection results according 
to the Mannheim Consensus [93].  
Not only does inclusion or exclusion of plaques influence carotid parameter values. Carotid 
diameter variations during cardiac cycle are well examined [94] and all carotid stiffness 
parameters include specifically diameter measures at diastolic and systolic phase (see table 
6.1). Therefore, it seems to be logical that similar definitions are available for the carotid 
wall thickness, since significant differences between systolic and diastolic CIMT were 
reported [13]. In line with our results, CIMT is smallest in systole and largest in diastole while 
the average of all analysed CIMT measures across heart cycle lay in-between (table 6.2). 
However, in terms of Young’s elastic modulus, which was the only carotid stiffness 
parameter considering CIMT (table 6.1), it is not specified which time point or measure of 
CIMT should be used for its calculation. Considering the earlier perspective that previous 
devices were not capable or were limited in measuring CIMT in predefined time points, we 
decided to use the average of all CIMT measurements as a stable outcome to calculate 
Young’s elastic modulus (chapter 6, table 6.1). Further research is needed to evaluate the 
clinical impact of different carotid structures (e.g. CIMT or roughness) on carotid functions, 
especially since carotid structure and function represents the atherosclerotic process in a 
slightly different way.  
 
Physical activity assessment 
The use of questionnaire to assess PA is still very common - especially in epidemiological 
studies with large sample sizes [95]. A questionnaire is easy to apply, the organisation and 
distribution is rather simple, it is relatively inexpensive and the self-administered tool is 
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commonly well accepted by the participants [95]. This being said, several methodological 
issues regarding the PA assessment may still have influenced the accuracy of the results, 
which in turn might reduce the sensitivity to detect changes.  
In the first follow-up, only the short questions were posed. In the second follow-up, the 
short questions were repeated and the long version of the IPAQ was introduced. Both 
questionnaires were self-reported assessments of PA behaviour. Especially in subjective 
measures, recall or desirability bias might be induced when asking about past PA [95,96]. In 
a sub-sample, there was a tendency to over report the total minutes spent in light to 
moderate PA and to under report the vigorous intensity compared to accelerometers (with a 
greater bias for men compared to women) [97]. In addition, older individuals (> 65 years) 
tended to over report their PA compared to younger people [97]. The degree of 
misclassification might be strong enough to prevent small differences due to PA from being 
detected. 
Although reliability and validity of both assessments were examined [97,98], reliability of 
subjective measures (e.g. questionnaires) are likely reduced compared to objective 
measurements (accelerometer), whereby correlations were around 0.45 [97]. The IPAQ was 
separately validated within the SAPALDIA 3 setting, also including middle aged to elderly 
participants, and the results verified the previous findings (paper submitted by Wanner et 
al.). We also found similar correlations when comparing the short questions and IPAQ 
information within the study sample used in chapter 8 (data not shown). Despite the fact 
that these correlations were relatively low to moderate, such thresholds are at the moment 
well accepted in the respective research community [96]. 
Both questionnaires offered the opportunity to investigate the frequency, duration and total 
amount of PA during the last seven days. After examination and discussion about the 
advantages and disadvantages of absolute and relative intensities, we decided to use 
intensities in minutes per week and not metabolic equivelent’s (METs) mainly to avoid 
misunderstanding of the definition of MET. This will be shortly outlined. Moderate and 
vigorous intensity is dependent on a person’s cardiorespiratory fitness level (VO2max) and it 
is known that this intensity may vary between individuals performing the same exercise [95]. 
In contrast, one MET corresponds to the energy expenditure at rest 
(~3.5 ml O2 × kg-1 × min-1) and is therefore an absolute value due to a specific performance 
(‘objective MET’) [99]. Interpersonal variation of MET’s may still exists due to dependent 
covariates such as sex and age [96], but it is presumably negligible compared to the fitness 
level variation. Depending on different PA guidelines, moderate intensity relates to 
approximately 3-6 MET’s and vigorous intensity to 6-8 MET’s [99,100]. However, when 
MET’s are calculated based on duration and subjective intensities (e.g. out of breath or 
sweat), one can assume that the ‘objective MET’ based on energy expenditure might differ 
from the ‘subjective MET’ based on intensities [95]. To explain this statement in more detail, 
we consider a fictive example including person A (trained) and person B (untrained). In the 
week before they fill in the questionnaire, they did exactly the same exercise (e.g. running 
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5mph ~ 8 MET [101], 2 times per week for 20 minutes). Since the IPAQ or the short questions 
(as most other PA questionnaires) did not assess the type of exercise (running at 5 mph) but 
rather the total amount of moderate or vigorous intensity performed in the last seven days, 
person A considered the personal exercise intensity as moderate while person B exercised at 
a vigorous intensity. By using the guidelines (e.g. the Guidelines for Data Processing and 
Analysis of the IPAQ [102]) the calculated ‘subjective MET’ differs between person A and B 
and do not correspond to the ‘objective MET’ value (8 MET = 5 mph). Misunderstanding 
might occur by interpreting the ‘subjective MET’ as ‘objective MET’. Since the IPAQ-MET’s 
were only transformed values of the subjective intensities, our conclusions regarding PA and 
carotid stiffness did not change. However, in terms of comparability to other different 
studies, MET’s might be an option for future investigations.  
Despite the mentioned limitations of the PA assessments, the choice of which method to use 
was a compromise between feasibility and accuracy. A lower accuracy of PA assessment 
methods may lower the variation of the exposure. This implies that the expected carotid 
stiffness effects of PA could lie beyond the detection limit. For future studies, objective 
measures of PA such as accelerometers would likely enhance the accuracy of the 
assessment. And the complementary inclusion of cardiorespiratory fitness, which is strongly 
correlated to cardiovascular health [103], might be a crucial determinant for future research 
to detect small differences in carotid function. However, for longitudinal data, it is assumed 
that a certain individual threshold is needed to induce a physiological response (e.g. a 
change in carotid stiffness) [96]. Therefore, subjective PA might still play a key role in future 
research.  
 
Study designs and biases – implications for the interpretation of study results 
SAPALDIA is to-date a ‘closed’ cohort traced since 1991 with the initial purpose to 
investigate air pollution and the occurrence of lung and heart disease during follow-up. 
‘Closed cohort’ means that no further members were added [104]. The advantages of this 
are that all members were observed over time and longitudinal data are available. This 
enables the investigation of prevalence but also of incidence and progression of diseases and 
other outcomes [72,104]. The potential downside of a ‘closed cohort’ is that the cohort size 
gets smaller with passing time [72,104]. A bias might be induced especially when dropouts 
differ from persistent members [72,104]. Loss to follow-up should therefore be prevented, 
particularly since cohorts are likely to suffer from a healthy survivor effect, which in turn 
affects the general interpretation of the study results [72,104]. A key part of identifying 
healthy survivor bias is intensive and prospective examination of participant’s health and 
environment information - a real strength of the SAPALDIA cohort study. This constitutes a 
basis for identifying determinants of healthy survivor bias. Since the magnitude of healthy 
survivor effect also depends on the research question (the number of healthy survivor 
determinants influence the degree of bias), this enables a more precise interpretation of the 
results.  
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All data used in this thesis were collected at the first and second SAPALDIA follow-up. 
Although SAPALDIA participants were highly committed to the study, loss to follow-up 
occurred. Internal statistical analysis showed that SAPALDIA 3 participants were more likely 
to be young, not obese, non-smokers (never or former smokers), of Swiss nationality, higher 
educated and without clinical symptoms compared to SAPALDIA 2 participants, indicating a 
certain healthy survivorship (Meier et al., paper in preparation). But what does this mean for 
the presented research? For instance, we excluded a priori participants with known manifest 
CVD, which means that this specific healthy survivor determinant might therefore be less 
capable to influence our results. Although the study sample represented the Swiss 
population in 1991 (sample recruitment based on randomization), the generalisation of 
SAPALDIA 3 results might be more transferable to younger people with generally better 
health characteristics (non-obese, non-smokers etc.) due to the loss of follow-up. However, 
healthy survivor effect might also help to explain why we have not found the expected 
association. We anticipated to find socioeconomic influences, but since SAPALDIA 3 
participants were more homogenously represented in terms of the socioeconomic status, 
this might explain why socioeconomic status was not a determinant of carotid stiffness.  
When interpreting the study results, one should be aware of the most common study errors 
[72]. Errors can generally be distinguished as systematic or random errors [104]. While 
random error decreases with increasing study size sample, (a further advantage of cohorts), 
systematic errors, also called bias, are unaffected by study size enlargement, since they refer 
to a specific source of error [104]. Besides the healthy survivor bias – which was already 
introduced – selection bias, information bias and confounding are the most prominent 
sources of error in observational studies [104, 105]. Selection bias may be reduced in the 
SAPALDIA cohort since the initial study sample was selected by randomization, although due 
to loss of follow-up healthy survivor bias was introduced. Forms of information bias are 
measurement errors, interviewer bias or recall bias [104,105]. Conducted validation and 
reproducibility studies help to identify systematic measurement errors. Intensive staff 
training and standard operating procedures may reduce bias introduced by fieldworkers. In 
addition, separated assessments of diseases, behaviour and symptoms may reduce recall 
bias (although a smoker might be more aware of smoking related symptoms than a non-
smoker). And DAG’s and intensive analyses may help to identify and adjust for possible 
confounders. 
Except for validation and reproducibility studies, which were separately conducted within 
the SAPALDIA 3 survey, the presented studies in this thesis were based on cross-sectional 
design. The study about prior cardiovascular risk factors and current carotid stiffness 
(chapter 7) was a special case of cross-sectional investigation since the exposure and 
outcome had a long-term relationship. Let us bear in mind that an assessment conducted at 
one specific time point is a snapshot and does not reflect change in time. Thus, the 
discussion about probable causes and effects (e.g. pathway analyses) were based on a priori 
defined hypotheses, since a cross-sectional design does not allow conclusions on this specific 
issue [104]. Therefore, only associations and no causal relationships can be confirmed.  
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Relevance of the study results 
To comprehend the relevance of the study results, it is important to define the framework 
condition in which the study results should be interpreted. Considering the common 
research process [106], which is not always a straight forward approach, the following stages 
can be determined: 1) Development of new tools or new ideas, which allows the 
investigation of basic pathways and relations within a new research field based on the 
current state of the art. 2) Conducting additional studies and collecting further information 
on the same research object, 3) achieving evidence, 4) creating knowledge, 5) adapting and 
applying the new knowledge (e.g. into policy) and finally 1’) developing new research 
questions within the new research field - leading again to stage one but on a higher level. 
The different stages are of course the result of the competitive work among various research 
centres and may partially overlap.  
Setting the conducted studies within this thesis into the context of the research spiral, we 
are currently switching between phase one and two: Carotid stiffness is assumed to be an 
early biomarker of cardiovascular risk [52]. Therefore, we examined the state of the art of 
ultrasound assessments (chapter 4, stage 1’) with the aim to enhance future measurement 
quality, which would then allow a more exact investigation of basic relations to carotid 
stiffness exposures. Ensuingly, the new ultrasound analysis program was developed and 
validated (chapter 5 and 6, stage 1) and first basic pathways were investigated within an 
epidemiological study (chapter 7 and 8, stage 1/2). Thus, relevance of the study results 
should be discussed in relation to the possibilities in stage 1 or 2. Potential implications with 
regard to e.g. public health or treatment are discussed in the section ‘outlook and 
perspectives’.  
The relevance of results in any study not only depend on the measured magnitude (effect 
size), but also on the statistical precision of the measured estimates (e.g. confidence 
interval), the reproducibility of analyses (e.g. ICC) and the critical reflection of 
methodological issues (strengths and limitations) [1]. To summarize the strengths and 
limitations: carotid structure and function measurements were validated and revealed good 
to excellent reproducible results. Associations of prior and current cardiovascular risk factors 
showed consistent relations, even though effect sizes seemed to be small in comparison to 
age as non-modifiable exposure. However, long latency periods of small exposures can also 
cumulatively expand the burden of disease. Therefore, it is of significance that most 
cardiovascular risk factors were still associated in the long term with carotid stiffness for 
both sexes (independent of age, education level, mean arterial pressure, medication and 
study area) and keeping in mind that exposures could have changed over time and inclusion 
of brachial BP may have affected the strength of association.  
To summarise the relevance of the study results, we can conclude that our analyses provides 
a powerful basis to continue the research and to collect further information on determinants 
of carotid stiffness and its underlying pathways.   
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OUTLOOK AND PERSPECTIVES 
Classical Epidemiological studies investigate health determinants and/or disease occurrence 
in the population [104]. Therefore, epidemiological research is a crucial element of public 
health activities, which aim to preserve, promote and improve the population’s health and 
quality of life [107,108]. Since health determinants in relation to carotid stiffness were 
investigated in the population-based SAPALDIA cohort, the long- and short-term 
perspectives rely on clarifications of important questions, such as: what are the short-term 
perspectives and are there any other aspects, which could further elucidate the complex 
relationship of risk factors and carotid stiffness? Which treatments and interventions might 
be implemented in the future to reduce atherosclerotic burden? What is the long-term role 
of atherosclerosis research for public health and why is it relevant?  
 
Short-term prospects  
We assessed prior cardiovascular risk factors in SAPALDIA 2 and also current cardiovascular 
risk factors in SAPALDIA 3, therefore the question needs to be answered: why did we not 
investigate the longitudinal changes in these risk factors? The reason is mainly due to the 
fact that blood parameters of SAPALDIA 3 remain to be determined due to unexpected 
delay. We assume that the associations of the 10-year risk exposure (longitudinal design) 
would be even stronger.This would strengthen our findings and therefore will be an aim for 
future investigation.  
Addressing the aspect of further research possibilities within the SAPALDIA cohort to clarify 
the complex relationship of different risk factors, other diseases or exposures were assessed 
within the surveys. With regard to SAPALDIA’s origin, air pollution has already been shown 
to be related to carotid intima media thickness [109,110], while associations with carotid 
stiffness remain to be evaluated. Other exposure effects such as noise, nutrition or other 
diseases and its intermediate phenotypes could be excellently investigated in relation to 
carotid stiffness. Family history might give additional insights to identifying possible 
transgenerational determinants. Complementary to the physical risk factors of carotid 
stiffness, psychological and psychosocial characteristics (e.g. mental disorders, stress or 
social support) may influence the development of atherosclerosis since it has already been 
shown to affect cardiovascular events and mortality [111]. An additional research field might 
be the gender related investigation beyond biological sex-specific differences as examined in 
chapter 7.  
In addition, there might also be the possibility to stratify by culture or environment. 
Switzerland not only has different cultural aspects (German, French and Italian); but it also 
encompasses both rural and urban characteristics. Therefore, the SAPALDIA database offers 
an excellent opportunity to examine such aspects in detail. In the presented studies, we 
commonly adjusted for areas as random effects but investigations by language or 
environment were beyond the scope of this thesis. 
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Returning to the unused capabilities of the raw database of ultrasound measurements, 
expert readers analysed all ultrasound images and the respective raw data contour detection 
results were saved in Hierarchical Data Format files (HDF5). At the moment, only the most 
widely used carotid structural parameters were extracted (CIMT and LD in diastole, systole 
and the respective average across heart cycle). These data were needed to calculate carotid 
stiffness parameters. However, HDF5 files contain a lot more information than those 
mentioned. Each clip, which was used in this thesis, includes at least around 90 single frames 
per heart cycle (10.7ms per frame, up to tree heart cycles were analysed). Overall, about 
17’000 clips and 17’000 images leading to a total number of about 2’500’000 single images 
(including SAPALDIA sample examinations, validation study and certifications) were analysed 
by DYARA and expert readers. From these, other parameters of interest could be calculated. 
For instance, CIMT variability [112] or intima media roughness [113,114] could be extracted 
from the HDF5 files. Since both LD and CIMT were assessed across the whole heart cycle, this 
could be done not only over a certain segment, but also over the whole heart cycle, which 
might provide additional information about atherosclerotic wall alterations. Therefore, HDF5 
files provide an excellent opportunity for future research, not excluding evaluation and 
further improvement of methodological and technological aspects, which could minimise 
measurement variations.  
Besides the examination of carotid structure and function, another measure of arterial 
stiffness was assessed within the SAPALDIA 3 survey – pulse wave velocity. While carotid 
stiffness is a direct measure of local arterial stiffness, pulse wave velocity quantifies the 
systemic arterial stiffness [88]. Since these measurements of arterial stiffness involve 
different segments of the artery and since elasticity (and therefore also pulse wave 
reflection) changes along the arterial tree, this suggests that different mechanisms interact 
with both forms of arterial stiffness [52]. Therefore, contribution of different risk factor may 
also vary between these two measurements [37,115]. Comparing these carotid stiffness and 
pulse wave velocity and investigating the respective effects of cardiovascular risk factor may 
help to understand the underlying pathways in more detail.  
While normal values already exist for pulse wave velocity and CIMT [116,117], no reference 
values have been published (up-to-date) for carotid stiffness. Normal values are the basis to 
identify individuals with potential deviating characteristics towards an increased 
cardiovascular risk. While established risk scores depend on a snapshot of current exposure 
to cardiovascular risk factors, carotid stiffness may overcome this weakness since it reflects 
the accumulated vascular damage based on the whole burden of exposure. First studies on 
reclassifications of Framingham Scores due to vascular ageing were performed indicating 
that a combined approach may prevent underestimation of individual’s cardiovascular risk 
[33]. However, whether a combination of pulse wave velocity, CIMT and carotid stiffness 
would even better predict cardiovascular events or re-classify people at risk remains to be 
evaluated in further studies.   
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Possible treatment and intervention perspectives 
All presented studies (chapter 4-8) aim to increase the amount of information to understand 
the complex relationship of different cardiovascular risk factors and carotid stiffness. 
Knowing the impact of certain cardiovascular risk factors on the atherosclerotic burden may 
affect the respective interventions or treatment, which may leads then to an optimal 
vascular ageing. The concept of ‘early vascular ageing’ (EVA) was presented in chapter 1. The 
counteracting approach of EVA is called ‘ADAM’ and it is defined as the ‘aggressive decrease 
of atherosclerosis modifiers’ [118]. A targeted use of ADAM by intensifying the respective 
treatment of a certain risk factor aims to reduce or minimize vascular changes. Thus, based 
on our results and on the direct pathways, main treatment targets seem to be BP and heart 
rate, which has also been confirmed by previous studies [36,75,79]. Considering now the 
interrelationships of the different cardiovascular risk factors (figure 1.1, figure 1.2 and figure 
8.3), it is of crucial importance for cardiovascular health and a preventive perspective to 
avoid unfavourable lifestyle behaviours and other modifiable risk factors in general [79,119–
121]. In the case of present cardiovascular risk factors (or even latent CVD), it is also of 
significance to apply ADAM and to treat patients with the best practice approach [122]. 
While the former perspective describes more the primary CVD prevention, the latter aims to 
optimise the secondary preventive effort [122].  
The question remains: which individuals should be targeted to receive preventive medicine 
and how could carotid stiffness assessment influence this decision? The decision is often 
based on cost-effectiveness by targeting those individuals at high risk [123]. In case of 
hypertension, already a more sophisticated approach is available, which considers different 
interventions and treatment depending on the individual’s risk of hypertension and 
cardiovascular exposure based on risk factors or organ damage [61]. Let us remember that 
carotid stiffness data includes no plaque occurrence since plaques reflect a different shape 
of atherosclerotic process [124]. Considering the crude overall range of the atherosclerotic 
process starting with non-pathological vascular remodelling, followed by pathological 
manifestation of plaques and ending with occurrence of cardiovascular events, our 
measurement of carotid stiffness refers to the first stage. Therefore, normal values of 
carotid stiffness might help to identify individuals at high risk for non-pathological vascular 
changes. This means that with regard to the whole atherosclerotic process, carotid stiffness 
might even enable an early diagnosis of cardiovascular risk. However, identification of early 
vascular damage even in asymptomatic individuals may not lead directly to a reduced or 
delayed development of CVD, but it potentially creates an important basis for further 
research attempting to reach this goal. From a preventive point of view, we should take this 
time advantage and implement early interventions [125]. Whether high-risk or population-
based strategies should be implemented remains to be evaluated [123]. 
  
9 | Synthesis, discussion and perspectives 
 
 
 
149 
Long-term investment - public health relevance  
The ‘Global Burden of Diseases 2013 Mortality and Causes of Death Collaborators’ recently 
published their new analysis for the global burden of disease with a sex- and age-specific 
focus [126]. Global life expectancy has increased since 1991 compared to 2013 (life 
expectancy at birth in Switzerland: males from 74 to 80 years and females from 81 to 85 
years), but mortality rate has decreased more in women compared to men, and this was the 
case in all age groups except the oldest one [126]. However, age-standardised death rates of 
CVD showed a decrease of 22% from 1990 to 2013 [126]. This seems to be confusing at a 
first glance, since one would assume that a population with increased life expectancy, death 
due to CVD would also increase. However, age-standardisation considers the differences in 
age distribution at the time point 1990 and 2013. This means, that the ‘standard population’ 
has improved since 1990, possibly due to health related promotion and lifestyle changes 
such as PA [126]. PA has been shown to be a suitable non-pharmacological treatment for 
primary or secondary CVD prevention – especially on the population level [127].  
However, looking at the total number of deaths from CVD, death has globally increased by 
40% (from 1990 to 2013) [126]. By comparing the total and the age-standardised value, we 
nicely see the impact of the ageing population. The three main causes of years of life lost in 
Switzerland in 2013 were ischaemic heart diseases, lung cancer and stroke [126]. Knowing 
the actual burden of the diseases is one aspect, but assuming a further increase in life 
expectancy, the burden of age-associated diseases will in particular increase [128]. 
According to the Swiss Federal Statistical Office, the population demography in people aged 
65 or more will change from 17.6% (2013) to 27.7% in 2050 [129]. From a cost-effectiveness 
perspective, the larger the incidence and prevalence of the disease (as CVD is assumed to 
occur more often with advancing age), the smaller the number needed to treat in order to 
avoid one event [128]. However, the relevance of primary prevention is not solely the 
prolongation of life expectancy, but more importantly, to increase the health related quality 
of life [130]. Thus, reduction or at least to postpone the burden of CVD is of greatest public 
health relevance and therefore, current research on atherosclerosis as ageing related 
disease is an investment for the future. 
 
CONCLUSION 
In order to investigate the multidimensional pathways of cardiovascular risk factors on the 
atherosclerotic burden, which will be an upcoming challenge in the near future, a new 
ultrasound analyses system was developed and validated and we investigated the long- and 
short-term associations of cardiovascular risk factors and carotid stiffness in elderly 
participants in the multicentre SAPALDIA cohort. Carotid stiffness indices can provide 
information on the elastic carotid properties and therefore reflect vascular damage 
accumulated over time [31].  
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Given the good reproducible results, these studies showed for the first time that most 
carotid stiffness parameters could be used interchangeably. In addition, the past preload of 
single cardiovascular exposures has added important information to the overall vascular 
damage assessed by carotid stiffness separately for both sexes. Since also sex-specific 
attributions to the atherosclerotic burden were found for heart rate, LDL-C and triglyceride, 
this indicates a different susceptibility among men and women, which should be further 
examined. Shifting our focus from the long-term to the short-term observations, we gained 
valuable insights in the multifactorial pathways of cardiovascular risk factors and carotid 
stiffness. Even though the strongest predictor of carotid stiffness was age, indicating that 
most alterations depend on normal vascular ageing, strengths of association regarding other 
risk factors such as heart rate or mean arterial pressure, were still substantial. However, age 
has also been shown to be a strong confounder and therefore, the assumed positive 
associations of PA could not be supported by our findings. Nevertheless, previous beneficial 
effects of PA on carotid stiffness were based on small intervention studies not 
representative of the general population. Since this was only the second epidemiological 
study examining the complex relationship of PA, cardiovascular risk factors and carotid 
stiffness in a cross-sectional design, we recommend further investigating PA determinants in 
correlation with carotid stiffness longitudinally, including a representative study sample. 
In conclusion, the presented studies within this thesis provide an important basis towards 
future investigations targeting the early and late consequences of atherosclerosis and its 
progression. In addition, evaluation of preventive or prognostic determinants of carotid 
structural and functional parameters may help to improve CVD management and may 
facilitate implementation of carotid ultrasound in clinical practice.  
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Team 
Sonographer 
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Prof. Dr. A. 
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Dratva, PD Dr. H. 
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Data 
collection  
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Ultrasound 
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done by trained 
and certified 
SAPALIDA 
fieldworkers 
Coordination 
and transfer 
of ultrasound 
raw data 
2010-
2012 
Administration and coordination to assure a fluent raw data 
transfer from Swiss TPH to DSBG. Strong collaboration with 
Dr. J. Dratva, M. Tarantino, Dr. M. Baumstark. 
Dr. J. Dratva, M. 
Tarantino, Dr. M. 
Baumstark 
DYARA 2010-2012 
Reader feedback and strong collaboration with the 
computer scientist Prof. Dr. Alexandra Teynor to improve 
user-friendly handling of the new ultrasound analysis 
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Prof. Dr. A. 
Teynor 
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data 
management 
and image 
analysis at 
DSBG 
2010-
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b. Systematic training of DSBG reader 
c. Coordination of reading procedure at DSBG and 
managing the reading center team (10 Readers)  
d. Monthly report / feedback of reading procedures with 
Swiss TPH (Dr. J. Dratva) 
e. Coordination of backup procedures with Dr. M. 
Baumstark (University of Freiburg, D) 
f. Coordination of data transfer (analysed ultrasound 
data) from DSBG Server to Swiss TPH Server (M. 
Tarantino, Dr. M. Baumstark) 
M. Tarantino, Dr. 
J. Dratva, Dr. M. 
Baumstark, The 
DSBG Reading 
Center Team 
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Table A continued 
 
Topic Time Contribution by the PhD student* 
Collaboration 
and contribution 
by the SAPALDIA 
Team 
Data entry, 
controlling, 
cleaning 
2012 
a. Generation of first ultrasound data set (analysed data) 
in October 2011 
b. Reception of new data from Swiss TPH in December 
2011 
c. Generation of final data set in February 2012  
d. Data cleaning of DSBG ultrasound data in February 
2012 
e. Data cleaning of blood pressure data in March 2012 
f. Reception of final joined ultrasound dataset including 
blood pressure data from Swiss TPH in June 2012 
g. Data entry of 100 IPAQ’s in April 2013 
h. Generation of CIMT and carotid stiffness codebook in 
strong collaboration with Dr. J. Dratva. 
i. Controlling: Single structural and functional 
parameters, were separately generated by E. Schaffner 
and on my part according to prior defined definitions in 
the SAPALDIA codebook. We compared our results 
minutely detailed and redefined some definitions due 
to unexpected deviations in the generated variables 
due to the complex CIMT methodology. 
E. Schaffner, Dr. J. 
Dratva and the 
SAPALDIA data 
management 
team 
Statistical 
analyses 
2013-
2014 
a. Research analysis plan and first analyses (paper and 
conference projects) were generated by the PhD 
student 
b. Discussion of research analysis plan and first results at 
the CIMT Working Groups meetings. 
c. Detailed discussion about statistical analyses (PD. Dr. C. 
Schindler, E. Schaffner) 
CIMT Working 
Group (Prof. Dr. 
A. Schmidt-
Trucksäss, Prof. 
Dr. N. Künzli, Prof. 
Dr. N. Probst-
Hensch, PD Dr. C. 
Schindler, Dr. 
Julia Dratva, S. 
Endes, E. 
Schaffner) 
Paper projects 2012-2014 
In all papers: all authors contributed to the interpretation 
of the results and have read, revised and approved the final 
version of the submitted manuscript.  
 
Additional specific tasks by the PhD student 
- Review (chapter 4): formatting and submitting the 
manuscript 
- DYARA validation paper (chapter 5), Reproducibility 
paper (chapter 6), sex-specific associations (chapter 7), 
IPAQ and carotid stiffness (chapter 8): Study 
conception and design, acquisition of data, contributed 
to the data analysis plan, analysis and interpretation of 
data, drafting of manuscript, formatting and submitting 
the manuscript (except DYARA validation paper).  
(Co-)authors 
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Table A continued 
 
Topic Time Contribution by the PhD student* 
Collaboration 
and contribution 
by the SAPALDIA 
Team 
Doctoral 
training 
2010-
2014 
The academic training was primarily oriented to achieve 
statistical and epidemiological skills in order to manage 
SAPALDIA2 and SAPALDIA3 database analysis. The absolved 
courses exceed the formal requirements for PhD thesis. A 
detailed course list can be found in the curriculum vitae. 
Overall, 34.25 credit points were acquired in 27 courses. 
The gained knowledge was summarised in internal 
presentations (DSBG) 
Mainly SSPH+ 
courses, MPH 
courses, Swiss 
Epidemiology 
Winter School  
Presentations 
excluding 
conferences 
2010-
2014 
Regular presentations (> 20) about past courses or status 
updates and research plans of the PhD project were given 
at the SAPALDIA workshops, in the CIMT Working Group 
Meetings, in the DSBG journal club or the DSBG research 
colloquium.  
 
Past 
conference 
abstracts and 
presentations 
2011-
2014 
Overall, the PhD student attendet in 10 national and 
international conferences. With exception of the first 
conference, 9 different projects were submitted and 
presented by the PhD student. As a result, statistical, 
methodological, writing and presenting skills were 
progressed due to new challenges within each project.  
CIMT Working 
Group Team 
Teaching 
activities by 
the PhD 
student 
2011-
2014 
Please find the teaching activity list in the curriculum vitae. 
Some of the teaching activities within the DSBG were 
specifically related to the PhD project ("Angewandte 
Gefässphysiologie in Bewegung und Gesundheit”).  
 
In a broader perspective, teaching activities for “Writing a 
master thesis in exercise and health sciences: a practical 
approach” was an application of the generated knowledge 
about general project management in SAPALDIA. The PhD 
student built up a new semester course. It was a win-win 
situation for both - the master students and the PhD 
student.  
Prof. Dr. A. 
Schmidt-
Trucksäss, PD Dr. 
H. Hanssen 
PWV database 2010-2011 
Data management - data entry, controlling and cleaning of 
pulse wave velocity data was done analogously to 
ultrasound data. Since the PWV database is now part of 
another PhD project, I did not analyse the data.  
 
 
* supervised by Prof. Dr. med. Arno Schmidt-Trucksäss, CIMT = carotid intima media thickness; DSBG = 
Department of Sport, Exercise and Health; DYARA = DYnamic ARtery Analysis program; SOP = standard 
operating procedures; MPH = Master of Public Health; SSPH+ = Swiss School of Public Health; Swiss TPH = Swiss 
Tropical and Public Health Institute,  
 
 
